>HZ157201.1 JP 2015130862-A/25: Micromirs
ACTACCTC
>HZ157196.1 JP 2015130862-A/20: Micromirs
ATTTGCAC
>HZ157195.1 JP 2015130862-A/19: Micromirs
AGCACTTT
>HZ157193.1 JP 2015130862-A/17: Micromirs
CGTAATGA
>HZ157192.1 JP 2015130862-A/16: Micromirs
GGTAAACT
>HZ157191.1 JP 2015130862-A/15: Micromirs
TCAACATC
>HZ157190.1 JP 2015130862-A/14: Micromirs
ATCAGTCT
>HZ157189.1 JP 2015130862-A/13: Micromirs
TCTGATAA
>HZ157182.1 JP 2015130862-A/6: Micromirs
CACACTCC
>HZ157180.1 JP 2015130862-A/4: Micromirs
TAGCATTA
>HZ157178.1 JP 2015130862-A/2: Micromirs
GATAAGCT
>HZ098654.1 JP 2015513919-A/8: RNA APTAMERS FOR THERAPEUTIC AND DIAGNOSTIC DELIVERY TO PANCREATIC CANCER CELLS
GAATGCCC
>HZ159938.1 JP 2015130862-A/2762: Micromirs
CCAGAGCC
>HZ159937.1 JP 2015130862-A/2761: Micromirs
GGTCACAA
>HZ159936.1 JP 2015130862-A/2760: Micromirs
TGGCAACA
>HZ159935.1 JP 2015130862-A/2759: Micromirs
AGCCCCGC
>HZ159934.1 JP 2015130862-A/2758: Micromirs
CCAGCGAG
>HZ159933.1 JP 2015130862-A/2757: Micromirs
GTCTAGTT
>HZ159932.1 JP 2015130862-A/2756: Micromirs
AAGCTCCT
>HZ159931.1 JP 2015130862-A/2755: Micromirs
GATTTGTT
>HZ159930.1 JP 2015130862-A/2754: Micromirs
GATTTGTT
>HZ159929.1 JP 2015130862-A/2753: Micromirs
AGTCTTCC
>HZ159928.1 JP 2015130862-A/2752: Micromirs
GGCATACA
>HZ159927.1 JP 2015130862-A/2751: Micromirs
TCCGCACC
>HZ159926.1 JP 2015130862-A/2750: Micromirs
GGGCTTCC
>HZ159925.1 JP 2015130862-A/2749: Micromirs
AGAACCGG
>HZ159924.1 JP 2015130862-A/2748: Micromirs
CGAGTGAC
>HZ159923.1 JP 2015130862-A/2747: Micromirs
CCTCCTGG
>HZ159922.1 JP 2015130862-A/2746: Micromirs
CTAGCCAG
>HZ159921.1 JP 2015130862-A/2745: Micromirs
AAATGAAT
>HZ159920.1 JP 2015130862-A/2744: Micromirs
CGGGCCAC
>HZ159919.1 JP 2015130862-A/2743: Micromirs
GCCCCGCC
>HZ159918.1 JP 2015130862-A/2742: Micromirs
AACGTGGG
>HZ159917.1 JP 2015130862-A/2741: Micromirs
ACCCAGGC
>HZ159916.1 JP 2015130862-A/2740: Micromirs
CAATGGGT
>HZ159915.1 JP 2015130862-A/2739: Micromirs
TGAACCAA
>HZ159914.1 JP 2015130862-A/2738: Micromirs
CCCTCCGC
>HZ159913.1 JP 2015130862-A/2737: Micromirs
GAACCTGC
>HZ159912.1 JP 2015130862-A/2736: Micromirs
TATAATAT
>HZ159911.1 JP 2015130862-A/2735: Micromirs
ATGTATTA
>HZ159910.1 JP 2015130862-A/2734: Micromirs
GGCCCACC
>HZ159909.1 JP 2015130862-A/2733: Micromirs
GCAGACAT
>HZ159908.1 JP 2015130862-A/2732: Micromirs
TTTCAACA
>HZ159907.1 JP 2015130862-A/2731: Micromirs
GGCGCCAT
>HZ159906.1 JP 2015130862-A/2730: Micromirs
TATCCTAA
>HZ159905.1 JP 2015130862-A/2729: Micromirs
CTGCCTCC
>HZ159904.1 JP 2015130862-A/2728: Micromirs
CACAGGTT
>HZ159903.1 JP 2015130862-A/2727: Micromirs
TGCACACT
>HZ159902.1 JP 2015130862-A/2726: Micromirs
TGCAGCCA
>HZ159901.1 JP 2015130862-A/2725: Micromirs
CAGCTGCT
>HZ159900.1 JP 2015130862-A/2724: Micromirs
CAGCCTAG
>HZ159899.1 JP 2015130862-A/2723: Micromirs
AGCCACAC
>HZ159898.1 JP 2015130862-A/2722: Micromirs
CATACAAG
>HZ159897.1 JP 2015130862-A/2721: Micromirs
GAGAGGGA
>HZ159896.1 JP 2015130862-A/2720: Micromirs
TATGTCTT
>HZ159895.1 JP 2015130862-A/2719: Micromirs
CTGGATCA
>HZ159894.1 JP 2015130862-A/2718: Micromirs
CGCAGCGA
>HZ159759.1 JP 2015130862-A/2583: Micromirs
CCTTTGCA
>HZ159758.1 JP 2015130862-A/2582: Micromirs
AGCACTTT
>HZ159757.1 JP 2015130862-A/2581: Micromirs
CCTCAAGA
>HZ159756.1 JP 2015130862-A/2580: Micromirs
CCTCTGGA
>HZ159755.1 JP 2015130862-A/2579: Micromirs
AGCGCCTT
>HZ159754.1 JP 2015130862-A/2578: Micromirs
CCTTTGTA
>HZ159753.1 JP 2015130862-A/2577: Micromirs
AGCGCCTT
>HZ159752.1 JP 2015130862-A/2576: Micromirs
AGCGCGTT
>HZ159751.1 JP 2015130862-A/2575: Micromirs
AACCATTT
>HZ159750.1 JP 2015130862-A/2574: Micromirs
AAGTGCGT
>HZ159749.1 JP 2015130862-A/2573: Micromirs
GCACTTTG
>HZ159748.1 JP 2015130862-A/2572: Micromirs
GCACTTTG
>HZ159747.1 JP 2015130862-A/2571: Micromirs
GAAGCACT
>HZ159746.1 JP 2015130862-A/2570: Micromirs
AAGCACTT
>HZ159745.1 JP 2015130862-A/2569: Micromirs
CCTTTGTA
>HZ159744.1 JP 2015130862-A/2568: Micromirs
AAGCACTT
>HZ159743.1 JP 2015130862-A/2567: Micromirs
AAGCACTT
>HZ159742.1 JP 2015130862-A/2566: Micromirs
AAGCACTT
>HZ159741.1 JP 2015130862-A/2565: Micromirs
CCTCTGGA
>HZ159740.1 JP 2015130862-A/2564: Micromirs
AAGCACTT
>HZ159739.1 JP 2015130862-A/2563: Micromirs
TTTGGAGA
>HZ159738.1 JP 2015130862-A/2562: Micromirs
GAGGCACT
>HZ159737.1 JP 2015130862-A/2561: Micromirs
GGCACTTT
>HZ159736.1 JP 2015130862-A/2560: Micromirs
ATGCACTT
>HZ159735.1 JP 2015130862-A/2559: Micromirs
ATGCACTT
>HZ159734.1 JP 2015130862-A/2558: Micromirs
CCTCTAGA
>HZ159733.1 JP 2015130862-A/2557: Micromirs
ATGCACTT
>HZ159732.1 JP 2015130862-A/2556: Micromirs
CCTCTAGA
>HZ159731.1 JP 2015130862-A/2555: Micromirs
AGCGCTTT
>HZ159730.1 JP 2015130862-A/2554: Micromirs
AAGCGCTT
>HZ159729.1 JP 2015130862-A/2553: Micromirs
CCTCTAGA
>HZ159728.1 JP 2015130862-A/2552: Micromirs
AGCGCTTT
>HZ159727.1 JP 2015130862-A/2551: Micromirs
CTCCAGAG
>HZ159726.1 JP 2015130862-A/2550: Micromirs
AGCGCTTT
>HZ159725.1 JP 2015130862-A/2549: Micromirs
AGCGCTTT
>HZ159724.1 JP 2015130862-A/2548: Micromirs
AGCGCTTT
>HZ159723.1 JP 2015130862-A/2547: Micromirs
ATGCACGA
>HZ159722.1 JP 2015130862-A/2546: Micromirs
GATGCACG
>HZ159721.1 JP 2015130862-A/2545: Micromirs
ATGCACGA
>HZ159720.1 JP 2015130862-A/2544: Micromirs
ATCTAGAG
>HZ159719.1 JP 2015130862-A/2543: Micromirs
CCTCCAGA
>HZ159718.1 JP 2015130862-A/2542: Micromirs
CCTCGAGA
>HZ159717.1 JP 2015130862-A/2541: Micromirs
AAGGAAGC
>HZ159716.1 JP 2015130862-A/2540: Micromirs
TTTGGAGA
>HZ159715.1 JP 2015130862-A/2539: Micromirs
AAGGCACT
>HZ159714.1 JP 2015130862-A/2538: Micromirs
AGTGTCAA
>HZ159713.1 JP 2015130862-A/2537: Micromirs
CCTTGAGA
>HZ159712.1 JP 2015130862-A/2536: Micromirs
CCTTGTGA
>HZ159711.1 JP 2015130862-A/2535: Micromirs
CCCTGTGA
>HZ159710.1 JP 2015130862-A/2534: Micromirs
TGAAATTT
>HZ159709.1 JP 2015130862-A/2533: Micromirs
GGCTGAGT
>HZ159708.1 JP 2015130862-A/2532: Micromirs
ACAGCACT
>HZ159707.1 JP 2015130862-A/2531: Micromirs
AAAAGACA
>HZ159706.1 JP 2015130862-A/2530: Micromirs
TCCTGAGT
>HZ159705.1 JP 2015130862-A/2529: Micromirs
TCTGCAGT
>HZ159704.1 JP 2015130862-A/2528: Micromirs
TACCAATC
>HZ159703.1 JP 2015130862-A/2527: Micromirs
TCTGCAGT
>HZ159702.1 JP 2015130862-A/2526: Micromirs
TCTGGAGT
>HZ159701.1 JP 2015130862-A/2525: Micromirs
CTACAATC
>HZ159700.1 JP 2015130862-A/2524: Micromirs
GGTGCAAA
>HZ159699.1 JP 2015130862-A/2523: Micromirs
GGTGCCTT
>HZ159698.1 JP 2015130862-A/2522: Micromirs
CTGGCTCC
>HZ159697.1 JP 2015130862-A/2521: Micromirs
GTGTTGAC
>HZ159696.1 JP 2015130862-A/2520: Micromirs
CCAGGGTC
>HZ159695.1 JP 2015130862-A/2519: Micromirs
CCGCTGCT
>HZ159694.1 JP 2015130862-A/2518: Micromirs
AGCAAGGA
>HZ159693.1 JP 2015130862-A/2517: Micromirs
AGGTGCAT
>HZ159692.1 JP 2015130862-A/2516: Micromirs
CAAAGGAT
>HZ159691.1 JP 2015130862-A/2515: Micromirs
GGGTGCAT
>HZ159690.1 JP 2015130862-A/2514: Micromirs
CAGGTGCA
>HZ159689.1 JP 2015130862-A/2513: Micromirs
CAAGGATT
>HZ159688.1 JP 2015130862-A/2512: Micromirs
AAGTCTTA
>HZ159687.1 JP 2015130862-A/2511: Micromirs
TGTGATGT
>HZ159686.1 JP 2015130862-A/2510: Micromirs
GGCTTGAA
>HZ159685.1 JP 2015130862-A/2509: Micromirs
TGTGGTTT
>HZ159684.1 JP 2015130862-A/2508: Micromirs
GTGCTGCT
>HZ159683.1 JP 2015130862-A/2507: Micromirs
TAATACTC
>HZ159682.1 JP 2015130862-A/2506: Micromirs
TGTTTGTT
>HZ159681.1 JP 2015130862-A/2505: Micromirs
TATGTTTC
>HZ159680.1 JP 2015130862-A/2504: Micromirs
CATGTACA
>HZ159679.1 JP 2015130862-A/2503: Micromirs
AGACCTTC
>HZ159678.1 JP 2015130862-A/2502: Micromirs
GCAGGTCC
>HZ159677.1 JP 2015130862-A/2501: Micromirs
TTCCCCAC
>HZ159676.1 JP 2015130862-A/2500: Micromirs
TTGCATAA
>HZ159675.1 JP 2015130862-A/2499: Micromirs
GATCCATG
>HZ159674.1 JP 2015130862-A/2498: Micromirs
TCCAGGTT
>HZ159673.1 JP 2015130862-A/2497: Micromirs
TGATGTCA
>HZ159672.1 JP 2015130862-A/2496: Micromirs
TTATCTGG
>HZ159671.1 JP 2015130862-A/2495: Micromirs
GCCTTTCA
>HZ159670.1 JP 2015130862-A/2494: Micromirs
TGTACGAT
>HZ159669.1 JP 2015130862-A/2493: Micromirs
TGTATGAT
>HZ159668.1 JP 2015130862-A/2492: Micromirs
AGTACAGG
>HZ159667.1 JP 2015130862-A/2491: Micromirs
GCTGCCCC
>HZ159666.1 JP 2015130862-A/2490: Micromirs
CCAGCCTC
>HZ159665.1 JP 2015130862-A/2489: Micromirs
GTGTATGA
>HZ159664.1 JP 2015130862-A/2488: Micromirs
TGAGCCTG
>HZ159663.1 JP 2015130862-A/2487: Micromirs
TCCCGTCT
>HZ159662.1 JP 2015130862-A/2486: Micromirs
GAGGAGTG
>HZ159661.1 JP 2015130862-A/2485: Micromirs
AGGCACAT
>HZ159660.1 JP 2015130862-A/2484: Micromirs
ATGGACTG
>HZ159659.1 JP 2015130862-A/2483: Micromirs
TGATAGGG
>HZ159658.1 JP 2015130862-A/2482: Micromirs
ATTGCACT
>HZ159657.1 JP 2015130862-A/2481: Micromirs
GGACAACC
>HZ159656.1 JP 2015130862-A/2480: Micromirs
GCAGATGA
>HZ159655.1 JP 2015130862-A/2479: Micromirs
CAAACAGT
>HZ159654.1 JP 2015130862-A/2478: Micromirs
TAACGGTT
>HZ159653.1 JP 2015130862-A/2477: Micromirs
ATTGCAAA
>HZ159652.1 JP 2015130862-A/2476: Micromirs
TGATCCCA
>HZ159651.1 JP 2015130862-A/2475: Micromirs
ATCGCAAA
>HZ159650.1 JP 2015130862-A/2474: Micromirs
ACACTGCC
>HZ159649.1 JP 2015130862-A/2473: Micromirs
ACACTGCC
>HZ159648.1 JP 2015130862-A/2472: Micromirs
CATATGCA
>HZ159647.1 JP 2015130862-A/2471: Micromirs
CATCATGA
>HZ159646.1 JP 2015130862-A/2470: Micromirs
GCCATCCA
>HZ159645.1 JP 2015130862-A/2469: Micromirs
ACTCCAAG
>HZ159644.1 JP 2015130862-A/2468: Micromirs
GACGACCT
>HZ159643.1 JP 2015130862-A/2467: Micromirs
TGCAAGAC
>HZ159642.1 JP 2015130862-A/2466: Micromirs
ACAGTATT
>HZ159641.1 JP 2015130862-A/2465: Micromirs
ATTCCCGA
>HZ159640.1 JP 2015130862-A/2464: Micromirs
CGTGTCAT
>HZ159639.1 JP 2015130862-A/2463: Micromirs
CACGTTTT
>HZ159638.1 JP 2015130862-A/2462: Micromirs
TTGCTGCT
>HZ159637.1 JP 2015130862-A/2461: Micromirs
TGCCCCTC
>HZ159636.1 JP 2015130862-A/2460: Micromirs
GACCGAGC
>HZ159635.1 JP 2015130862-A/2459: Micromirs
AAGTCCAG
>HZ159634.1 JP 2015130862-A/2458: Micromirs
TCTGTTGA
>HZ159633.1 JP 2015130862-A/2457: Micromirs
AGGTGAAG
>HZ159632.1 JP 2015130862-A/2456: Micromirs
TGTTACAT
>HZ159631.1 JP 2015130862-A/2455: Micromirs
GGTCTACT
>HZ159630.1 JP 2015130862-A/2454: Micromirs
TGTTATAT
>HZ159629.1 JP 2015130862-A/2453: Micromirs
GGGTAACC
>HZ159628.1 JP 2015130862-A/2452: Micromirs
GCAACATT
>HZ159627.1 JP 2015130862-A/2451: Micromirs
TCTAGGAA
>HZ159626.1 JP 2015130862-A/2450: Micromirs
TTCTGATC
>HZ159625.1 JP 2015130862-A/2449: Micromirs
AACAACTT
>HZ159624.1 JP 2015130862-A/2448: Micromirs
CCTTGTAT
>HZ159623.1 JP 2015130862-A/2447: Micromirs
GGTCAACC
>HZ159622.1 JP 2015130862-A/2446: Micromirs
TATTACAT
>HZ159621.1 JP 2015130862-A/2445: Micromirs
TGTTACAT
>HZ159620.1 JP 2015130862-A/2444: Micromirs
AGTCTACC
>HZ159619.1 JP 2015130862-A/2443: Micromirs
AGTCAGGA
>HZ159618.1 JP 2015130862-A/2442: Micromirs
AAGTCCAG
>HZ159617.1 JP 2015130862-A/2441: Micromirs
GCAACCTC
>HZ159616.1 JP 2015130862-A/2440: Micromirs
TTGTGTGA
>HZ159615.1 JP 2015130862-A/2439: Micromirs
CTCTATGT
>JE996758.1 Sequence 34 from Patent WO2015113725
TCAGTTCA
>JE996732.1 Sequence 8 from Patent WO2015113725
TCAGTTCA
>JE958059.1 Sequence 6 from Patent EP2668294
CAGGAGCC
>JE958058.1 Sequence 5 from Patent EP2668294
GTATAACA
>JE958057.1 Sequence 4 from Patent EP2668294
ACCAACTG
>JE958056.1 Sequence 3 from Patent EP2668294
CCAGTTAG
>JE958055.1 Sequence 2 from Patent EP2668294
AGTTGCTT
>JE958054.1 Sequence 1 from Patent EP2668294
TTGAGCCT
>HZ073798.1 JP 2014065741-A/1: PROPHYLAXIS AND TREATMENT OF PRDC
CCGCCATG
>HZ059969.1 JP 2015512254-A/21: BORONIC ACID CONJUGATES OF OLIGONUCLEOTIDE ANALOGUES
GCTGGCAG
>JE972213.1 Sequence 1 from Patent EP2859900
CCGCCATG
>JE966882.1 Sequence 16 from Patent WO2015118056
CTGAGATT
>JE966871.1 Sequence 5 from Patent WO2015118056
GTGCACTG
>JE830530.1 Sequence 75 from Patent WO2015075154
GTCTAATT
>JE830529.1 Sequence 74 from Patent WO2015075154
CAGATTAA
>JE830510.1 Sequence 55 from Patent WO2015075154
CACCCCCA
>HZ040705.1 JP 2015510504-A/55: Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
GGTTTTGG
>HZ035285.1 JP 2015098444-A/2: miRNA with inhibitory effect on the glioma formation
TTATAAAG
>HW646376.1 JP 2014205691-A/50: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGTCGTT
>HW646334.1 JP 2014205691-A/8: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGTCGTT
>HW662019.1 JP 2013172750-A/139: Compositions and methods for detection of hepatitis A virus nucleic acid
GAAGAAAG
>HW645724.1 JP 2014196306-A/102: Composition comprising a complexed (m)RNA and a naked mRNA for providing or enhancing an immunostimulatory response in a mammal and uses thereof
TGGATCCA
>HW645723.1 JP 2014196306-A/101: Composition comprising a complexed (m)RNA and a naked mRNA for providing or enhancing an immunostimulatory response in a mammal and uses thereof
ACCTAGGT
>HW645677.1 JP 2014196306-A/55: Composition comprising a complexed (m)RNA and a naked mRNA for providing or enhancing an immunostimulatory response in a mammal and uses thereof
GGTTTTGG
>HW943579.1 JP 2015508661-A/2471: MULTIMODAL PCR TARGET DETECTION
GAGTTCTC
>HW943578.1 JP 2015508661-A/2470: MULTIMODAL PCR TARGET DETECTION
CTTTAGCG
>HW943574.1 JP 2015508661-A/2466: MULTIMODAL PCR TARGET DETECTION
ACTGTCTG
>HW805180.1 JP 2015007059-A/18: MICRO-RNAS OF THE MIR-15 FAMILY MODULATE CARDIOMYOCYTE SURVIVAL AND CARDIAC REPAIR
AGCAGCAC
>HW805101.1 JP 2015015950-A/106: Methods and Agents for Screening for Compounds Capable of Modulating Gene Expression
TATTTATT
>HW766529.1 JP 2014528698-A/192: COMPOSITIONS AND METHOD FOR DETECTING HUMAN PARVOVIRUS NUCLEIC ACID AND FOR DETECTING HEPATITIS A VIRUS NUCLEIC ACIDS IN SINGLE-PLEX OR MULTIPLEX ASSAYS
CTAAAGTC
>DI482211.1 KR 1020140120933-A/69: Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
GGTTTTGG
>HW939594.1 JP 2015509000-A/4: CRYSTAL STRUCTURE OF HCV POLYMERASE COMPLEXES AND METHODS OF USE
TACCCGGN
>HW939593.1 JP 2015509000-A/3: CRYSTAL STRUCTURE OF HCV POLYMERASE COMPLEXES AND METHODS OF USE
TACCCGGG
>HW827877.1 JP 2013539360-A/55: Complexation of nucleic acids with disulfide-linked cationic polymers for transfection and immunostimulation
GGTTTTGG
>HW825054.1 JP 2014014371-A/283: RNAse H-Based Assays Utilizing Modified RNA Monomers
GNNNNNNN
>HW825053.1 JP 2014014371-A/282: RNAse H-Based Assays Utilizing Modified RNA Monomers
TNNNNNNN
>HW825052.1 JP 2014014371-A/281: RNAse H-Based Assays Utilizing Modified RNA Monomers
ANNNNNNN
>HW825051.1 JP 2014014371-A/280: RNAse H-Based Assays Utilizing Modified RNA Monomers
AAGCNNNN
>HW825050.1 JP 2014014371-A/279: RNAse H-Based Assays Utilizing Modified RNA Monomers
AAGCTNNN
>HW798423.1 JP 2014237674-A/10: COMBINATION THERAPY FOR THE TREATMENT OF OCULAR NEOVASCULAR DISORDERS
GTGAATGC
>HW798422.1 JP 2014237674-A/9: COMBINATION THERAPY FOR THE TREATMENT OF OCULAR NEOVASCULAR DISORDERS
TTGGACGC
>HW906498.1 WO 2015030078-A/5: therapeutic agent for corneal epithelium disorder
ACATTTCA
>HW835242.1 JP 2015042177-A/20: USE OF MULTIPLE TRANSFORMATION ENHANCER SEQUENCES TO IMPROVE PLANT TRANSFORMATION EFFICIENCY
TGTWTGTK
>HW666989.1 JP 2013241465-A/1: MULTIVALENT PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS
CCGCCATG
>HW634768.1 JP 2014158477-A/16: COMPOUNDS AND METHODS ASSOCIATED WITH DIFFERENTIAL METHYLATION OF HUMAN PAPILLOMA VIRUS GENOMES IN EPITHELIAL CELLS
TAAGGGTG
>HW634760.1 JP 2014158477-A/8: COMPOUNDS AND METHODS ASSOCIATED WITH DIFFERENTIAL METHYLATION OF HUMAN PAPILLOMA VIRUS GENOMES IN EPITHELIAL CELLS
TAAGGGCG
>HW820772.1 JP 2015502134-A/14: CHIMERIC DOUBLE-STRANDED NUCLEIC ACID
GAATACCA
>HW649487.1 JP 2014523870-A/6: CLEAVABLE LIPIDS
TTTGAATT
>HW663175.1 JP 2013212110-A/3: OLIGONUCLEOTIDE ANALOG AND METHOD FOR TREATING FLAVIVIRUS INFECTIONS
CATATTGA
>HW663173.1 JP 2013212110-A/1: OLIGONUCLEOTIDE ANALOG AND METHOD FOR TREATING FLAVIVIRUS INFECTIONS
TCAATATG
>HW915254.1 JP 2015503343-A/41: METHOD AND CONSTRUCT FOR SYNTHETIC BIDIRECTIONAL SCBV PLANT PROMOTER
CTTGGAGC
>HW915204.1 JP 2015503342-A/40: CONSTRUCT AND METHOD FOR SYTHETIC BIDIRECTIONAL PLANT PROMOTER UBI1
CTTGGAGC
>HW942187.1 JP 2015508661-A/1079: MULTIMODAL PCR TARGET DETECTION
AGATGCTC
>HW941865.1 JP 2015508661-A/757: MULTIMODAL PCR TARGET DETECTION
TTTTGCAA
>HW914702.1 JP 2015504650-A/41: INDUCED EXON INCLUSION IN SPINAL MUSCLE ATROPHY
GCTGGCAG
>HW914701.1 JP 2015504650-A/40: INDUCED EXON INCLUSION IN SPINAL MUSCLE ATROPHY
GCTGGCAG
>HW914700.1 JP 2015504650-A/39: INDUCED EXON INCLUSION IN SPINAL MUSCLE ATROPHY
GCTGGCAG
>HW914699.1 JP 2015504650-A/38: INDUCED EXON INCLUSION IN SPINAL MUSCLE ATROPHY
GCTGGCAG
>HW914698.1 JP 2015504650-A/37: INDUCED EXON INCLUSION IN SPINAL MUSCLE ATROPHY
GCTGGCAG
>HW914697.1 JP 2015504650-A/36: INDUCED EXON INCLUSION IN SPINAL MUSCLE ATROPHY
GCTGGCAG
>HW914696.1 JP 2015504650-A/35: INDUCED EXON INCLUSION IN SPINAL MUSCLE ATROPHY
GCTGGCAG
>HW914695.1 JP 2015504650-A/34: INDUCED EXON INCLUSION IN SPINAL MUSCLE ATROPHY
GCTGGCAG
>HW914694.1 JP 2015504650-A/33: INDUCED EXON INCLUSION IN SPINAL MUSCLE ATROPHY
GCTGGCAG
>HW941361.1 JP 2015508661-A/253: MULTIMODAL PCR TARGET DETECTION
TAATTATT
>HW636989.1 WO 2014142092-A/9: New PI polyamide
WCWCGWGW
>HW636988.1 WO 2014142092-A/8: New PI polyamide
WCWCGWGW
>HW809688.1 JP 2014533111-A/129: Sequences and their use for detection of Salmonella
GGGCCCTT
>HW809686.1 JP 2014533111-A/127: Sequences and their use for detection of Salmonella
GCGGCCGT
>HW809685.1 JP 2014533111-A/126: Sequences and their use for detection of Salmonella
CGGCGCCT
>HW809683.1 JP 2014533111-A/124: Sequences and their use for detection of Salmonella
GGGGCCCT
>HW809679.1 JP 2014533111-A/120: Sequences and their use for detection of Salmonella
GGGTCCCT
>HW809677.1 JP 2014533111-A/118: Sequences and their use for detection of Salmonella
AAGGGCCC
>HW809675.1 JP 2014533111-A/116: Sequences and their use for detection of Salmonella
ACGGCCGC
>HW809674.1 JP 2014533111-A/115: Sequences and their use for detection of Salmonella
AGGCGCCG
>HW809673.1 JP 2014533111-A/114: Sequences and their use for detection of Salmonella
AGGGCCCC
>HW809671.1 JP 2014533111-A/112: Sequences and their use for detection of Salmonella
AGGGACCC
>HW835228.1 JP 2015042177-A/6: USE OF MULTIPLE TRANSFORMATION ENHANCER SEQUENCES TO IMPROVE PLANT TRANSFORMATION EFFICIENCY
CTGACGAA
>HW632495.1 JP 2014173032-A/9: New PI polyamide
WCWCGWGW
>HW632494.1 JP 2014173032-A/8: New PI polyamide
WCWCGWGW
>HW648893.1 JP 2014523235-A/4: Bilirubin Oxydase from Magnaporthe oryzae and applications thereof
GCGGCCGC
>DI449202.1 KR 1020140107334-A/40: CONSTRUCT AND METHOD FOR SYNTHETIC BIDIRECTIONAL PLANT PROMOTER UBI1
CTTGGAGC
>DI449153.1 KR 1020140109909-A/41: METHOD AND CONSTRUCT FOR SYNTHETIC BIDIRECTIONAL SCBV PLANT PROMOTER
CTTGGAGC
>DI484658.1 KR 1020140120944-A/1: PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS
CCGCCATG
>JD688094.1 Sequence 89025 from Patent EP2850187
CTGTTCAA
>JD688093.1 Sequence 89024 from Patent EP2850187
GCCTTTTG
>JD688090.1 Sequence 89021 from Patent EP2850187
CCAACCAT
>JD688089.1 Sequence 89020 from Patent EP2850187
AGCCCTGT
>JC990426.1 Sequence 12 from Patent EP2686451
WGAAATCT
>JC985841.1 Sequence 9 from Patent WO2014179446
CACACTCC
>JC963571.1 Sequence 35 from Patent WO2014167282
TTCNNGAA
>JC963563.1 Sequence 27 from Patent WO2014167282
RYGRYGGT
>JC963562.1 Sequence 26 from Patent WO2014167282
TGACGTCA
>JC962039.1 Sequence 83 from Patent WO2014018512
CCACCATG
>JC962037.1 Sequence 81 from Patent WO2014018512
CCACCATG
>JC962030.1 Sequence 74 from Patent WO2014018512
AACCAATG
>JC962029.1 Sequence 73 from Patent WO2014018512
AAACAATG
>JC962028.1 Sequence 72 from Patent WO2014018512
AACAAATG
>JC962027.1 Sequence 71 from Patent WO2014018512
CAAACATG
>JC962026.1 Sequence 70 from Patent WO2014018512
AAAACATG
>JC962025.1 Sequence 69 from Patent WO2014018512
CAAAAATG
>JC962024.1 Sequence 68 from Patent WO2014018512
AAAAAATG
>JC955867.1 Sequence 13 from Patent WO2014142984
TGACGTCA
>HW615550.1 JP 2014516562-A/29: CULTURE MEDIA FOR STEM CELLS
ACTCCCAG
>HW615547.1 JP 2014516562-A/26: CULTURE MEDIA FOR STEM CELLS
GGATGGAG
>HW615544.1 JP 2014516562-A/23: CULTURE MEDIA FOR STEM CELLS
TGGTGGAG
>HW615541.1 JP 2014516562-A/20: CULTURE MEDIA FOR STEM CELLS
GGTGGTGG
>HW615536.1 JP 2014516562-A/15: CULTURE MEDIA FOR STEM CELLS
TTGCCCAG
>HW615533.1 JP 2014516562-A/12: CULTURE MEDIA FOR STEM CELLS
AGGAGCAG
>HW615530.1 JP 2014516562-A/9: CULTURE MEDIA FOR STEM CELLS
CCTCCTGG
>HW615527.1 JP 2014516562-A/6: CULTURE MEDIA FOR STEM CELLS
TGGCTCTG
>HW615524.1 JP 2014516562-A/3: CULTURE MEDIA FOR STEM CELLS
GCAGCCAG
>HW614093.1 JP 2014516027-A/12: METHODS OF MODULATING MICRORNAS IN THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
AACTGGAC
>HW612980.1 WO 2014126254-A/6: Membrane bound type protein expression vector
TCTTTCCT
>DI394569.1 KR 1020140020968-A/177: PLANT REGULATORY ELEMENTS AND USES THEREOF
ACACGCTG
>DI378657.1 KR 1020140064399-A/2: SINGLE STRANDED DNA APTAMERS SPECIFICALLY BINDING TO SALMONELLA TYPHIMURIUM AND PRODUCTION METHOD THEREOF
GCGTGCGG
>DI378037.1 KR 1020140061138-A/20: Polynucleotide and use thereof
GTCGTATC
>DI393652.1 KR 1020140015455-A/151: APTAMERS FOR CLOSTRIDIUM DIFFICILE DIAGNOSTICS
NNANANCN
>DI408299.1 KR 1020140059256-A/30: METHODS FOR TAGGING DNA-ENCODED LIBRARIES
CAGTGTCA
>DI408290.1 KR 1020140059256-A/15: METHODS FOR TAGGING DNA-ENCODED LIBRARIES
CAGACTGG
>DI408289.1 KR 1020140059256-A/14: METHODS FOR TAGGING DNA-ENCODED LIBRARIES
GTGAGTGC
>DI389490.1 KR 1020140014103-A/255: Compositions comprising anti-IGF-1 receptor antibodies and methods for obtaining said antibodies
DYKDDDDK
>DI388711.1 KR 1020140001229-A/18: Recombinant expression vector elements(rEVEs) for enhancing expression of recombinant proteins in host cells
AATATATT
>DI402992.1 KR 1020140019479-A/1: Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
CCGCCATG
>DI402399.1 KR 1020140037210-A/30: CULTURE MEDIA FOR STEM CELLS
ACTCCCAG
>DI402396.1 KR 1020140037210-A/27: CULTURE MEDIA FOR STEM CELLS
GGATGGAG
>DI402393.1 KR 1020140037210-A/24: CULTURE MEDIA FOR STEM CELLS
TGGTGGAG
>DI402390.1 KR 1020140037210-A/21: CULTURE MEDIA FOR STEM CELLS
GGTGGTGG
>DI402385.1 KR 1020140037210-A/16: CULTURE MEDIA FOR STEM CELLS
TTGCCCAG
>DI402382.1 KR 1020140037210-A/13: CULTURE MEDIA FOR STEM CELLS
AGGAGCAG
>DI402379.1 KR 1020140037210-A/10: CULTURE MEDIA FOR STEM CELLS
CCTCCTGG
>DI402376.1 KR 1020140037210-A/7: CULTURE MEDIA FOR STEM CELLS
TGGCTCTG
>DI402373.1 KR 1020140037210-A/4: CULTURE MEDIA FOR STEM CELLS
GCAGCCAG
>DI399179.1 KR 1020130137725-A/33: OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
TTCGCGAA
>DI399171.1 KR 1020130137725-A/24: OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
AGGCTTTA
>DI399170.1 KR 1020130137725-A/23: OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
TAGCAGTG
>DI399169.1 KR 1020130137725-A/22: OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
CAGCGATA
>DI399168.1 KR 1020130137725-A/21: OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
GTGCAGCA
>DI399165.1 KR 1020130137725-A/18: OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
GCGCCGAC
>DI399164.1 KR 1020130137725-A/17: OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
AGCAGCAT
>DI399163.1 KR 1020130137725-A/16: OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
CGGGCGGC
>DI399159.1 KR 1020130137725-A/12: OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
GCTCGGCT
>DI399158.1 KR 1020130137725-A/11: OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
CGGCCCGG
>DI399157.1 KR 1020130137725-A/10: OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
TGCCGGCT
>DI399156.1 KR 1020130137725-A/9: OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
TGCCTCGT
>DI399155.1 KR 1020130137725-A/8: OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
TTCGCGAA
>DI399151.1 KR 1020130137725-A/4: OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
GTGNAGNA
>DI399149.1 KR 1020130137725-A/2: OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
TGCCTNGT
>HW609602.1 JP 2014515268-A/16: Detection of Methicillin-Resistant Staphylococcus Aureus
TTTTTTTN
>HW608875.1 JP 2014513938-A/77: CLONAL STRAINS OF ATTENUATED VACCINIA VIRUSES AND METHODS OF USE THEREOF
GCGGCCGC
>HW608205.1 JP 2014513929-A/151: APTAMERS FOR C. DIFFICILE DIAGNOSTICS
NNANANCN
>HW588188.1 JP 2013116116-A/126: Identification of Clonal Cells by Repeats in T-Cell Receptor V/D/J Genes
CTAACTGG
>HW599037.1 JP 2013530154-A/38: OLIGONUCLEOTIDE ANALOGUES HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS
GCTGGCAG
>HW596400.1 JP 2013166791-A/3: KALLIKREIN INHIBITORS AND USES THEREOF
TTCGCGAA
>HW580548.1 JP 2014511180-A/35: DELIVERY OF PROTEINS USING ADENO-ASSOCIATED VIRUS (AAV) VECTORS
GCGGCCGC
>HW576675.1 JP 2014103948-A/1: A method for specifically amplifying a target DNA
ACAAGCCC
>JC739826.1 Sequence 64 from Patent WO2014052931
TNCTCCTT
>JC739795.1 Sequence 33 from Patent WO2014052931
TCCTTGAG
>JC573478.1 Sequence 25 from Patent EP2723866
TGTGTGTG
>JC584451.1 Sequence 13 from Patent EP2723906
GCCTCGCC
>JC584449.1 Sequence 11 from Patent EP2723906
TATGCATG
>JC614073.1 Sequence 72 from Patent WO2014059260
ATGTTGTG
>JC614069.1 Sequence 68 from Patent WO2014059260
ACACTGAG
>JC614068.1 Sequence 67 from Patent WO2014059260
GTTTCAAG
>JC611354.1 Sequence 10 from Patent EP2702998
AAGACCCA
>JC598988.1 Sequence 2 from Patent WO2014070767
TCATACTA
>JC598987.1 Sequence 1 from Patent WO2014070767
ACTACCTC
>JC582993.1 Sequence 20 from Patent EP2723902
AATAATAT
>JC538212.1 Sequence 5 from Patent EP2700719
TGGCTCTG
>JC505486.1 Sequence 30 from Patent EP2748357
CAGTGTCA
>JC505471.1 Sequence 15 from Patent EP2748357
CAGACTGG
>JC505470.1 Sequence 14 from Patent EP2748357
GTGAGTGC
>JC537507.1 Sequence 12 from Patent WO2014062635
AAGCTTTT
>JC530933.1 Sequence 71 from Patent WO2014082993
TTGCTATA
>JC529954.1 Sequence 139 from Patent EP2699078
CCACGTGG
>JC527373.1 Sequence 570 from Patent WO2014085621
GGCGCGCC
>JC477206.1 Sequence 43 from Patent EP2739737
WTGCTACC
>JC477194.1 Sequence 31 from Patent EP2739737
WTTGTTTC
>JC504974.1 Sequence 43 from Patent WO2014110163
ANAAANAA
>JC518270.1 Sequence 177 from Patent EP2733152
ACACGCTG
>HW533909.1 JP 2014510265-A/107: Methods and Compositions Relating to Inhibition of IGF-1R
DYKDDDDK
>BD354857.1 WO 2003070954-A/7: Transcription factor, transcription factor gene, recombinant vector containing transcription factor gene, Aspergillus oryzae transformed by the vector and method for use of Aspergillus oryzae
ACCTGCCC
>BD306658.1 WO 2003041495-A/7: Chimeric Non-Human Animal
AGTCGACA
>BD392987.1 WO 2003089466-A/93: A novel protein and DNA encoding it
TCATTGTT
>BD392969.1 WO 2003089466-A/75: A novel protein and DNA encoding it
ATGCAAAT
>BD392964.1 WO 2003089466-A/70: A novel protein and DNA encoding it
GGACCTGC
>BD392963.1 WO 2003089466-A/69: A novel protein and DNA encoding it
TTGGGAGG
>BD142362.1 WO 2002018602-A/6: Novel polypeptide
CTCTAAAG
>BD093202.1 WO 2001000848-A/12: Useful polypeptide
CTCTAAAG
>BD092167.1 WO 2000079275-A/41: Diagnostic and therapeutic agents for the diseases related monocytes and macrophages
CTCTAGAG
>HW521581.1 JP 2014057597-A/577: Targeted Whole Genome Amplification Method for Identification of Pathogens
TTCCGTAA
>HW521554.1 JP 2014057597-A/550: Targeted Whole Genome Amplification Method for Identification of Pathogens
TCGTATTG
>HW521549.1 JP 2014057597-A/545: Targeted Whole Genome Amplification Method for Identification of Pathogens
TCCGCTAA
>HW521541.1 JP 2014057597-A/537: Targeted Whole Genome Amplification Method for Identification of Pathogens
TATTCGCT
>HW521540.1 JP 2014057597-A/536: Targeted Whole Genome Amplification Method for Identification of Pathogens
TATTAGCG
>HW521532.1 JP 2014057597-A/528: Targeted Whole Genome Amplification Method for Identification of Pathogens
TACTCGTT
>HW521529.1 JP 2014057597-A/525: Targeted Whole Genome Amplification Method for Identification of Pathogens
TACCGTTA
>HW521525.1 JP 2014057597-A/521: Targeted Whole Genome Amplification Method for Identification of Pathogens
TAATCGYA
>HW521524.1 JP 2014057597-A/520: Targeted Whole Genome Amplification Method for Identification of Pathogens
TAATAMCG
>HW521508.1 JP 2014057597-A/504: Targeted Whole Genome Amplification Method for Identification of Pathogens
GCGTAATA
>HW521482.1 JP 2014057597-A/478: Targeted Whole Genome Amplification Method for Identification of Pathogens
CTTCGTAA
>HW521479.1 JP 2014057597-A/475: Targeted Whole Genome Amplification Method for Identification of Pathogens
CTATCGTA
>HW521476.1 JP 2014057597-A/472: Targeted Whole Genome Amplification Method for Identification of Pathogens
CGTATAAC
>HW521475.1 JP 2014057597-A/471: Targeted Whole Genome Amplification Method for Identification of Pathogens
CGTAATAT
>HW521473.1 JP 2014057597-A/469: Targeted Whole Genome Amplification Method for Identification of Pathogens
CGGTAAAT
>HW521459.1 JP 2014057597-A/455: Targeted Whole Genome Amplification Method for Identification of Pathogens
CATACGAA
>HW521440.1 JP 2014057597-A/436: Targeted Whole Genome Amplification Method for Identification of Pathogens
ATTAACGC
>HW521437.1 JP 2014057597-A/433: Targeted Whole Genome Amplification Method for Identification of Pathogens
ATGAAGCG
>HW521436.1 JP 2014057597-A/432: Targeted Whole Genome Amplification Method for Identification of Pathogens
ATCCGTTA
>HW521435.1 JP 2014057597-A/431: Targeted Whole Genome Amplification Method for Identification of Pathogens
ATCATACG
>HW521430.1 JP 2014057597-A/426: Targeted Whole Genome Amplification Method for Identification of Pathogens
ATACGGAA
>HW521429.1 JP 2014057597-A/425: Targeted Whole Genome Amplification Method for Identification of Pathogens
ATACGATG
>HW521420.1 JP 2014057597-A/416: Targeted Whole Genome Amplification Method for Identification of Pathogens
AATCGCTA
>HW521379.1 JP 2014057597-A/375: Targeted Whole Genome Amplification Method for Identification of Pathogens
GGTTTAAC
>HW521376.1 JP 2014057597-A/372: Targeted Whole Genome Amplification Method for Identification of Pathogens
GGCATTAC
>HW521363.1 JP 2014057597-A/359: Targeted Whole Genome Amplification Method for Identification of Pathogens
GCCTTTAC
>HW521362.1 JP 2014057597-A/358: Targeted Whole Genome Amplification Method for Identification of Pathogens
GCAATAAC
>HW521322.1 JP 2014057597-A/318: Targeted Whole Genome Amplification Method for Identification of Pathogens
CGATTGCG
>HW521296.1 JP 2014057597-A/292: Targeted Whole Genome Amplification Method for Identification of Pathogens
ATTATCGG
>HW521294.1 JP 2014057597-A/290: Targeted Whole Genome Amplification Method for Identification of Pathogens
ATTACCGC
>HW521256.1 JP 2014057597-A/252: Targeted Whole Genome Amplification Method for Identification of Pathogens
ACGTTTAT
>HW521247.1 JP 2014057597-A/243: Targeted Whole Genome Amplification Method for Identification of Pathogens
AATTAACG
>HW521246.1 JP 2014057597-A/242: Targeted Whole Genome Amplification Method for Identification of Pathogens
AATGCGGT
>HW521224.1 JP 2014057597-A/220: Targeted Whole Genome Amplification Method for Identification of Pathogens
AACGATTG
>HW521207.1 JP 2014057597-A/203: Targeted Whole Genome Amplification Method for Identification of Pathogens
AAAACGCT
>HW521179.1 JP 2014057597-A/175: Targeted Whole Genome Amplification Method for Identification of Pathogens
ATTTTTTT
>HW521178.1 JP 2014057597-A/174: Targeted Whole Genome Amplification Method for Identification of Pathogens
AATTTTTT
>HW521177.1 JP 2014057597-A/173: Targeted Whole Genome Amplification Method for Identification of Pathogens
AAATTTTT
>HW521176.1 JP 2014057597-A/172: Targeted Whole Genome Amplification Method for Identification of Pathogens
AAAATTTT
>HW521175.1 JP 2014057597-A/171: Targeted Whole Genome Amplification Method for Identification of Pathogens
AAAAATTT
>HW521174.1 JP 2014057597-A/170: Targeted Whole Genome Amplification Method for Identification of Pathogens
AAAAAATT
>HW521173.1 JP 2014057597-A/169: Targeted Whole Genome Amplification Method for Identification of Pathogens
AAAAAAAT
>HW521156.1 JP 2014057597-A/152: Targeted Whole Genome Amplification Method for Identification of Pathogens
TTTTTTTT
>HW521089.1 JP 2014057597-A/85: Targeted Whole Genome Amplification Method for Identification of Pathogens
TTTTTTTC
>HW521088.1 JP 2014057597-A/84: Targeted Whole Genome Amplification Method for Identification of Pathogens
TTTTTTCC
>HW521087.1 JP 2014057597-A/83: Targeted Whole Genome Amplification Method for Identification of Pathogens
TTTTTCCC
>HW521086.1 JP 2014057597-A/82: Targeted Whole Genome Amplification Method for Identification of Pathogens
TTTTCCCC
>HW521085.1 JP 2014057597-A/81: Targeted Whole Genome Amplification Method for Identification of Pathogens
TTTCCCCC
>HW521084.1 JP 2014057597-A/80: Targeted Whole Genome Amplification Method for Identification of Pathogens
TTCCCCCC
>HW521083.1 JP 2014057597-A/79: Targeted Whole Genome Amplification Method for Identification of Pathogens
TCCCCCCC
>HW521082.1 JP 2014057597-A/78: Targeted Whole Genome Amplification Method for Identification of Pathogens
CGGGGGGG
>HW521081.1 JP 2014057597-A/77: Targeted Whole Genome Amplification Method for Identification of Pathogens
CCGGGGGG
>HW521080.1 JP 2014057597-A/76: Targeted Whole Genome Amplification Method for Identification of Pathogens
CCCGGGGG
>HW521079.1 JP 2014057597-A/75: Targeted Whole Genome Amplification Method for Identification of Pathogens
CCCCGGGG
>HW521078.1 JP 2014057597-A/74: Targeted Whole Genome Amplification Method for Identification of Pathogens
CCCCCGGG
>HW521077.1 JP 2014057597-A/73: Targeted Whole Genome Amplification Method for Identification of Pathogens
CCCCCCGG
>HW521076.1 JP 2014057597-A/72: Targeted Whole Genome Amplification Method for Identification of Pathogens
CCCCCCCG
>HW521050.1 JP 2014057597-A/46: Targeted Whole Genome Amplification Method for Identification of Pathogens
GGGGGGGG
>HW521049.1 JP 2014057597-A/45: Targeted Whole Genome Amplification Method for Identification of Pathogens
CCCCCCCC
>HW521019.1 JP 2014057597-A/15: Targeted Whole Genome Amplification Method for Identification of Pathogens
AAAAAAAA
>HW521009.1 JP 2014057597-A/5: Targeted Whole Genome Amplification Method for Identification of Pathogens
AATTCCGG
>HW509613.1 JP 2014057579-A/7: AAV VIRIONS WITH DECREASED IMMUNOREACTIVITY AND USES THEREFOR
CCTGCAGG
>DI339819.1 KR 1020130105006-A/16: Method for analyzing regulatory sequence of gene expression in microgravity
TAGTGGAT
>DI353894.1 KR 1020130124267-A/2: Nucleic Acid Aptamer Capable of Specifically Binding to Tetracyclines Compound and Use thereof
CGGTGGTG
>DI353893.1 KR 1020130124267-A/1: Nucleic Acid Aptamer Capable of Specifically Binding to Tetracyclines Compound and Use thereof
CGCTGGTG
>DI351154.1 KR 1020130118227-A/38: OLIGONUCLEOTIDE ANALOGUES HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS
GCTGGCAG
>DI357726.1 KR 1020130024978-A/1: PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS
CCGCCATG
>DI359190.1 KR 1020130090893-A/2: PROCESS
GATAAGCT
>DI368888.1 KR 1020130113544-A/1: PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS
CCGCCATG
>HW502780.1 WO 2014045674-A/11: DNA Having Neuronal Activity-Dependent Promoter Activity and Vector Comprising the Same
TGACGTCA
>HW476093.1 JP 2013027401-A/16: High Throughput Genome Sequencing on DNA Arrays
AGCTANNN
>HW480777.1 JP 2013049698-A/3: PREVENTION AND REDUCTION OF BLOOD LOSS
TTCGCGAA
>HW480431.1 JP 2013067655-A/1: USE OF A PCV2 IMMUNOGENIC COMPOSITION FOR LESSENING CLINICAL SYMPTOMS IN PIGS
CCGCCATG
>HW472359.1 JP 2013005814-A/3: METHOD OF GENERATING COSMETIC PRODUCT FOR SKIN CARE
GTAAGAGK
>HW464879.1 JP 2014031373-A/6: STABILIZED IMMUNE MODULATORY RNA (SIMRA) COMPOUNDS FOR TLR7 AND TLR8
TGCTGCTT
>HW467129.1 JP 2014033674-A/1558: COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF APOB
GCCACCAA
>HW413335.1 JP 2014012014-A/18: RECOMBINANT EXPRESSION VECTOR ELEMENTS (REVES) FOR ENHANCING EXPRESSION OF RECOMBINANT PROTEINS IN HOST CELLS
AATATATT
>HW410995.1 JP 2014003980-A/27: DISEASE RESISTANT PLANTS
CAGCCTTT
>HW390714.1 JP 2013240279-A/2: The oligonucleotide containing the functional element on a NXF gene promoter, and its use
ATGACTCA
>HW390713.1 JP 2013240279-A/1: The oligonucleotide containing the functional element on a NXF gene promoter, and its use
GTGACTCA
>HW381754.1 JP 2013234135-A/12: New PI polyamide
WCWCGWGW
>HW381753.1 JP 2013234135-A/11: New PI polyamide
WCWCGWGW
>HW381752.1 JP 2013234135-A/10: New PI polyamide
WCWWCCCW
>HW381751.1 JP 2013234135-A/9: New PI polyamide
WGGGWWGW
>HW381746.1 JP 2013234135-A/4: New PI polyamide
WWGWGGGW
>HW381745.1 JP 2013234135-A/3: New PI polyamide
WCCCWCWW
>FW348784.1 JP 2010053132-A/14: Compositions and methods for generating chimeric heteromultimers
TAAGGAGG
>HW364795.1 JP 2012175982-A/5: NUCLEIC ACID BINDING POLYPEPTIDE LIBRARY
NNNNGGCG
>JC427588.1 Sequence 20 from Patent EP2536436
TAACGGTT
>JC427574.1 Sequence 6 from Patent EP2536436
AACGGTTT
>JC371826.1 Sequence 5396 from Patent EP2470660
AGTATCCT
>JC371809.1 Sequence 5379 from Patent EP2470660
TTTACCAC
>JC371651.1 Sequence 5221 from Patent EP2470660
AATATCAC
>JC371639.1 Sequence 5209 from Patent EP2470660
ATTAATTT
>JC371567.1 Sequence 5137 from Patent EP2470660
GTGAAAAT
>JC371534.1 Sequence 5104 from Patent EP2470660
AATATCAC
>JC371470.1 Sequence 5040 from Patent EP2470660
ACCGCCAA
>JC371377.1 Sequence 4947 from Patent EP2470660
CAGTGGAA
>JC371325.1 Sequence 4895 from Patent EP2470660
TACATGAA
>JC371323.1 Sequence 4893 from Patent EP2470660
AACATTCC
>JC371030.1 Sequence 4600 from Patent EP2470660
AATAAGAA
>JC371019.1 Sequence 4589 from Patent EP2470660
TGTTAAAT
>JC258420.1 Sequence 118 from Patent EP2361979
CCGNNGGC
>JC258415.1 Sequence 113 from Patent EP2361979
CCGGTGGC
>JC258411.1 Sequence 109 from Patent EP2361979
CCGCAGGC
>JC258404.1 Sequence 102 from Patent EP2361979
CCGGTGGC
>JC258400.1 Sequence 98 from Patent EP2361979
CCGCGGGC
>JC258417.1 Sequence 115 from Patent EP2361979
CCGGTGGC
>JC258409.1 Sequence 107 from Patent EP2361979
CCGCGGGC
>JC258406.1 Sequence 104 from Patent EP2361979
CCGACGGC
>JC258402.1 Sequence 100 from Patent EP2361979
CCGCAGGC
>JC258398.1 Sequence 96 from Patent EP2361979
CCGAGGGC
>JC370941.1 Sequence 4511 from Patent EP2470660
TTAAAAAA
>JC370881.1 Sequence 4451 from Patent EP2470660
TTTTTTAA
>JC370628.1 Sequence 4198 from Patent EP2470660
GTATTGAA
>JC370204.1 Sequence 3774 from Patent EP2470660
AAAAAAAT
>JC370155.1 Sequence 3725 from Patent EP2470660
TTCAAGCT
>JC370081.1 Sequence 3651 from Patent EP2470660
GATGTTTT
>JC369639.1 Sequence 3209 from Patent EP2470660
ATTATTTG
>JC471687.1 Sequence 12 from Patent EP2420571
TATATTAT
>JC312059.1 Sequence 177 from Patent WO2012134921
ACACGCTG
>JC265702.1 Sequence 72 from Patent WO2013017542
GGCAGTGT
>JC272065.1 Sequence 14 from Patent WO2011157294
AGCAGCAA
>JC272062.1 Sequence 11 from Patent WO2011157294
AGCAGCAT
>JC245725.1 Sequence 86 from Patent EP2325209
ACGTRAGT
>JC208656.1 Sequence 7 from Patent WO2012007919
YACGTGGC
>JC208653.1 Sequence 4 from Patent WO2012007919
CACGTGGC
>JC208652.1 Sequence 3 from Patent WO2012007919
TACGTGTC
>JC208651.1 Sequence 2 from Patent WO2012007919
YACGTGKC
>JC106134.1 Sequence 47 from Patent WO2013177287
GGCGCGCC
>JC106133.1 Sequence 46 from Patent WO2013177287
TTAATTAA
>JC101446.1 Sequence 41 from Patent WO2013181615
GTTACTGV
>HW340372.1 JP 2013198488-A/113: METHODS FOR SELECTING MEDICATIONS
GGCTGCGC
>HW340353.1 JP 2013198488-A/94: METHODS FOR SELECTING MEDICATIONS
GGCGCGGC
>HW340352.1 JP 2013198488-A/93: METHODS FOR SELECTING MEDICATIONS
GGCGCGGG
>HW349994.1 JP 2013534908-A/7: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS
ATCTTGCC
>HW349989.1 JP 2013534908-A/2: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS
GGCAAGAT
>HW348958.1 WO 2013157410-A/4: FZD10 Binding Peptides
GGCAGCAG
>HW355228.1 JP 2013534132-A/2: Process
GATAAGCT
>JC048814.1 Sequence 68 from Patent EP2653559
GTCGTATC
>JC060379.1 Sequence 55 from Patent EP2650368
GGTTTTGG
>JC047955.1 Sequence 28 from Patent EP2660317
TCTGTAAA
>JC047954.1 Sequence 27 from Patent EP2660317
TTTACAGA
>JC047951.1 Sequence 24 from Patent EP2660317
GTTCCGGC
>JC047950.1 Sequence 23 from Patent EP2660317
GCCGGAAC
>JC040192.1 Sequence 63 from Patent WO2013186398
GCATGTGC
>JC019515.1 Sequence 29 from Patent EP2676676
TTAATTAA
>JC002538.1 Sequence 1 from Patent EP2254595
CCGCCATG
>JC002521.1 Sequence 8 from Patent EP2591800
TCAACGTT
>JB973471.1 Sequence 7 from Patent EP2683411
TTACTTGA
>JB973022.1 Sequence 125 from Patent EP2683729
ANNNANNA
>JB972908.1 Sequence 11 from Patent EP2683729
AAAGNAGG
>JB974572.1 Sequence 35 from Patent EP2678433
GCGGCCGC
>HW329145.1 JP 2013532141-A/15: REGULATION OF METABOLISM BY miR-378
GTCAGGAG
>HW329138.1 JP 2013532141-A/8: REGULATION OF METABOLISM BY miR-378
AGTCCAGT
>HW313890.1 JP 2013530160-A/20: ANTIMIR-451 FOR THE TREATMENT OF POLYCYTHEMIAS
TAACGGTT
>HW313876.1 JP 2013530160-A/6: ANTIMIR-451 FOR THE TREATMENT OF POLYCYTHEMIAS
AACGGTTT
>HW106547.1 JP 2012017344-A/18: Microparticles with Adsorbent Surfaces, Methods of Making Same and Uses Thereof
TCTTCGAA
>HW106546.1 JP 2012017344-A/17: Microparticles with Adsorbent Surfaces, Methods of Making Same and Uses Thereof
TCATCGAT
>HW106545.1 JP 2012017344-A/16: Microparticles with Adsorbent Surfaces, Methods of Making Same and Uses Thereof
TCAACGCT
>HW106544.1 JP 2012017344-A/15: Microparticles with Adsorbent Surfaces, Methods of Making Same and Uses Thereof
TCAGCGCT
>HW106543.1 JP 2012017344-A/14: Microparticles with Adsorbent Surfaces, Methods of Making Same and Uses Thereof
TCGACGTC
>HW106542.1 JP 2012017344-A/13: Microparticles with Adsorbent Surfaces, Methods of Making Same and Uses Thereof
GCAACGTT
>HW106541.1 JP 2012017344-A/12: Microparticles with Adsorbent Surfaces, Methods of Making Same and Uses Thereof
TCAACGTT
>HW058208.1 WO 2012165653-A/10: An improved oligonucleotide and a pharmaceutical composition containing the oligonucleotide
CTAACCCT
>HW055355.1 JP 2012524526-A/23: Universal Tags, Probes and Detection Methods for Multiple Targets Detection of Biomolecules
AGGTCGCA
>HV780019.1 JP 2012514475-A/201: Recurrent Gene Fusions in Cancer
CAATGAGC
>HV779958.1 JP 2012514475-A/140: Recurrent Gene Fusions in Cancer
GGTGCCTG
>HV779935.1 JP 2012514475-A/117: Recurrent Gene Fusions in Cancer
AGAGAGGA
>HV775536.1 JP 2012511031-A/6: COMPOSITIONS AND METHODS RELATING TO miR-31
TCGGCGCA
>HV775535.1 JP 2012511031-A/5: COMPOSITIONS AND METHODS RELATING TO miR-31
TCTTGCCA
>HW287603.1 JP 2013138674-A/17: METHOD FOR MAKING TARGETED THERAPEUTIC AGENTS
NCTAAANC
>HW287597.1 JP 2013138674-A/11: METHOD FOR MAKING TARGETED THERAPEUTIC AGENTS
NCTAACNC
>HW290115.1 JP 2013526840-A/4: Recombinant Butyrylcholinesterases and Truncates Thereof
GCTGGTGG
>DI211641.1 KR 1020100102235-A/11: A method to reduce directional bias in transcription
GACTAGTC
>DI211484.1 KR 1020100113582-A/1: PCV2 Mycoplasma hyopneumoniae immunogenic compositions
CCGCCATG
>DI246065.1 KR 1020120107521-A/126: IDENTIFICATION OF CLONAL CELLS BY REPEATS IN (EG.) T-CELL RECEPTOR V/D/J GENES
CTAACTGG
>DI233004.1 KR 1020110125226-A/74: HYBRIDIZATION LINKERS
GCYAGYAG
>DI233001.1 KR 1020110125226-A/71: HYBRIDIZATION LINKERS
CYACYAGC
>DI209926.1 KR 1020100099158-A/18: Micro-RNAs of the MIR-15 Family Modulate Cardiomyocyte Survival and Cardiac Repair
AGCAGCAC
>DI232475.1 KR 1020110111474-A/201: RECURRENT GENE FUSIONS IN CANCER
CAATGAGC
>DI232414.1 KR 1020110111474-A/140: RECURRENT GENE FUSIONS IN CANCER
GGTGCCTG
>DI232391.1 KR 1020110111474-A/117: RECURRENT GENE FUSIONS IN CANCER
AGAGAGGA
>DI207824.1 KR 1020100018044-A/20: INCREASED PRODUCTION OF A TARGET PRODUCT VIA STABILIZATION OF MRNA
AAAGGAGG
>DI207749.1 KR 1020100018029-A/16: IMMUNO STIMULATING COMPLEX AND OLIGONUCLEOTIDE FORMULATIONS FOR INDUCING ENHANCED INTERFERON-GAMMA RESPONSES
CCGCGCGG
>DI243978.1 KR 1020120102086-A/22: BIOSYNTHETIC SYSTEM THAT PRODUCES IMMUNOGENIC POLYSACCHARIDES IN PROKARYOTIC CELLS
CCGCGCGG
>DI194876.1 KR 1020100014724-A/18: Recombinant expression vector elements (rEVEs) for enhancing expression of recombinant proteins in host cells
AATATATT
>DI194857.1 KR 1020090118993-A/32: METHOD FOR CLONING COGNATE ANTIBODIES
AGTCAGTC
>DI194372.1 KR 1020090109584-A/1: Prevention and treatment of sub-clinical PCVD
CCGCCATG
>DI193655.1 KR 1020090099005-A/1: Treatment of PRDC in pigs
CCGCCATG
>DI240570.1 KR 1020120104514-A/1: Methods of reducing virucidal activity in PCV-2 compositions and PCV-2 compositions with an improved immunogenicity
CCGCCATG
>DI220270.1 KR 1020120002482-A/6: COMPOSITION FOR REGULATING COLLAGEN
CTCCCTCA
>DI220269.1 KR 1020120002482-A/5: COMPOSITION FOR REGULATING COLLAGEN
CTCAAGAA
>DI180364.1 KR 1020090006221-A/73: LINKERS
CCATGGGC
>DI180331.1 KR 1020090006221-A/23: LINKERS
GCGGCCGC
>DI217538.1 KR 1020120103796-A/4: Biosensor utilizing conductive particles and the combination of polynucleotides corresponding to conductive particles, and method for detecting electric signal using the same
AGTCGTTT
>DI217537.1 KR 1020120103796-A/3: Biosensor utilizing conductive particles and the combination of polynucleotides corresponding to conductive particles, and method for detecting electric signal using the same
GTTGCCAT
>DI174532.1 KR 1020090121624-A/3: Method for Screening Anti-Tumor Agent Having the Ability of Inhibiting Transcription Promoting Activity of hTAFII68-TEC Fusion Protein
AAAGGTCA
>DI215870.1 KR 1020120089971-A/15: Detecting method of insect-resistant GM chines cabbage using specific primers, probes and plasmid
GCCCGGGC
>JB837333.1 Sequence 11 from Patent WO2013106639
TACCCGGG
>JB759861.1 Sequence 69 from Patent WO2013113326
GGTTTTGG
>JB759964.1 Sequence 55 from Patent WO2013113325
GGTTTTGG
>JB765038.1 Sequence 20 from Patent EP2603609
AATAATAT
>JB761185.1 Sequence 55 from Patent WO2013113502
GGTTTTGG
>JB831671.1 Sequence 8 from Patent EP2516664
GCTGGTGG
>JB760538.1 Sequence 69 from Patent WO2013113501
GGTTTTGG
>JB760390.1 Sequence 69 from Patent WO2013113736
GGTTTTGG
>HW274939.1 JP 2012126742-A/1: Immunogenic and Therapeutic Compositions for Streptococcus pyogenes
AAAAAAAA
>JB734353.1 Sequence 41 from Patent WO2013082551
GCTGGCAG
>JB734352.1 Sequence 40 from Patent WO2013082551
GCTGGCAG
>JB734351.1 Sequence 39 from Patent WO2013082551
GCTGGCAG
>JB734350.1 Sequence 38 from Patent WO2013082551
GCTGGCAG
>JB734349.1 Sequence 37 from Patent WO2013082551
GCTGGCAG
>JB734348.1 Sequence 36 from Patent WO2013082551
GCTGGCAG
>JB734347.1 Sequence 35 from Patent WO2013082551
GCTGGCAG
>JB734346.1 Sequence 34 from Patent WO2013082551
GCTGGCAG
>JB734345.1 Sequence 33 from Patent WO2013082551
GCTGGCAG
>JB623865.1 Sequence 15 from Patent EP2610341
AGCGAGCG
>JB623830.1 Sequence 15 from Patent EP2610340
AGCGAGCG
>JB614841.1 Sequence 129 from Patent WO2013070662
GGGCCCTT
>JB614839.1 Sequence 127 from Patent WO2013070662
GCGGCCGT
>JB614838.1 Sequence 126 from Patent WO2013070662
CGGCGCCT
>JB614836.1 Sequence 124 from Patent WO2013070662
GGGGCCCT
>JB614832.1 Sequence 120 from Patent WO2013070662
GGGTCCCT
>JB614830.1 Sequence 118 from Patent WO2013070662
AAGGGCCC
>JB614828.1 Sequence 116 from Patent WO2013070662
ACGGCCGC
>JB614827.1 Sequence 115 from Patent WO2013070662
AGGCGCCG
>JB614826.1 Sequence 114 from Patent WO2013070662
AGGGCCCC
>JB614824.1 Sequence 112 from Patent WO2013070662
AGGGACCC
>JB416406.1 Sequence 69 from Patent EP2623121
GGTTTTGG
>JB405989.1 Sequence 38 from Patent WO2012150960
GCTGGCAG
>JB396277.1 Sequence 30 from Patent WO2012168930
ACTCCCAG
>JB396274.1 Sequence 27 from Patent WO2012168930
GGATGGAG
>JB396271.1 Sequence 24 from Patent WO2012168930
TGGTGGAG
>JB396268.1 Sequence 21 from Patent WO2012168930
GGTGGTGG
>JB396263.1 Sequence 16 from Patent WO2012168930
TTGCCCAG
>JB396260.1 Sequence 13 from Patent WO2012168930
AGGAGCAG
>JB396257.1 Sequence 10 from Patent WO2012168930
CCTCCTGG
>JB396254.1 Sequence 7 from Patent WO2012168930
TGGCTCTG
>JB396251.1 Sequence 4 from Patent WO2012168930
GCAGCCAG
>JB363036.1 Sequence 1 from Patent EP2460816
CCGCCATG
>JB360941.1 Sequence 22 from Patent EP2448952
GGTNNTGG
>JB360928.1 Sequence 9 from Patent EP2448952
GGNNNNGG
>JB386349.1 Sequence 9 from Patent WO2012032510
ACACACAC
>JB328926.1 Sequence 1 from Patent EP2460817
CCGCCATG
>JB319371.1 Sequence 1 from Patent EP2460820
CCGCCATG
>JB318477.1 Sequence 106 from Patent EP2351859
TATTTATT
>JB311317.1 Sequence 1 from Patent EP2460819
CCGCCATG
>JB302821.1 Sequence 1 from Patent EP2460818
CCGCCATG
>JB292846.1 Sequence 1 from Patent EP2481421
CCGCCATG
>JB275352.1 Sequence 2 from Patent EP2332896
ACCCGTCA
>JB275351.1 Sequence 1 from Patent EP2332896
TGACGGGT
>JB277219.1 Sequence 1 from Patent EP2481420
CCGCCATG
>JB260144.1 Sequence 1 from Patent EP2460821
CCGCCATG
>JB252916.1 Sequence 17 from Patent EP2432476
GTGAATGC
>JB252915.1 Sequence 16 from Patent EP2432476
TTGGACGC
>JB239955.1 Sequence 15 from Patent EP2584038
AGCGAGCG
>JB236242.1 Sequence 34 from Patent EP2441769
GAATGCNB
>CBTH010000013.1 Coxiella burnetii WGS project CBTH000000000 data, contig 00013, whole genome shotgun sequence
GACAGCTG
>CBTH010000062.1 Coxiella burnetii WGS project CBTH000000000 data, contig 00062, whole genome shotgun sequence
GAAAGCCA
>CBTH010000074.1 Coxiella burnetii WGS project CBTH000000000 data, contig 00074, whole genome shotgun sequence
GAGATACC
>CBTH010000082.1 Coxiella burnetii WGS project CBTH000000000 data, contig 00082, whole genome shotgun sequence
CCAAGGTG
>CBTH010000083.1 Coxiella burnetii WGS project CBTH000000000 data, contig 00083, whole genome shotgun sequence
TATCGGGT
>CBTH010000092.1 Coxiella burnetii WGS project CBTH000000000 data, contig 00092, whole genome shotgun sequence
GCGTTAAA
>CBTH010000114.1 Coxiella burnetii WGS project CBTH000000000 data, contig 00114, whole genome shotgun sequence
TCGAACAG
>CBTH010000117.1 Coxiella burnetii WGS project CBTH000000000 data, contig 00117, whole genome shotgun sequence
GTAATTTC
>HW241416.1 JP 2013511520-A/14: BIOSYNTHETIC SYSTEM THAT PRODUCES IMMUNOGENIC POLYSACCHARIDES IN PROKARYOTIC CELLS
CCGCGCGG
>HW163265.1 JP 2013078317-A/80: PHARMACEUTICAL COMPOSITION COMPRISING ANTI-MIRNA ANTISENSE OLIGONUCLEOTIDES
AACGAACA
>HW163262.1 JP 2013078317-A/77: PHARMACEUTICAL COMPOSITION COMPRISING ANTI-MIRNA ANTISENSE OLIGONUCLEOTIDES
TTAGCATT
>HW163259.1 JP 2013078317-A/74: PHARMACEUTICAL COMPOSITION COMPRISING ANTI-MIRNA ANTISENSE OLIGONUCLEOTIDES
TCACACTC
>HW163256.1 JP 2013078317-A/71: PHARMACEUTICAL COMPOSITION COMPRISING ANTI-MIRNA ANTISENSE OLIGONUCLEOTIDES
GATTTGCA
>HW158084.1 JP 2013510189-A/30: Non-DNA Base-Containing Polynucleotide Compositions and Their Use for the Modulation of Immune Responses
NGGGTGGN
>HW158079.1 JP 2013510189-A/25: Non-DNA Base-Containing Polynucleotide Compositions and Their Use for the Modulation of Immune Responses
NGGGTGGN
>HW123112.1 JP 2013503893-A/1: METHODS OF REDUCING VIRICIDAL ACTIVITY IN PCV-2 COMPOSITIONS AND PCV-2 COMPOSITIONS WITH AN IMPROVED IMMUNOGENICITY
CCGCCATG
>HW117576.1 JP 2011505831-A/15: Compositions and methods related to mRNA translational enhancer elements
AGCGAGCG
>HW106293.1 JP 2012016357-A/1: PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS
CCGCCATG
>HW106276.1 JP 2012025766-A/26: Method for Treating Inflammation
CGCGTCTC
>HW106275.1 JP 2012025766-A/25: Method for Treating Inflammation
AATTGAGA
>HW106212.1 JP 2012025737-A/26: Method for Treating Inflammation
CGCGTCTC
>HW106211.1 JP 2012025737-A/25: Method for Treating Inflammation
AATTGAGA
>HW113821.1 JP 2012031191-A/6: COMPOSITIONS AND METHODS FOR INDUCING AN IMMUNE RESPONSE IN A MAMMAL AND METHODS OF AVOIDING AN IMMUNE RESPONSE TO OLIGONUCLEOTIDE AGENTS SUCH AS SHORT INTERFERING RNAs
GTCCTTCA
>HW117827.1 JP 2012505221-A/25: USE OF INHIBITORS OF TOLL-LIKE RECEPTORS IN THE PREVENTION AND TREATMENT OF HYPERCHOLESTEROLEMIA AND HYPERLIPIDEMIA AND DISEASES RELATED THERETO
CTATCTGT
>HW117825.1 JP 2012505221-A/23: USE OF INHIBITORS OF TOLL-LIKE RECEPTORS IN THE PREVENTION AND TREATMENT OF HYPERCHOLESTEROLEMIA AND HYPERLIPIDEMIA AND DISEASES RELATED THERETO
CTATCTGA
>HW087266.1 JP 2013031447-A/57: TARGETED INTEGRATION AND EXPRESSION OF EXOGENOUS NUCLEIC ACID SEQUENCES
GACCACAT
>HW071748.1 JP 2012532123-A/22: Novel guanosine rich modified oligonucleotides and antiproliferative activity thereof
GGTNNTGG
>HW071735.1 JP 2012532123-A/9: Novel guanosine rich modified oligonucleotides and antiproliferative activity thereof
GGNNNNGG
>HW071572.1 JP 2012531210-A/27: Single Nucleotide Polymorphisms in BRCA1 and Cancer Risk
GGCCATTA
>HW071571.1 JP 2012531210-A/26: Single Nucleotide Polymorphisms in BRCA1 and Cancer Risk
GAACGTTG
>HW071566.1 JP 2012531210-A/21: Single Nucleotide Polymorphisms in BRCA1 and Cancer Risk
GGACGCTG
>HW071565.1 JP 2012531210-A/20: Single Nucleotide Polymorphisms in BRCA1 and Cancer Risk
GACCACTA
>HW071564.1 JP 2012531210-A/19: Single Nucleotide Polymorphisms in BRCA1 and Cancer Risk
AGCCGCTG
>HW071555.1 JP 2012531210-A/10: Single Nucleotide Polymorphisms in BRCA1 and Cancer Risk
GGCCGCTG
>HW071554.1 JP 2012531210-A/9: Single Nucleotide Polymorphisms in BRCA1 and Cancer Risk
GGCCGCTA
>HW071553.1 JP 2012531210-A/8: Single Nucleotide Polymorphisms in BRCA1 and Cancer Risk
GGCCACTA
>HW071552.1 JP 2012531210-A/7: Single Nucleotide Polymorphisms in BRCA1 and Cancer Risk
GGCCACCA
>HW071551.1 JP 2012531210-A/6: Single Nucleotide Polymorphisms in BRCA1 and Cancer Risk
GGACGCTA
>HW071550.1 JP 2012531210-A/5: Single Nucleotide Polymorphisms in BRCA1 and Cancer Risk
GACGACTA
>HW071549.1 JP 2012531210-A/4: Single Nucleotide Polymorphisms in BRCA1 and Cancer Risk
GAACGCTG
>HW071548.1 JP 2012531210-A/3: Single Nucleotide Polymorphisms in BRCA1 and Cancer Risk
GAACGCTA
>HW071547.1 JP 2012531210-A/2: Single Nucleotide Polymorphisms in BRCA1 and Cancer Risk
AGCCATTA
>HW071546.1 JP 2012531210-A/1: Single Nucleotide Polymorphisms in BRCA1 and Cancer Risk
AGCCACTA
>HW067733.1 JP 2013010761-A/2: Evolving New Molecular Function
ACCCGTCA
>HW067732.1 JP 2013010761-A/1: Evolving New Molecular Function
TGACGGGT
>HW103511.1 JP 2013503164-A/4: Development of Universal Cancer Drugs and Vaccines
GTAAGAGK
>HW068036.1 WO 2013014843-A/14: Method of detecting a target substance, a sensor chip, and detection machine
CCCAGGTT
>JB172416.1 Sequence 48 from Patent WO2012130909
TCCTGTAC
>JB172415.1 Sequence 47 from Patent WO2012130909
AACCCGTA
>JB172414.1 Sequence 46 from Patent WO2012130909
AACCCGTA
>JB172413.1 Sequence 45 from Patent WO2012130909
GTCCAGTT
>JB172412.1 Sequence 44 from Patent WO2012130909
TTCCCTTT
>JB172411.1 Sequence 43 from Patent WO2012130909
TGGAAGAC
>JB172410.1 Sequence 42 from Patent WO2012130909
ATGTTTAG
>JB172409.1 Sequence 41 from Patent WO2012130909
GAGAAAGC
>JB172408.1 Sequence 40 from Patent WO2012130909
CCTGTCTG
>JB176685.1 Sequence 21 from Patent WO2012103545
TGTMTCNT
>JB176672.1 Sequence 8 from Patent WO2012103545
CTGTCTCT
>JB155156.1 Sequence 27 from Patent EP2514825
CAGCCTTT
>JB152142.1 Sequence 12 from Patent WO2012153135
AACTGGAC
>JB088001.1 Sequence 8 from Patent EP2502634
TCAACGTT
>JB136947.1 Sequence 39 from Patent EP2540840
CCCGCCGT
>JB136726.1 Sequence 36 from Patent EP2476758
TGGAGTGT
>JB136725.1 Sequence 35 from Patent EP2476758
CTGGACTT
>JB136719.1 Sequence 29 from Patent EP2476758
TACAGTAG
>JB136701.1 Sequence 11 from Patent EP2476758
AATGACAC
>JB074634.1 Sequence 6 from Patent WO2012170889
TTTGAATT
>JB031951.1 Sequence 8 from Patent EP2526966
TCAACGTT
>JB031838.1 Sequence 39 from Patent EP2527466
CCCGCCGT
>JB037407.1 Sequence 1 from Patent WO2012107724
ACAAATGT
>JB036601.1 Sequence 73 from Patent EP2530152
GAAGCAAG
>JB036291.1 Sequence 15 from Patent EP2527439
AGCGAGCG
>JA916695.1 Sequence 20 from Patent WO2012145374
AGTCCAGT
>JA916694.1 Sequence 19 from Patent WO2012145374
AAGTCCAG
>JA916685.1 Sequence 10 from Patent WO2012145374
CTGGACTT
>JA916684.1 Sequence 9 from Patent WO2012145374
ACTGGACT
>JA899691.1 Sequence 2 from Patent EP2545941
GAAGTGCT
>JA899690.1 Sequence 1 from Patent EP2545941
TCAGTGCA
>XM_004256960.1 Entamoeba invadens IP1 Hypothetical protein (EIN_385200) mRNA, partial cds
GTTGAAAA
>XM_004185304.1 Entamoeba invadens IP1 Hypothetical protein (EIN_234430) mRNA, partial cds
ACATTTAA
>HW060250.1 JP 2012527444-A/10: TARGETING MICRORNAS FOR METABOLIC DISORDERS
ATGCTGCT
>HW050638.1 JP 2012525415-A/10: METHODS FOR TREATING OR PREVENTING OPHTHALMOLOGICAL DISEASES
GTGAATGC
>HW050637.1 JP 2012525415-A/9: METHODS FOR TREATING OR PREVENTING OPHTHALMOLOGICAL DISEASES
TTGGACGC
>HW048381.1 JP 2012524539-A/26: PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF HCV PATIENTS THAT ARE POOR-RESPONDERS TO INTERFERON
GTCACACT
>HW048379.1 JP 2012524539-A/24: PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF HCV PATIENTS THAT ARE POOR-RESPONDERS TO INTERFERON
TCACACTC
>HW048361.1 JP 2012524539-A/6: PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF HCV PATIENTS THAT ARE POOR-RESPONDERS TO INTERFERON
CACACTCC
>JA893330.1 Sequence 113 from Patent EP2465949
GGCTGCGC
>JA893311.1 Sequence 94 from Patent EP2465949
GGCGCGGC
>JA893310.1 Sequence 93 from Patent EP2465949
GGCGCGGG
>HV987213.1 JP 2011213738-A/3: KALLIKREIN INHIBITORS AND USES THEREOF
TTCGCGAA
>JA851626.1 Sequence 1 from Patent EP2456891
ACCGTCAT
>HV961077.1 WO 2012133896-A/12: polyamide compound and pharmaceutical composition for mitochondria disease
TCGCATAA
>HV961074.1 WO 2012133896-A/9: polyamide compound and pharmaceutical composition for mitochondria disease
ATGGCAGA
>HV961071.1 WO 2012133896-A/6: polyamide compound and pharmaceutical composition for mitochondria disease
AGCCCGGT
>HV961068.1 WO 2012133896-A/3: polyamide compound and pharmaceutical composition for mitochondria disease
TGGCAGAG
>HV959632.1 JP 2012187106-A/106: Methods and Agents for Screening for Compounds Capable of Modulating Gene Expression
TATTTATT
>HV965255.1 JP 2012522977-A/60: METHODS AND MEANS FOR TREATMENT OF OSTEOARTHRITIS
TTGCTATA
>HV961953.1 JP 2012520080-A/153: REAGENTS AND METHODS FOR PCR
CGCCGCGC
>HV961814.1 JP 2012520080-A/14: REAGENTS AND METHODS FOR PCR
CCGCCGGC
>HV961813.1 JP 2012520080-A/13: REAGENTS AND METHODS FOR PCR
CAGCCGGC
>HE599924.1 Ovis aries uncharacterised small RNA, clone P4C10
TCTCACAC
>HE599875.1 Ovis aries uncharacterised small RNA, clone P3A6
TGGACTGA
>HV955864.1 JP 2012518435-A/6: FREE CIRCULATING DNA BIO-MARKERS AND THEIR APPLICATIONS
TTTTGGGG
>HV950306.1 WO 2012121396-A/2: A fluorescent probe and usage thereof
TGTGGGCA
>HV950305.1 WO 2012121396-A/1: A fluorescent probe and usage thereof
GCCGGCGG
>HV947349.1 JP 2012183039-A/21: RNA MOLECULE BOUND TO RABBIT-DERIVED IgG AND USE THEREOF
CCTTGGAA
>HV942218.1 JP 2012161318-A/4: SYSTEMS AND METHODS FOR PROTEIN PRODUCTION
TGACGTGA
>HV942217.1 JP 2012161318-A/3: SYSTEMS AND METHODS FOR PROTEIN PRODUCTION
TGACGTGG
>JA802524.1 Sequence 69 from Patent EP2522745
TTTTTCAC
>JA802523.1 Sequence 68 from Patent EP2522745
CTTTTCAC
>JA802490.1 Sequence 35 from Patent EP2522745
GAGCTGCC
>JA802467.1 Sequence 12 from Patent EP2522745
GCTTTCAC
>JA808926.1 Sequence 59 from Patent EP2468864
TCGGAGTT
>JA808919.1 Sequence 52 from Patent EP2468864
TCGGAGTT
>JA808907.1 Sequence 40 from Patent EP2468864
GGATCTTA
>JA808897.1 Sequence 30 from Patent EP2468864
CGATTTTT
>JA808891.1 Sequence 24 from Patent EP2468864
CTACACAA
>JA808879.1 Sequence 12 from Patent EP2468864
GGATCTTA
>JA806124.1 Sequence 27 from Patent EP2522733
CAGCCTTT
>JA806014.1 Sequence 27 from Patent EP2522732
CAGCCTTT
>JA805904.1 Sequence 27 from Patent EP2522731
CAGCCTTT
>JA809947.1 Sequence 1080 from Patent EP2468864
GAACAGGG
>JA822950.1 Sequence 59 from Patent EP2471920
TCGGAGTT
>JA822943.1 Sequence 52 from Patent EP2471920
TCGGAGTT
>JA822931.1 Sequence 40 from Patent EP2471920
GGATCTTA
>JA822921.1 Sequence 30 from Patent EP2471920
CGATTTTT
>JA822915.1 Sequence 24 from Patent EP2471920
CTACACAA
>JA822903.1 Sequence 12 from Patent EP2471920
GGATCTTA
>JA823971.1 Sequence 1080 from Patent EP2471920
GAACAGGG
>HV856552.1 JP 2010507386-A/11: Oligoribonucleotides and uses thereof
GTTGTGTN
>HV937146.1 JP 2011519280-A/12: NEURAL REGENERATING CELLS WITH ALTERATIONS IN DNA METHYLATION
CCTCGGCC
>HV937142.1 JP 2011519280-A/8: NEURAL REGENERATING CELLS WITH ALTERATIONS IN DNA METHYLATION
CCTCGGGG
>HV937138.1 JP 2011519280-A/4: NEURAL REGENERATING CELLS WITH ALTERATIONS IN DNA METHYLATION
TTACGCCT
>HV937147.1 JP 2011519280-A/13: NEURAL REGENERATING CELLS WITH ALTERATIONS IN DNA METHYLATION
GTCCGATG
>HV937143.1 JP 2011519280-A/9: NEURAL REGENERATING CELLS WITH ALTERATIONS IN DNA METHYLATION
GGACGATC
>HV937139.1 JP 2011519280-A/5: NEURAL REGENERATING CELLS WITH ALTERATIONS IN DNA METHYLATION
TCTCGGAG
>HV937135.1 JP 2011519280-A/1: NEURAL REGENERATING CELLS WITH ALTERATIONS IN DNA METHYLATION
CATCGCCC
>HV937148.1 JP 2011519280-A/14: NEURAL REGENERATING CELLS WITH ALTERATIONS IN DNA METHYLATION
GTCCGATG
>HV937144.1 JP 2011519280-A/10: NEURAL REGENERATING CELLS WITH ALTERATIONS IN DNA METHYLATION
GGACGATC
>HV937140.1 JP 2011519280-A/6: NEURAL REGENERATING CELLS WITH ALTERATIONS IN DNA METHYLATION
TCTCGGAG
>HV937136.1 JP 2011519280-A/2: NEURAL REGENERATING CELLS WITH ALTERATIONS IN DNA METHYLATION
CATCGCCC
>HV937145.1 JP 2011519280-A/11: NEURAL REGENERATING CELLS WITH ALTERATIONS IN DNA METHYLATION
CCTCGGCC
>HV937141.1 JP 2011519280-A/7: NEURAL REGENERATING CELLS WITH ALTERATIONS IN DNA METHYLATION
CCTCGGGG
>HV937137.1 JP 2011519280-A/3: NEURAL REGENERATING CELLS WITH ALTERATIONS IN DNA METHYLATION
TTACGCCT
>HV925598.1 JP 2010515707-A/24: Dbait and its standalone uses thereof
GCTGTGCA
>HV925581.1 JP 2010515707-A/7: Dbait and its standalone uses thereof
ACGCACGG
>HV930619.1 JP 2011502474-A/16: COMPOUNDS AND METHODS ASSOCIATED WITH DIFFERENTIAL METHYLATION OF HUMAN PAPILLOMA VIRUS GENOMES IN EPITHELIAL CELLS
TAAGGGTG
>HV930611.1 JP 2011502474-A/8: COMPOUNDS AND METHODS ASSOCIATED WITH DIFFERENTIAL METHYLATION OF HUMAN PAPILLOMA VIRUS GENOMES IN EPITHELIAL CELLS
TAAGGGCG
>HV932588.1 JP 2011516077-A/119: METHODS, AGENTS AND KITS FOR THE DETECTION OF CANCER
TGGTGGAG
>HV932587.1 JP 2011516077-A/118: METHODS, AGENTS AND KITS FOR THE DETECTION OF CANCER
GGAGGCTG
>HV932586.1 JP 2011516077-A/117: METHODS, AGENTS AND KITS FOR THE DETECTION OF CANCER
CTCCTCCT
>HV932585.1 JP 2011516077-A/116: METHODS, AGENTS AND KITS FOR THE DETECTION OF CANCER
CTGGGGCT
>HV932584.1 JP 2011516077-A/115: METHODS, AGENTS AND KITS FOR THE DETECTION OF CANCER
CAGGAGAA
>HV932583.1 JP 2011516077-A/114: METHODS, AGENTS AND KITS FOR THE DETECTION OF CANCER
TCTGGAGC
>HV932582.1 JP 2011516077-A/113: METHODS, AGENTS AND KITS FOR THE DETECTION OF CANCER
CTGGGCAA
>HV932581.1 JP 2011516077-A/112: METHODS, AGENTS AND KITS FOR THE DETECTION OF CANCER
GAAGGCAG
>HV932580.1 JP 2011516077-A/111: METHODS, AGENTS AND KITS FOR THE DETECTION OF CANCER
GGCAGCAG
>HV932579.1 JP 2011516077-A/110: METHODS, AGENTS AND KITS FOR THE DETECTION OF CANCER
CTTCCTCC
>HV932578.1 JP 2011516077-A/109: METHODS, AGENTS AND KITS FOR THE DETECTION OF CANCER
CCAGGCTG
>HV781591.1 JP 2010046099-A/57: METHODS AND COMPOSITIONS FOR TARGETED CLEAVAGE AND RECOMBINATION
GACCACAT
>HV813906.1 JP 2011046725-A/48: Immunogenic Compositions for Streptococcus pyogenes
AGTTGGTA
>HV802856.1 JP 2010155842-A/3: PREVENTION AND REDUCTION OF BLOOD LOSS
TTCGCGAA
>HV856563.1 JP 2010507386-A/22: Oligoribonucleotides and uses thereof
NGTTGTGT
>HV856561.1 JP 2010507386-A/20: Oligoribonucleotides and uses thereof
GTTGTGTN
>HV856559.1 JP 2010507386-A/18: Oligoribonucleotides and uses thereof
GTTGTGTN
>HV856558.1 JP 2010507386-A/17: Oligoribonucleotides and uses thereof
GTTGTGTN
>HV856557.1 JP 2010507386-A/16: Oligoribonucleotides and uses thereof
GTTGTGTN
>HV856556.1 JP 2010507386-A/15: Oligoribonucleotides and uses thereof
TTTTGGGG
>HV856555.1 JP 2010507386-A/14: Oligoribonucleotides and uses thereof
GTTGTGTN
>HV816779.1 JP 2011078417-A/4: Methods for Preserving Organs and Tissues
TTCGCGAA
>HV784749.1 JP 2010001310-A/34: Methods and Products for Stimulating the Immune System Using Immunotherapeutic Oligonucleotides and Cytokines
TCAACGTC
>HV784747.1 JP 2010001310-A/32: Methods and Products for Stimulating the Immune System Using Immunotherapeutic Oligonucleotides and Cytokines
CCAACGTT
>HV784745.1 JP 2010001310-A/30: Methods and Products for Stimulating the Immune System Using Immunotherapeutic Oligonucleotides and Cytokines
TCTTCGAA
>HV784744.1 JP 2010001310-A/29: Methods and Products for Stimulating the Immune System Using Immunotherapeutic Oligonucleotides and Cytokines
TCTTCGAT
>HV784743.1 JP 2010001310-A/28: Methods and Products for Stimulating the Immune System Using Immunotherapeutic Oligonucleotides and Cytokines
TCAGCGCT
>HV784742.1 JP 2010001310-A/27: Methods and Products for Stimulating the Immune System Using Immunotherapeutic Oligonucleotides and Cytokines
TCAAGCTT
>HV784741.1 JP 2010001310-A/26: Methods and Products for Stimulating the Immune System Using Immunotherapeutic Oligonucleotides and Cytokines
TCAACGTT
>HV778246.1 WO 2012091101-A/18: A bioluminescent probe system for multiply recognizing ligands
TTTCGCGC
>HV778242.1 WO 2012091101-A/14: A bioluminescent probe system for multiply recognizing ligands
TGACGTCA
>pdb|3K18|A Chain A, Tellurium Modified Dna-8mer
GNGNACAC
>pdb|1R3O|D Chain D, Crystal Structure Of The First Rna Duplex In L-Conformation At 1.9a Resolution
NNNNNNNN
>pdb|1R3O|C Chain C, Crystal Structure Of The First Rna Duplex In L-Conformation At 1.9a Resolution
NNNNNNNN
>pdb|1R3O|B Chain B, Crystal Structure Of The First Rna Duplex In L-Conformation At 1.9a Resolution
NNNNNNNN
>pdb|1R3O|A Chain A, Crystal Structure Of The First Rna Duplex In L-Conformation At 1.9a Resolution
NNNNNNNN
>pdb|1BAE|B Chain B, Structure Of Dna (5'-D 5mcctttacc-3')2, Nmr, 1 Structure
NCTTTACC
>pdb|1BAE|A Chain A, Structure Of Dna (5'-D 5mcctttacc-3')2, Nmr, 1 Structure
NCTTTACC
>HV760966.1 JP 2012121820-A/6: Polypeptides having sulfo sugar chains
TTCCTCTG
>HV755972.1 JP 2012508016-A/1409: COMBINATORIAL ANTIBODY LIBRARIES AND USES THEREOF
CCATGGCG
>HV755971.1 JP 2012508016-A/1408: COMBINATORIAL ANTIBODY LIBRARIES AND USES THEREOF
CCATGGCA
>HV755960.1 JP 2012508016-A/1397: COMBINATORIAL ANTIBODY LIBRARIES AND USES THEREOF
GCGGCCGC
>HV758984.1 JP 2012508017-A/112: Anti-DLL4 Antibodies and Uses Thereof
GCGGCCGC
>HV750823.1 JP 2012507984-A/37: Improved production of riboflavin
GCCCCGAA
>HV750822.1 JP 2012507984-A/36: Improved production of riboflavin
TTCGGGGC
>HV742645.1 JP 2012506709-A/108: Sequencing of nucleic acid molecules by mass spectrometry
GCGTGGTG
>HV742605.1 JP 2012506709-A/68: Sequencing of nucleic acid molecules by mass spectrometry
GCACGTCC
>HV742555.1 JP 2012506709-A/18: Sequencing of nucleic acid molecules by mass spectrometry
GCACGTCC
>HV704828.1 JP 2012504962-A/49: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
GAACGGTG
>HV704826.1 JP 2012504962-A/47: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
NGGAGCAN
>HV704816.1 JP 2012504962-A/37: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
AACAGCGC
>HV704815.1 JP 2012504962-A/36: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
AGTCAGCG
>HV704814.1 JP 2012504962-A/35: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
ACAGCGCA
>HV704813.1 JP 2012504962-A/34: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
TCAGCGAG
>HV704811.1 JP 2012504962-A/32: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
AACAGCGC
>HV704810.1 JP 2012504962-A/31: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
ACAGCGAG
>HV704809.1 JP 2012504962-A/30: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
CAGCGAGG
>HV704808.1 JP 2012504962-A/29: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
GACAGCGC
>HV704807.1 JP 2012504962-A/28: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
CAGCGAGA
>HV704804.1 JP 2012504962-A/25: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
AGGGTTAG
>HV704802.1 JP 2012504962-A/23: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
GGTGGAAG
>HV704798.1 JP 2012504962-A/19: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
GAACGGTG
>HV704794.1 JP 2012504962-A/15: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
GGAGCAAA
>HV704791.1 JP 2012504962-A/12: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
AGCGAGAA
>HV704790.1 JP 2012504962-A/11: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
GTCAGCGA
>HV704789.1 JP 2012504962-A/10: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
GCCCAACT
>HV704788.1 JP 2012504962-A/9: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
GCCCAACT
>HV704787.1 JP 2012504962-A/8: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
GCCTCCAA
>HV704784.1 JP 2012504962-A/5: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
GCCTCCCC
>HV704783.1 JP 2012504962-A/4: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
GCCTCCTA
>HV704782.1 JP 2012504962-A/3: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
GCCTCCAT
>HV704781.1 JP 2012504962-A/2: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
GCCTCCAG
>HV704780.1 JP 2012504962-A/1: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
GCCTCCAG
>HV744600.1 JP 2012507299-A/69: LIGHT TARGETING MOLECULES AND USES THEREOF
GCGGCCGC
>HV702721.1 JP 2012072152-A/10: COMBINATION THERAPY FOR THE TREATMENT OF OCULAR NEOVASCULAR DISORDERS
GTGAATGC
>HV702720.1 JP 2012072152-A/9: COMBINATION THERAPY FOR THE TREATMENT OF OCULAR NEOVASCULAR DISORDERS
TTGGACGC
>HV701537.1 JP 2012083193-A/33: METHOD FOR DETECTING GLYCOSYLATION OF HISTONE PROTEINS, AND ANTIBODIES USED IN THE METHOD
CCCTCCCY
>HV701485.1 JP 2012080807-A/14: DNA primer set for discriminating Cerasus clones
ACCAGCCC
>AB417122.1 Bombyx mori non-coding RNA, ovarian small RNA-30932, complete sequence
TGAAGCAT
>HV694853.1 JP 2012504402-A/385: Cross-species-specific PSCAxCD3, CD19xCD3, C-METxCD3, EndosialinxCD3, EpCAMxCD3, IGF-1RxCD3 or FAPalpha xCD3 bispecific single chain antibody
DYKDDDDK
>HV694467.1 JP 2012504395-A/70: Tetracycline inducible transcription control sequence
ATGTAAAC
>HV597469.1 JP 2010539959-A/2850: Micromirs
CAGCTGGG
>HV597468.1 JP 2010539959-A/2849: Micromirs
TATACCCA
>HV597467.1 JP 2010539959-A/2848: Micromirs
TCGCGCCT
>HV597466.1 JP 2010539959-A/2847: Micromirs
ATGGGATC
>HV597465.1 JP 2010539959-A/2846: Micromirs
TGCTGCTG
>HV597464.1 JP 2010539959-A/2845: Micromirs
AAACCATC
>HV597463.1 JP 2010539959-A/2844: Micromirs
GGCATCCT
>HV597462.1 JP 2010539959-A/2843: Micromirs
GGTTTAGC
>HV597461.1 JP 2010539959-A/2842: Micromirs
AGTATTCT
>HV597460.1 JP 2010539959-A/2841: Micromirs
TGACCGCG
>HV597459.1 JP 2010539959-A/2840: Micromirs
AGAATGTG
>HV597458.1 JP 2010539959-A/2839: Micromirs
ACTACAGT
>HV597457.1 JP 2010539959-A/2838: Micromirs
TGGCCTGG
>HV597456.1 JP 2010539959-A/2837: Micromirs
AAGCATTA
>HV597455.1 JP 2010539959-A/2836: Micromirs
ACAACACC
>HV597454.1 JP 2010539959-A/2835: Micromirs
ACAACACT
>HV597453.1 JP 2010539959-A/2834: Micromirs
TCCTGTAA
>HV597452.1 JP 2010539959-A/2833: Micromirs
CGGGAAGT
>HV597451.1 JP 2010539959-A/2832: Micromirs
ATCTCTGA
>HV597450.1 JP 2010539959-A/2831: Micromirs
AACTCTAC
>HV597449.1 JP 2010539959-A/2830: Micromirs
ACAGGCAA
>HV597448.1 JP 2010539959-A/2829: Micromirs
CAGTCCCA
>HV597447.1 JP 2010539959-A/2828: Micromirs
CGCGTGCG
>HV597446.1 JP 2010539959-A/2827: Micromirs
TGGCTCAG
>HV597445.1 JP 2010539959-A/2826: Micromirs
GTCCTTCC
>HV597444.1 JP 2010539959-A/2825: Micromirs
ACGAGCTT
>HV597443.1 JP 2010539959-A/2824: Micromirs
CTACGGGT
>HV597442.1 JP 2010539959-A/2823: Micromirs
GCGAGCTT
>HV597441.1 JP 2010539959-A/2822: Micromirs
CTACGGGT
>HV597440.1 JP 2010539959-A/2821: Micromirs
ACTACCTC
>HV597439.1 JP 2010539959-A/2820: Micromirs
CACATGAT
>HV597438.1 JP 2010539959-A/2819: Micromirs
AGTGCCAA
>HV597437.1 JP 2010539959-A/2818: Micromirs
CCCGTTGA
>HV597436.1 JP 2010539959-A/2817: Micromirs
CAATAATT
>HV597435.1 JP 2010539959-A/2816: Micromirs
AACAGTCA
>HV597434.1 JP 2010539959-A/2815: Micromirs
CAGAGAAG
>HV597433.1 JP 2010539959-A/2814: Micromirs
AGCCGGGT
>HV597432.1 JP 2010539959-A/2813: Micromirs
CCCTGCCT
>HV597431.1 JP 2010539959-A/2812: Micromirs
AGCTCCCC
>HV597430.1 JP 2010539959-A/2811: Micromirs
TTAAGGGC
>HV597429.1 JP 2010539959-A/2810: Micromirs
AGCGCGGA
>HV597428.1 JP 2010539959-A/2809: Micromirs
CTCTACTG
>HV597427.1 JP 2010539959-A/2808: Micromirs
GGTAACTG
>HV597426.1 JP 2010539959-A/2807: Micromirs
TAGTAGAC
>HV597425.1 JP 2010539959-A/2806: Micromirs
CTGCGCAC
>HV597424.1 JP 2010539959-A/2805: Micromirs
CTCAGCAG
>HV597423.1 JP 2010539959-A/2804: Micromirs
AGCACTTT
>HV597422.1 JP 2010539959-A/2803: Micromirs
CCCGTCCC
>HV597421.1 JP 2010539959-A/2802: Micromirs
AGTGCAAT
>HV597420.1 JP 2010539959-A/2801: Micromirs
TCCCCACC
>HV597419.1 JP 2010539959-A/2800: Micromirs
TCCCAACC
>HV597418.1 JP 2010539959-A/2799: Micromirs
AGTGCAAT
>HV597417.1 JP 2010539959-A/2798: Micromirs
CAAGACTC
>HV597416.1 JP 2010539959-A/2797: Micromirs
TCCGCTGA
>HV597415.1 JP 2010539959-A/2796: Micromirs
CTCTGCTG
>HV597414.1 JP 2010539959-A/2795: Micromirs
CCTCACTA
>HV597413.1 JP 2010539959-A/2794: Micromirs
CAGCTCCC
>HV597412.1 JP 2010539959-A/2793: Micromirs
TAGCTTTA
>HV597411.1 JP 2010539959-A/2792: Micromirs
AACCAAAG
>HV597410.1 JP 2010539959-A/2791: Micromirs
GAGCCAGT
>HV597409.1 JP 2010539959-A/2790: Micromirs
GACACAGT
>HV597408.1 JP 2010539959-A/2789: Micromirs
TAAGTTGC
>HV597407.1 JP 2010539959-A/2788: Micromirs
TTCGTTGC
>HV597406.1 JP 2010539959-A/2787: Micromirs
TTCCAAGT
>HV597405.1 JP 2010539959-A/2786: Micromirs
CGATATTA
>HV597404.1 JP 2010539959-A/2785: Micromirs
GTGTCAGT
>HV597403.1 JP 2010539959-A/2784: Micromirs
TTTTGAGT
>HV597402.1 JP 2010539959-A/2783: Micromirs
CCCGTTCA
>HV597401.1 JP 2010539959-A/2782: Micromirs
TCCGACCC
>HV597400.1 JP 2010539959-A/2781: Micromirs
GCACCCGC
>HV597399.1 JP 2010539959-A/2780: Micromirs
TGTAATGG
>HV597398.1 JP 2010539959-A/2779: Micromirs
CCGCTGCC
>HV597397.1 JP 2010539959-A/2778: Micromirs
AGAAGAGG
>HV597396.1 JP 2010539959-A/2777: Micromirs
CTCCTCTA
>HV597395.1 JP 2010539959-A/2776: Micromirs
AGAAATCC
>HV597394.1 JP 2010539959-A/2775: Micromirs
AAACCACC
>HV597393.1 JP 2010539959-A/2774: Micromirs
TGAGGTAT
>HV597392.1 JP 2010539959-A/2773: Micromirs
GTTTCCAG
>HV597391.1 JP 2010539959-A/2772: Micromirs
CCAGGGCA
>HV597390.1 JP 2010539959-A/2771: Micromirs
AGTTCCTG
>HV597389.1 JP 2010539959-A/2770: Micromirs
TTGTTACT
>HV597388.1 JP 2010539959-A/2769: Micromirs
GGTACTGG
>HV597387.1 JP 2010539959-A/2768: Micromirs
GAGGTCTC
>HV597386.1 JP 2010539959-A/2767: Micromirs
AGATCCCA
>HV597385.1 JP 2010539959-A/2766: Micromirs
CATGGTGC
>HV597384.1 JP 2010539959-A/2765: Micromirs
ATGAGCAG
>HV597383.1 JP 2010539959-A/2764: Micromirs
GGCTGGAG
>HV597382.1 JP 2010539959-A/2763: Micromirs
TCTCCTCC
>HV597381.1 JP 2010539959-A/2762: Micromirs
CCAGAGCC
>HV597380.1 JP 2010539959-A/2761: Micromirs
GGTCACAA
>HV597379.1 JP 2010539959-A/2760: Micromirs
TGGCAACA
>HV597378.1 JP 2010539959-A/2759: Micromirs
AGCCCCGC
>HV597377.1 JP 2010539959-A/2758: Micromirs
CCAGCGAG
>HV597376.1 JP 2010539959-A/2757: Micromirs
GTCTAGTT
>HV597375.1 JP 2010539959-A/2756: Micromirs
AAGCTCCT
>HV597374.1 JP 2010539959-A/2755: Micromirs
GATTTGTT
>HV597373.1 JP 2010539959-A/2754: Micromirs
GATTTGTT
>HV597372.1 JP 2010539959-A/2753: Micromirs
AGTCTTCC
>HV597371.1 JP 2010539959-A/2752: Micromirs
GGCATACA
>HV597370.1 JP 2010539959-A/2751: Micromirs
TCCGCACC
>HV597369.1 JP 2010539959-A/2750: Micromirs
GGGCTTCC
>HV597368.1 JP 2010539959-A/2749: Micromirs
AGAACCGG
>HV597367.1 JP 2010539959-A/2748: Micromirs
CGAGTGAC
>HV597366.1 JP 2010539959-A/2747: Micromirs
CCTCCTGG
>HV597365.1 JP 2010539959-A/2746: Micromirs
CTAGCCAG
>HV597364.1 JP 2010539959-A/2745: Micromirs
AAATGAAT
>HV597363.1 JP 2010539959-A/2744: Micromirs
CGGGCCAC
>HV597362.1 JP 2010539959-A/2743: Micromirs
GCCCCGCC
>HV597361.1 JP 2010539959-A/2742: Micromirs
AACGTGGG
>HV597360.1 JP 2010539959-A/2741: Micromirs
ACCCAGGC
>HV597359.1 JP 2010539959-A/2740: Micromirs
CAATGGGT
>HV597358.1 JP 2010539959-A/2739: Micromirs
TGAACCAA
>HV597357.1 JP 2010539959-A/2738: Micromirs
CCCTCCGC
>HV597356.1 JP 2010539959-A/2737: Micromirs
GAACCTGC
>HV597355.1 JP 2010539959-A/2736: Micromirs
TATAATAT
>HV597354.1 JP 2010539959-A/2735: Micromirs
ATGTATTA
>HV597353.1 JP 2010539959-A/2734: Micromirs
GGCCCACC
>HV597352.1 JP 2010539959-A/2733: Micromirs
GCAGACAT
>HV597351.1 JP 2010539959-A/2732: Micromirs
TTTCAACA
>HV597350.1 JP 2010539959-A/2731: Micromirs
GGCGCCAT
>HV597349.1 JP 2010539959-A/2730: Micromirs
TATCCTAA
>HV597348.1 JP 2010539959-A/2729: Micromirs
CTGCCTCC
>HV597347.1 JP 2010539959-A/2728: Micromirs
CACAGGTT
>HV597346.1 JP 2010539959-A/2727: Micromirs
TGCACACT
>HV597345.1 JP 2010539959-A/2726: Micromirs
TGCAGCCA
>HV597344.1 JP 2010539959-A/2725: Micromirs
CAGCTGCT
>HV597343.1 JP 2010539959-A/2724: Micromirs
CAGCCTAG
>HV597342.1 JP 2010539959-A/2723: Micromirs
AGCCACAC
>HV597341.1 JP 2010539959-A/2722: Micromirs
CATACAAG
>HV597340.1 JP 2010539959-A/2721: Micromirs
GAGAGGGA
>HV597339.1 JP 2010539959-A/2720: Micromirs
TATGTCTT
>HV597338.1 JP 2010539959-A/2719: Micromirs
CTGGATCA
>HV597337.1 JP 2010539959-A/2718: Micromirs
CGCAGCGA
>HV597336.1 JP 2010539959-A/2717: Micromirs
GCGATCCC
>HV597335.1 JP 2010539959-A/2716: Micromirs
GCCCCCAG
>HV597334.1 JP 2010539959-A/2715: Micromirs
GCAAGCAC
>HV597333.1 JP 2010539959-A/2714: Micromirs
TGCCCAAG
>HV597332.1 JP 2010539959-A/2713: Micromirs
GTGCTGGT
>HV597331.1 JP 2010539959-A/2712: Micromirs
TACTATTA
>HV597330.1 JP 2010539959-A/2711: Micromirs
AGCAGACA
>HV597329.1 JP 2010539959-A/2710: Micromirs
GCCAGGTC
>HV597328.1 JP 2010539959-A/2709: Micromirs
CAGAATAC
>HV597327.1 JP 2010539959-A/2708: Micromirs
TGGGAGAA
>HV597326.1 JP 2010539959-A/2707: Micromirs
GTAAACCC
>HV597325.1 JP 2010539959-A/2706: Micromirs
TGTCAGCA
>HV597324.1 JP 2010539959-A/2705: Micromirs
CTTACTAG
>HV597323.1 JP 2010539959-A/2704: Micromirs
GAGACTCA
>HV597322.1 JP 2010539959-A/2703: Micromirs
CAGACAGC
>HV597321.1 JP 2010539959-A/2702: Micromirs
TCTATAGT
>HV597320.1 JP 2010539959-A/2701: Micromirs
TTTCCCCC
>HV597319.1 JP 2010539959-A/2700: Micromirs
CTGGTACT
>HV597318.1 JP 2010539959-A/2699: Micromirs
TACCTTGT
>HV597317.1 JP 2010539959-A/2698: Micromirs
GCAAGGGA
>HV597316.1 JP 2010539959-A/2697: Micromirs
GCAGACTG
>HV597315.1 JP 2010539959-A/2696: Micromirs
TTGCTAGC
>HV597314.1 JP 2010539959-A/2695: Micromirs
TATCTCCA
>HV597313.1 JP 2010539959-A/2694: Micromirs
GTCCAGGT
>HV597312.1 JP 2010539959-A/2693: Micromirs
GTAGAGTT
>HV597311.1 JP 2010539959-A/2692: Micromirs
GGGAAGTC
>HV597310.1 JP 2010539959-A/2691: Micromirs
GTTTTGAG
>HV597309.1 JP 2010539959-A/2690: Micromirs
CCAATGAC
>HV597308.1 JP 2010539959-A/2689: Micromirs
GGGACCCC
>HV597307.1 JP 2010539959-A/2688: Micromirs
AGGCTCGG
>HV597306.1 JP 2010539959-A/2687: Micromirs
CAGGCGTT
>HV597305.1 JP 2010539959-A/2686: Micromirs
AACATTCC
>HV597304.1 JP 2010539959-A/2685: Micromirs
CTGCCCAG
>HV597303.1 JP 2010539959-A/2684: Micromirs
GGTCCTCG
>HV597302.1 JP 2010539959-A/2683: Micromirs
TTTAGCTC
>HV597301.1 JP 2010539959-A/2682: Micromirs
AAACACCC
>HV597300.1 JP 2010539959-A/2681: Micromirs
ACCACCCC
>HV597299.1 JP 2010539959-A/2680: Micromirs
GATTTGAA
>HV597298.1 JP 2010539959-A/2679: Micromirs
CAGTAGTT
>HV597297.1 JP 2010539959-A/2678: Micromirs
TGGGATTT
>HV597296.1 JP 2010539959-A/2677: Micromirs
CCGCAGCC
>HV597295.1 JP 2010539959-A/2676: Micromirs
CAGTGTGT
>HV597294.1 JP 2010539959-A/2675: Micromirs
GCCCGTGT
>HV597293.1 JP 2010539959-A/2674: Micromirs
CCTAGACC
>HV597292.1 JP 2010539959-A/2673: Micromirs
TCTGTAAG
>HV597291.1 JP 2010539959-A/2672: Micromirs
TGACACAA
>HV597290.1 JP 2010539959-A/2671: Micromirs
GATGACGT
>HV597289.1 JP 2010539959-A/2670: Micromirs
AGTGACAC
>HV597288.1 JP 2010539959-A/2669: Micromirs
GGCAGGCT
>HV597287.1 JP 2010539959-A/2668: Micromirs
GCACACTT
>HV597286.1 JP 2010539959-A/2667: Micromirs
CTGGTGCC
>HV597285.1 JP 2010539959-A/2666: Micromirs
GCAGAGAC
>HV597284.1 JP 2010539959-A/2665: Micromirs
TTGACACA
>HV597283.1 JP 2010539959-A/2664: Micromirs
CCATGGTC
>HV597282.1 JP 2010539959-A/2663: Micromirs
AATAAGCT
>HV597281.1 JP 2010539959-A/2662: Micromirs
ATAAAATT
>HV597280.1 JP 2010539959-A/2661: Micromirs
TTGTTCTG
>HV597279.1 JP 2010539959-A/2660: Micromirs
TGGTTCTC
>HV597278.1 JP 2010539959-A/2659: Micromirs
TGTGGCCA
>HV597277.1 JP 2010539959-A/2658: Micromirs
CTATGGAA
>HV597276.1 JP 2010539959-A/2657: Micromirs
CAATGCAT
>HV597275.1 JP 2010539959-A/2656: Micromirs
ATACGCCC
>HV597274.1 JP 2010539959-A/2655: Micromirs
AAACCATA
>HV597273.1 JP 2010539959-A/2654: Micromirs
TCCTCTTT
>HV597272.1 JP 2010539959-A/2653: Micromirs
CAACTGTA
>HV597271.1 JP 2010539959-A/2652: Micromirs
AACCAGTT
>HV597270.1 JP 2010539959-A/2651: Micromirs
AACACAAG
>HV597269.1 JP 2010539959-A/2650: Micromirs
CATTCTCA
>HV597268.1 JP 2010539959-A/2649: Micromirs
CCAAATGA
>HV597267.1 JP 2010539959-A/2648: Micromirs
CACAAGAA
>HV597266.1 JP 2010539959-A/2647: Micromirs
TTTTATCT
>HV597265.1 JP 2010539959-A/2646: Micromirs
AATTAGAA
>HV597264.1 JP 2010539959-A/2645: Micromirs
CCACATCT
>HV597263.1 JP 2010539959-A/2644: Micromirs
AACTGGCT
>HV597262.1 JP 2010539959-A/2643: Micromirs
ACACACTC
>HV597261.1 JP 2010539959-A/2642: Micromirs
ATGAGCGT
>HV597260.1 JP 2010539959-A/2641: Micromirs
TCACTTCA
>HV597259.1 JP 2010539959-A/2640: Micromirs
CGAGCGGA
>HV597258.1 JP 2010539959-A/2639: Micromirs
GCCAACTC
>HV597257.1 JP 2010539959-A/2638: Micromirs
CTGTTTTC
>HV597256.1 JP 2010539959-A/2637: Micromirs
TCATTAAC
>HV597255.1 JP 2010539959-A/2636: Micromirs
TTTATACA
>HV597254.1 JP 2010539959-A/2635: Micromirs
GAACATAC
>HV597253.1 JP 2010539959-A/2634: Micromirs
CAGGCGCC
>HV597252.1 JP 2010539959-A/2633: Micromirs
ACCGTGCC
>HV597251.1 JP 2010539959-A/2632: Micromirs
TGTCAACC
>HV597250.1 JP 2010539959-A/2631: Micromirs
AGCTACTT
>HV597249.1 JP 2010539959-A/2630: Micromirs
TAAACTTT
>HV597248.1 JP 2010539959-A/2629: Micromirs
TTTACTTT
>HV597247.1 JP 2010539959-A/2628: Micromirs
AGCAGCTC
>HV597246.1 JP 2010539959-A/2627: Micromirs
CGTGCAAA
>HV597245.1 JP 2010539959-A/2626: Micromirs
GAGCTCAT
>HV597244.1 JP 2010539959-A/2625: Micromirs
TGGTAATA
>HV597243.1 JP 2010539959-A/2624: Micromirs
GCTTACCC
>HV597242.1 JP 2010539959-A/2623: Micromirs
AGGACTAG
>HV597241.1 JP 2010539959-A/2622: Micromirs
CACCGTTT
>HV597240.1 JP 2010539959-A/2621: Micromirs
TCACCTGT
>HV597239.1 JP 2010539959-A/2620: Micromirs
CTTGATTT
>HV597238.1 JP 2010539959-A/2619: Micromirs
ATGGGTCG
>HV597237.1 JP 2010539959-A/2618: Micromirs
GTGGGTCG
>HV597236.1 JP 2010539959-A/2617: Micromirs
AGTAAGAC
>HV597235.1 JP 2010539959-A/2616: Micromirs
TCAGGCAC
>HV597234.1 JP 2010539959-A/2615: Micromirs
TAGTTGTC
>HV597233.1 JP 2010539959-A/2614: Micromirs
TTTTTGCT
>HV597232.1 JP 2010539959-A/2613: Micromirs
CAGTTTTG
>HV597231.1 JP 2010539959-A/2612: Micromirs
TTACTTTT
>HV597230.1 JP 2010539959-A/2611: Micromirs
ATACCTTT
>HV597229.1 JP 2010539959-A/2610: Micromirs
AATACTTT
>HV597228.1 JP 2010539959-A/2609: Micromirs
AGTACTTT
>HV597227.1 JP 2010539959-A/2608: Micromirs
ATTACTTT
>HV597226.1 JP 2010539959-A/2607: Micromirs
ATTACTTT
>HV597225.1 JP 2010539959-A/2606: Micromirs
ATTACTTT
>HV597224.1 JP 2010539959-A/2605: Micromirs
TACAGTTT
>HV597223.1 JP 2010539959-A/2604: Micromirs
ACAGTTTT
>HV597222.1 JP 2010539959-A/2603: Micromirs
TCAGTTTT
>HV597221.1 JP 2010539959-A/2602: Micromirs
ATTACTTT
>HV597220.1 JP 2010539959-A/2601: Micromirs
TGGTTTTT
>HV597219.1 JP 2010539959-A/2600: Micromirs
ATTACTTT
>HV597218.1 JP 2010539959-A/2599: Micromirs
AGATTTTT
>HV597217.1 JP 2010539959-A/2598: Micromirs
ATTACTTT
>HV597216.1 JP 2010539959-A/2597: Micromirs
AGGTTCTT
>HV597215.1 JP 2010539959-A/2596: Micromirs
ATTACTTT
>HV597214.1 JP 2010539959-A/2595: Micromirs
CCAGTTTT
>HV597213.1 JP 2010539959-A/2594: Micromirs
ATTTACTG
>HV597212.1 JP 2010539959-A/2593: Micromirs
GTTTGCTG
>HV597211.1 JP 2010539959-A/2592: Micromirs
ATGCAGAA
>HV597210.1 JP 2010539959-A/2591: Micromirs
CGAATGTT
>HV597209.1 JP 2010539959-A/2590: Micromirs
GATCCCCG
>HV597208.1 JP 2010539959-A/2589: Micromirs
TCTGTCAC
>HV597207.1 JP 2010539959-A/2588: Micromirs
GAATCCTT
>HV597206.1 JP 2010539959-A/2587: Micromirs
TGCCCACC
>HV597205.1 JP 2010539959-A/2586: Micromirs
AATTTCTC
>HV597204.1 JP 2010539959-A/2585: Micromirs
CAAGGCAT
>HV597203.1 JP 2010539959-A/2584: Micromirs
TGTGGGAG
>HV597202.1 JP 2010539959-A/2583: Micromirs
CCTTTGCA
>HV597201.1 JP 2010539959-A/2582: Micromirs
AGCACTTT
>HV597200.1 JP 2010539959-A/2581: Micromirs
CCTCAAGA
>HV597199.1 JP 2010539959-A/2580: Micromirs
CCTCTGGA
>HV597198.1 JP 2010539959-A/2579: Micromirs
AGCGCCTT
>HV597197.1 JP 2010539959-A/2578: Micromirs
CCTTTGTA
>HV597196.1 JP 2010539959-A/2577: Micromirs
AGCGCCTT
>HV597195.1 JP 2010539959-A/2576: Micromirs
AGCGCGTT
>HV597194.1 JP 2010539959-A/2575: Micromirs
AACCATTT
>HV597193.1 JP 2010539959-A/2574: Micromirs
AAGTGCGT
>HV597192.1 JP 2010539959-A/2573: Micromirs
GCACTTTG
>HV597191.1 JP 2010539959-A/2572: Micromirs
GCACTTTG
>HV597190.1 JP 2010539959-A/2571: Micromirs
GAAGCACT
>HV597189.1 JP 2010539959-A/2570: Micromirs
AAGCACTT
>HV597188.1 JP 2010539959-A/2569: Micromirs
CCTTTGTA
>HV597187.1 JP 2010539959-A/2568: Micromirs
AAGCACTT
>HV597186.1 JP 2010539959-A/2567: Micromirs
AAGCACTT
>HV597185.1 JP 2010539959-A/2566: Micromirs
AAGCACTT
>HV597184.1 JP 2010539959-A/2565: Micromirs
CCTCTGGA
>HV597183.1 JP 2010539959-A/2564: Micromirs
AAGCACTT
>HV597182.1 JP 2010539959-A/2563: Micromirs
TTTGGAGA
>HV597181.1 JP 2010539959-A/2562: Micromirs
GAGGCACT
>HV597180.1 JP 2010539959-A/2561: Micromirs
GGCACTTT
>HV597179.1 JP 2010539959-A/2560: Micromirs
ATGCACTT
>HV597178.1 JP 2010539959-A/2559: Micromirs
ATGCACTT
>HV597177.1 JP 2010539959-A/2558: Micromirs
CCTCTAGA
>HV597176.1 JP 2010539959-A/2557: Micromirs
ATGCACTT
>HV597175.1 JP 2010539959-A/2556: Micromirs
CCTCTAGA
>HV597174.1 JP 2010539959-A/2555: Micromirs
AGCGCTTT
>HV597173.1 JP 2010539959-A/2554: Micromirs
AAGCGCTT
>HV597172.1 JP 2010539959-A/2553: Micromirs
CCTCTAGA
>HV597171.1 JP 2010539959-A/2552: Micromirs
AGCGCTTT
>HV597170.1 JP 2010539959-A/2551: Micromirs
CTCCAGAG
>HV597169.1 JP 2010539959-A/2550: Micromirs
AGCGCTTT
>HV597168.1 JP 2010539959-A/2549: Micromirs
AGCGCTTT
>HV597167.1 JP 2010539959-A/2548: Micromirs
AGCGCTTT
>HV597166.1 JP 2010539959-A/2547: Micromirs
ATGCACGA
>HV597165.1 JP 2010539959-A/2546: Micromirs
GATGCACG
>HV597164.1 JP 2010539959-A/2545: Micromirs
ATGCACGA
>HV597163.1 JP 2010539959-A/2544: Micromirs
ATCTAGAG
>HV597162.1 JP 2010539959-A/2543: Micromirs
CCTCCAGA
>HV597161.1 JP 2010539959-A/2542: Micromirs
CCTCGAGA
>HV597160.1 JP 2010539959-A/2541: Micromirs
AAGGAAGC
>HV597159.1 JP 2010539959-A/2540: Micromirs
TTTGGAGA
>HV597158.1 JP 2010539959-A/2539: Micromirs
AAGGCACT
>HV597157.1 JP 2010539959-A/2538: Micromirs
AGTGTCAA
>HV597156.1 JP 2010539959-A/2537: Micromirs
CCTTGAGA
>HV597155.1 JP 2010539959-A/2536: Micromirs
CCTTGTGA
>HV597154.1 JP 2010539959-A/2535: Micromirs
CCCTGTGA
>HV597153.1 JP 2010539959-A/2534: Micromirs
TGAAATTT
>HV597152.1 JP 2010539959-A/2533: Micromirs
GGCTGAGT
>HV597151.1 JP 2010539959-A/2532: Micromirs
ACAGCACT
>HV597150.1 JP 2010539959-A/2531: Micromirs
AAAAGACA
>HV597149.1 JP 2010539959-A/2530: Micromirs
TCCTGAGT
>HV597148.1 JP 2010539959-A/2529: Micromirs
TCTGCAGT
>HV597147.1 JP 2010539959-A/2528: Micromirs
TACCAATC
>HV597146.1 JP 2010539959-A/2527: Micromirs
TCTGCAGT
>HV597145.1 JP 2010539959-A/2526: Micromirs
TCTGGAGT
>HV597144.1 JP 2010539959-A/2525: Micromirs
CTACAATC
>HV597143.1 JP 2010539959-A/2524: Micromirs
GGTGCAAA
>HV597142.1 JP 2010539959-A/2523: Micromirs
GGTGCCTT
>HV597141.1 JP 2010539959-A/2522: Micromirs
CTGGCTCC
>HV597140.1 JP 2010539959-A/2521: Micromirs
GTGTTGAC
>HV597139.1 JP 2010539959-A/2520: Micromirs
CCAGGGTC
>HV597138.1 JP 2010539959-A/2519: Micromirs
CCGCTGCT
>HV597137.1 JP 2010539959-A/2518: Micromirs
AGCAAGGA
>HV597136.1 JP 2010539959-A/2517: Micromirs
AGGTGCAT
>HV597135.1 JP 2010539959-A/2516: Micromirs
CAAAGGAT
>HV597134.1 JP 2010539959-A/2515: Micromirs
GGGTGCAT
>HV597133.1 JP 2010539959-A/2514: Micromirs
CAGGTGCA
>HV597132.1 JP 2010539959-A/2513: Micromirs
CAAGGATT
>HV597131.1 JP 2010539959-A/2512: Micromirs
AAGTCTTA
>HV597130.1 JP 2010539959-A/2511: Micromirs
TGTGATGT
>HV597129.1 JP 2010539959-A/2510: Micromirs
GGCTTGAA
>HV597128.1 JP 2010539959-A/2509: Micromirs
TGTGGTTT
>HV597127.1 JP 2010539959-A/2508: Micromirs
GTGCTGCT
>HV597126.1 JP 2010539959-A/2507: Micromirs
TAATACTC
>HV597125.1 JP 2010539959-A/2506: Micromirs
TGTTTGTT
>HV597124.1 JP 2010539959-A/2505: Micromirs
TATGTTTC
>HV597123.1 JP 2010539959-A/2504: Micromirs
CATGTACA
>HV597122.1 JP 2010539959-A/2503: Micromirs
AGACCTTC
>HV597121.1 JP 2010539959-A/2502: Micromirs
GCAGGTCC
>HV597120.1 JP 2010539959-A/2501: Micromirs
TTCCCCAC
>HV597119.1 JP 2010539959-A/2500: Micromirs
TTGCATAA
>HV597118.1 JP 2010539959-A/2499: Micromirs
GATCCATG
>HV597117.1 JP 2010539959-A/2498: Micromirs
TCCAGGTT
>HV597116.1 JP 2010539959-A/2497: Micromirs
TGATGTCA
>HV597115.1 JP 2010539959-A/2496: Micromirs
TTATCTGG
>HV597114.1 JP 2010539959-A/2495: Micromirs
GCCTTTCA
>HV597113.1 JP 2010539959-A/2494: Micromirs
TGTACGAT
>HV597112.1 JP 2010539959-A/2493: Micromirs
TGTATGAT
>HV597111.1 JP 2010539959-A/2492: Micromirs
AGTACAGG
>HV597110.1 JP 2010539959-A/2491: Micromirs
GCTGCCCC
>HV597109.1 JP 2010539959-A/2490: Micromirs
CCAGCCTC
>HV597108.1 JP 2010539959-A/2489: Micromirs
GTGTATGA
>HV597107.1 JP 2010539959-A/2488: Micromirs
TGAGCCTG
>HV597106.1 JP 2010539959-A/2487: Micromirs
TCCCGTCT
>HV597105.1 JP 2010539959-A/2486: Micromirs
GAGGAGTG
>HV597104.1 JP 2010539959-A/2485: Micromirs
AGGCACAT
>HV597103.1 JP 2010539959-A/2484: Micromirs
ATGGACTG
>HV597102.1 JP 2010539959-A/2483: Micromirs
TGATAGGG
>HV597101.1 JP 2010539959-A/2482: Micromirs
ATTGCACT
>HV597100.1 JP 2010539959-A/2481: Micromirs
GGACAACC
>HV597099.1 JP 2010539959-A/2480: Micromirs
GCAGATGA
>HV597098.1 JP 2010539959-A/2479: Micromirs
CAAACAGT
>HV597097.1 JP 2010539959-A/2478: Micromirs
TAACGGTT
>HV597096.1 JP 2010539959-A/2477: Micromirs
ATTGCAAA
>HV597095.1 JP 2010539959-A/2476: Micromirs
TGATCCCA
>HV597094.1 JP 2010539959-A/2475: Micromirs
ATCGCAAA
>HV597093.1 JP 2010539959-A/2474: Micromirs
ACACTGCC
>HV597092.1 JP 2010539959-A/2473: Micromirs
ACACTGCC
>HV597091.1 JP 2010539959-A/2472: Micromirs
CATATGCA
>HV597090.1 JP 2010539959-A/2471: Micromirs
CATCATGA
>HV597089.1 JP 2010539959-A/2470: Micromirs
GCCATCCA
>HV597088.1 JP 2010539959-A/2469: Micromirs
ACTCCAAG
>HV597087.1 JP 2010539959-A/2468: Micromirs
GACGACCT
>HV597086.1 JP 2010539959-A/2467: Micromirs
TGCAAGAC
>HV597085.1 JP 2010539959-A/2466: Micromirs
ACAGTATT
>HV597084.1 JP 2010539959-A/2465: Micromirs
ATTCCCGA
>HV597083.1 JP 2010539959-A/2464: Micromirs
CGTGTCAT
>HV597082.1 JP 2010539959-A/2463: Micromirs
CACGTTTT
>HV597081.1 JP 2010539959-A/2462: Micromirs
TTGCTGCT
>HV597080.1 JP 2010539959-A/2461: Micromirs
TGCCCCTC
>HV597079.1 JP 2010539959-A/2460: Micromirs
GACCGAGC
>HV597078.1 JP 2010539959-A/2459: Micromirs
AAGTCCAG
>HV597077.1 JP 2010539959-A/2458: Micromirs
TCTGTTGA
>HV597076.1 JP 2010539959-A/2457: Micromirs
AGGTGAAG
>HV597075.1 JP 2010539959-A/2456: Micromirs
TGTTACAT
>HV597074.1 JP 2010539959-A/2455: Micromirs
GGTCTACT
>HV597073.1 JP 2010539959-A/2454: Micromirs
TGTTATAT
>HV597072.1 JP 2010539959-A/2453: Micromirs
GGGTAACC
>HV597071.1 JP 2010539959-A/2452: Micromirs
GCAACATT
>HV597070.1 JP 2010539959-A/2451: Micromirs
TCTAGGAA
>HV597069.1 JP 2010539959-A/2450: Micromirs
TTCTGATC
>HV597068.1 JP 2010539959-A/2449: Micromirs
AACAACTT
>HV597067.1 JP 2010539959-A/2448: Micromirs
CCTTGTAT
>HV597066.1 JP 2010539959-A/2447: Micromirs
GGTCAACC
>HV597065.1 JP 2010539959-A/2446: Micromirs
TATTACAT
>HV597064.1 JP 2010539959-A/2445: Micromirs
TGTTACAT
>HV597063.1 JP 2010539959-A/2444: Micromirs
AGTCTACC
>HV597062.1 JP 2010539959-A/2443: Micromirs
AGTCAGGA
>HV597061.1 JP 2010539959-A/2442: Micromirs
AAGTCCAG
>HV597060.1 JP 2010539959-A/2441: Micromirs
GCAACCTC
>HV597059.1 JP 2010539959-A/2440: Micromirs
TTGTGTGA
>HV597058.1 JP 2010539959-A/2439: Micromirs
CTCTATGT
>HV597057.1 JP 2010539959-A/2438: Micromirs
CTCTATGA
>HV597056.1 JP 2010539959-A/2437: Micromirs
AGAATCTA
>HV597055.1 JP 2010539959-A/2436: Micromirs
CTCTATGA
>HV597054.1 JP 2010539959-A/2435: Micromirs
ACGAACAA
>HV597053.1 JP 2010539959-A/2434: Micromirs
CCTGCTAA
>HV597052.1 JP 2010539959-A/2433: Micromirs
GTATTATA
>HV597051.1 JP 2010539959-A/2432: Micromirs
TCTGATAA
>HV597050.1 JP 2010539959-A/2431: Micromirs
GTATTATA
>HV597049.1 JP 2010539959-A/2430: Micromirs
ATTTTGAG
>HV597048.1 JP 2010539959-A/2429: Micromirs
AAGCACTT
>HV597047.1 JP 2010539959-A/2428: Micromirs
CAGCACTT
>HV597046.1 JP 2010539959-A/2427: Micromirs
AGTTTGAG
>HV597045.1 JP 2010539959-A/2426: Micromirs
GCGGCACT
>HV597044.1 JP 2010539959-A/2425: Micromirs
CCAGCAGG
>HV597043.1 JP 2010539959-A/2424: Micromirs
GGTCGATC
>HV597042.1 JP 2010539959-A/2423: Micromirs
TGTATTAT
>HV597041.1 JP 2010539959-A/2422: Micromirs
AGCAACAG
>HV597040.1 JP 2010539959-A/2421: Micromirs
AGTGCAAT
>HV597039.1 JP 2010539959-A/2420: Micromirs
GGGGCATT
>HV597038.1 JP 2010539959-A/2419: Micromirs
ATCCACCC
>HV597037.1 JP 2010539959-A/2418: Micromirs
CGTGCAAT
>HV597036.1 JP 2010539959-A/2417: Micromirs
CCAAGGAT
>HV597035.1 JP 2010539959-A/2416: Micromirs
AGGTGTGT
>HV597034.1 JP 2010539959-A/2415: Micromirs
TTCTGATA
>HV597033.1 JP 2010539959-A/2414: Micromirs
CCTGGGGG
>HV597032.1 JP 2010539959-A/2413: Micromirs
ACACTGCC
>HV597031.1 JP 2010539959-A/2412: Micromirs
TTAGTGAT
>HV597030.1 JP 2010539959-A/2411: Micromirs
CACTGCCT
>HV597029.1 JP 2010539959-A/2410: Micromirs
TAGTGATT
>HV597028.1 JP 2010539959-A/2409: Micromirs
TGCTGATT
>HV597027.1 JP 2010539959-A/2408: Micromirs
ACACTGCC
>HV597026.1 JP 2010539959-A/2407: Micromirs
GGGCAGAC
>HV597025.1 JP 2010539959-A/2406: Micromirs
GGAGTCAG
>HV597024.1 JP 2010539959-A/2405: Micromirs
AGCACCCC
>HV597023.1 JP 2010539959-A/2404: Micromirs
TGTGTGAG
>HV597022.1 JP 2010539959-A/2403: Micromirs
TGAGACGG
>HV597021.1 JP 2010539959-A/2402: Micromirs
GCTTTATA
>HV597020.1 JP 2010539959-A/2401: Micromirs
GAGGCACT
>HV597019.1 JP 2010539959-A/2400: Micromirs
GCAATGCA
>HV597018.1 JP 2010539959-A/2399: Micromirs
GAAACATT
>HV597017.1 JP 2010539959-A/2398: Micromirs
ACAATGCA
>HV597016.1 JP 2010539959-A/2397: Micromirs
GGACAGGG
>HV597015.1 JP 2010539959-A/2396: Micromirs
AGGCGCTC
>HV597014.1 JP 2010539959-A/2395: Micromirs
GATATTGT
>HV597013.1 JP 2010539959-A/2394: Micromirs
GATGCTGG
>HV597012.1 JP 2010539959-A/2393: Micromirs
AAGCCGTT
>HV597011.1 JP 2010539959-A/2392: Micromirs
ATATAGGA
>HV597010.1 JP 2010539959-A/2391: Micromirs
AATGAAAA
>HV597009.1 JP 2010539959-A/2390: Micromirs
TGCTCTTG
>HV597008.1 JP 2010539959-A/2389: Micromirs
CATACCTA
>HV597007.1 JP 2010539959-A/2388: Micromirs
CCCAGGGG
>HV597006.1 JP 2010539959-A/2387: Micromirs
GCCCAGAG
>HV597005.1 JP 2010539959-A/2386: Micromirs
GTGCTTTG
>HV597004.1 JP 2010539959-A/2385: Micromirs
AGGTGTGT
>HV597003.1 JP 2010539959-A/2384: Micromirs
GAGGGCCA
>HV597002.1 JP 2010539959-A/2383: Micromirs
GCCCAGAG
>HV597001.1 JP 2010539959-A/2382: Micromirs
CCTACTAG
>HV597000.1 JP 2010539959-A/2381: Micromirs
GGGGATGC
>HV596999.1 JP 2010539959-A/2380: Micromirs
TGGGGCAG
>HV596998.1 JP 2010539959-A/2379: Micromirs
GGACCACC
>HV596997.1 JP 2010539959-A/2378: Micromirs
TGTAATGT
>HV596996.1 JP 2010539959-A/2377: Micromirs
CCAGCTTT
>HV596995.1 JP 2010539959-A/2376: Micromirs
CCAGCTTT
>HV596994.1 JP 2010539959-A/2375: Micromirs
CCAGCTTT
>HV596993.1 JP 2010539959-A/2374: Micromirs
CCAGCTTT
>HV596992.1 JP 2010539959-A/2373: Micromirs
ACTAAATT
>HV596991.1 JP 2010539959-A/2372: Micromirs
TGTGCAAT
>HV596990.1 JP 2010539959-A/2371: Micromirs
GGCATAGC
>HV596989.1 JP 2010539959-A/2370: Micromirs
ATCTTGCC
>HV596988.1 JP 2010539959-A/2369: Micromirs
GACTGAAA
>HV596987.1 JP 2010539959-A/2368: Micromirs
ATGTTTAC
>HV596986.1 JP 2010539959-A/2367: Micromirs
GACTGAAA
>HV596985.1 JP 2010539959-A/2366: Micromirs
ATGTTTAC
>HV596984.1 JP 2010539959-A/2365: Micromirs
TTCTCCCA
>HV596983.1 JP 2010539959-A/2364: Micromirs
CTCTCCCA
>HV596982.1 JP 2010539959-A/2363: Micromirs
ATGTTTAC
>HV596981.1 JP 2010539959-A/2362: Micromirs
ACCTCCCA
>HV596980.1 JP 2010539959-A/2361: Micromirs
ATGTTTAC
>HV596979.1 JP 2010539959-A/2360: Micromirs
GACTGAAA
>HV596978.1 JP 2010539959-A/2359: Micromirs
ATGTTTAC
>HV596977.1 JP 2010539959-A/2358: Micromirs
AAGCAATT
>HV596976.1 JP 2010539959-A/2357: Micromirs
AAGCACTT
>HV596975.1 JP 2010539959-A/2356: Micromirs
TGTTAAAG
>HV596974.1 JP 2010539959-A/2355: Micromirs
AAGCACTT
>HV596973.1 JP 2010539959-A/2354: Micromirs
CATGTTAA
>HV596972.1 JP 2010539959-A/2353: Micromirs
AAGCACTT
>HV596971.1 JP 2010539959-A/2352: Micromirs
TGTTAAAG
>HV596970.1 JP 2010539959-A/2351: Micromirs
AAGCACTT
>HV596969.1 JP 2010539959-A/2350: Micromirs
CGTTTAAG
>HV596968.1 JP 2010539959-A/2349: Micromirs
AAGCACTT
>HV596967.1 JP 2010539959-A/2348: Micromirs
ATTGCACT
>HV596966.1 JP 2010539959-A/2347: Micromirs
ATTGCACT
>HV596965.1 JP 2010539959-A/2346: Micromirs
CCTTGTAT
>HV596964.1 JP 2010539959-A/2345: Micromirs
AATCGGTC
>HV596963.1 JP 2010539959-A/2344: Micromirs
ATGGTGCT
>HV596962.1 JP 2010539959-A/2343: Micromirs
TGAAACCA
>HV596961.1 JP 2010539959-A/2342: Micromirs
GAAACCAG
>HV596960.1 JP 2010539959-A/2341: Micromirs
ATGGTGCT
>HV596959.1 JP 2010539959-A/2340: Micromirs
GAAATCAG
>HV596958.1 JP 2010539959-A/2339: Micromirs
ATGGTGCT
>HV596957.1 JP 2010539959-A/2338: Micromirs
GGTAAACC
>HV596956.1 JP 2010539959-A/2337: Micromirs
TCCCACAT
>HV596955.1 JP 2010539959-A/2336: Micromirs
GCTTCTGC
>HV596954.1 JP 2010539959-A/2335: Micromirs
CACATACA
>HV596953.1 JP 2010539959-A/2334: Micromirs
GGGGGCCC
>HV596952.1 JP 2010539959-A/2333: Micromirs
CCAACCCT
>HV596951.1 JP 2010539959-A/2332: Micromirs
GAGCTCCT
>HV596950.1 JP 2010539959-A/2331: Micromirs
AATCTAGT
>HV596949.1 JP 2010539959-A/2330: Micromirs
CTAAGCTC
>HV596948.1 JP 2010539959-A/2329: Micromirs
CACTGTGA
>HV596947.1 JP 2010539959-A/2328: Micromirs
CTAAGCCC
>HV596946.1 JP 2010539959-A/2327: Micromirs
CACTGTGA
>HV596945.1 JP 2010539959-A/2326: Micromirs
GAGAACAG
>HV596944.1 JP 2010539959-A/2325: Micromirs
TTACTTGA
>HV596943.1 JP 2010539959-A/2324: Micromirs
AAGAATAG
>HV596942.1 JP 2010539959-A/2323: Micromirs
AAGAATAG
>HV596941.1 JP 2010539959-A/2322: Micromirs
TTACTTGA
>HV596940.1 JP 2010539959-A/2321: Micromirs
TCTCCGCC
>HV596939.1 JP 2010539959-A/2320: Micromirs
AGTGCAAT
>HV596938.1 JP 2010539959-A/2319: Micromirs
CAGTAGGC
>HV596937.1 JP 2010539959-A/2318: Micromirs
CAGTAGGC
>HV596936.1 JP 2010539959-A/2317: Micromirs
ACTGAGCC
>HV596935.1 JP 2010539959-A/2316: Micromirs
AGGAACCC
>HV596934.1 JP 2010539959-A/2315: Micromirs
CAATGTGA
>HV596933.1 JP 2010539959-A/2314: Micromirs
AGGAACCC
>HV596932.1 JP 2010539959-A/2313: Micromirs
CAATGTGA
>HV596931.1 JP 2010539959-A/2312: Micromirs
AGTGACTT
>HV596930.1 JP 2010539959-A/2311: Micromirs
AAATACAC
>HV596929.1 JP 2010539959-A/2310: Micromirs
AAACTGAC
>HV596928.1 JP 2010539959-A/2309: Micromirs
GCTACTGA
>HV596927.1 JP 2010539959-A/2308: Micromirs
GATGTAGC
>HV596926.1 JP 2010539959-A/2307: Micromirs
ATGCCAGG
>HV596925.1 JP 2010539959-A/2306: Micromirs
AATGTAGC
>HV596924.1 JP 2010539959-A/2305: Micromirs
GCCCTGTG
>HV596923.1 JP 2010539959-A/2304: Micromirs
CGGTGGTG
>HV596922.1 JP 2010539959-A/2303: Micromirs
ACGGTGTG
>HV596921.1 JP 2010539959-A/2302: Micromirs
TGAAGAAC
>HV596920.1 JP 2010539959-A/2301: Micromirs
TGGCAGCT
>HV596919.1 JP 2010539959-A/2300: Micromirs
GGACAATC
>HV596918.1 JP 2010539959-A/2299: Micromirs
CACAATTC
>HV596917.1 JP 2010539959-A/2298: Micromirs
CTCAACTC
>HV596916.1 JP 2010539959-A/2297: Micromirs
AGAACCAT
>HV596915.1 JP 2010539959-A/2296: Micromirs
CGGAACCA
>HV596914.1 JP 2010539959-A/2295: Micromirs
CAAGCACA
>HV596913.1 JP 2010539959-A/2294: Micromirs
GATGCAGT
>HV596912.1 JP 2010539959-A/2293: Micromirs
CAGAGATT
>HV596911.1 JP 2010539959-A/2292: Micromirs
CTGAGATT
>HV596910.1 JP 2010539959-A/2291: Micromirs
ATAGGTCA
>HV596909.1 JP 2010539959-A/2290: Micromirs
AGACAGGC
>HV596908.1 JP 2010539959-A/2289: Micromirs
GCCTGCTG
>HV596907.1 JP 2010539959-A/2288: Micromirs
AGACTGTT
>HV596906.1 JP 2010539959-A/2287: Micromirs
CAAAGGGA
>HV596905.1 JP 2010539959-A/2286: Micromirs
CACGCACA
>HV596904.1 JP 2010539959-A/2285: Micromirs
CTGGTGTT
>HV596903.1 JP 2010539959-A/2284: Micromirs
GATAAGCT
>HV596902.1 JP 2010539959-A/2283: Micromirs
TACTACAG
>HV596901.1 JP 2010539959-A/2282: Micromirs
AGCACTTT
>HV596900.1 JP 2010539959-A/2281: Micromirs
TAATGCAG
>HV596899.1 JP 2010539959-A/2280: Micromirs
AGCACTTT
>HV596898.1 JP 2010539959-A/2279: Micromirs
TCGTCTTA
>HV596897.1 JP 2010539959-A/2278: Micromirs
TCGTCTTA
>HV596896.1 JP 2010539959-A/2277: Micromirs
TACATTCC
>HV596895.1 JP 2010539959-A/2276: Micromirs
AATGAAGG
>HV596894.1 JP 2010539959-A/2275: Micromirs
CAAAGGGA
>HV596893.1 JP 2010539959-A/2274: Micromirs
ACATTTCA
>HV596892.1 JP 2010539959-A/2273: Micromirs
GCATAGGA
>HV596891.1 JP 2010539959-A/2272: Micromirs
TATACCTC
>HV596890.1 JP 2010539959-A/2271: Micromirs
GGTAAGAC
>HV596889.1 JP 2010539959-A/2270: Micromirs
GCAGTATT
>HV596888.1 JP 2010539959-A/2269: Micromirs
AGTAAGAT
>HV596887.1 JP 2010539959-A/2268: Micromirs
GCAGTATT
>HV596886.1 JP 2010539959-A/2267: Micromirs
GGTAAGAT
>HV596885.1 JP 2010539959-A/2266: Micromirs
ACAGTGTT
>HV596884.1 JP 2010539959-A/2265: Micromirs
TGCAAAAC
>HV596883.1 JP 2010539959-A/2264: Micromirs
TGCAAAAC
>HV596882.1 JP 2010539959-A/2263: Micromirs
ATTTGCAC
>HV596881.1 JP 2010539959-A/2262: Micromirs
TGCAAAAC
>HV596880.1 JP 2010539959-A/2261: Micromirs
ATTTGCAC
>HV596879.1 JP 2010539959-A/2260: Micromirs
AACACTGG
>HV596878.1 JP 2010539959-A/2259: Micromirs
GACTACTG
>HV596877.1 JP 2010539959-A/2258: Micromirs
AACACTGG
>HV596876.1 JP 2010539959-A/2257: Micromirs
CTCTGGAC
>HV596875.1 JP 2010539959-A/2256: Micromirs
GGTGGTGA
>HV596874.1 JP 2010539959-A/2255: Micromirs
AACTACCT
>HV596873.1 JP 2010539959-A/2254: Micromirs
TTGTTGCC
>HV596872.1 JP 2010539959-A/2253: Micromirs
AACTACCT
>HV596871.1 JP 2010539959-A/2252: Micromirs
CAATATTG
>HV596870.1 JP 2010539959-A/2251: Micromirs
GTGCTGCT
>HV596869.1 JP 2010539959-A/2250: Micromirs
CCCCACTG
>HV596868.1 JP 2010539959-A/2249: Micromirs
GCTGTTAC
>HV596867.1 JP 2010539959-A/2248: Micromirs
AAAACCCC
>HV596866.1 JP 2010539959-A/2247: Micromirs
GGGCCAGT
>HV596865.1 JP 2010539959-A/2246: Micromirs
AAAGACCC
>HV596864.1 JP 2010539959-A/2245: Micromirs
AGGCCAGT
>HV596863.1 JP 2010539959-A/2244: Micromirs
AATTGGCA
>HV596862.1 JP 2010539959-A/2243: Micromirs
ATAGGTCA
>HV596861.1 JP 2010539959-A/2242: Micromirs
AGGCAAGG
>HV596860.1 JP 2010539959-A/2241: Micromirs
GCCCTGGG
>HV596859.1 JP 2010539959-A/2240: Micromirs
GACCCCTC
>HV596858.1 JP 2010539959-A/2239: Micromirs
GGCACAGG
>HV596857.1 JP 2010539959-A/2238: Micromirs
GGGGGCAG
>HV596856.1 JP 2010539959-A/2237: Micromirs
CTCTGGGT
>HV596855.1 JP 2010539959-A/2236: Micromirs
TGCCTGGT
>HV596854.1 JP 2010539959-A/2235: Micromirs
CGGTACTC
>HV596853.1 JP 2010539959-A/2234: Micromirs
CAGGACTG
>HV596852.1 JP 2010539959-A/2233: Micromirs
AAGCGCAG
>HV596851.1 JP 2010539959-A/2232: Micromirs
ATTCCGTT
>HV596850.1 JP 2010539959-A/2231: Micromirs
AACATATC
>HV596849.1 JP 2010539959-A/2230: Micromirs
CGGCACTC
>HV596848.1 JP 2010539959-A/2229: Micromirs
GCCCCTGC
>HV596847.1 JP 2010539959-A/2228: Micromirs
TCCCCGCC
>HV596846.1 JP 2010539959-A/2227: Micromirs
AACATATC
>HV596845.1 JP 2010539959-A/2226: Micromirs
TTTAGGGC
>HV596844.1 JP 2010539959-A/2225: Micromirs
TGCACCTT
>HV596843.1 JP 2010539959-A/2224: Micromirs
TAGGGCAG
>HV596842.1 JP 2010539959-A/2223: Micromirs
TGCACCTT
>HV596841.1 JP 2010539959-A/2222: Micromirs
CAAGGGAT
>HV596840.1 JP 2010539959-A/2221: Micromirs
ATGTGGGA
>HV596839.1 JP 2010539959-A/2220: Micromirs
GTTGTAGC
>HV596838.1 JP 2010539959-A/2219: Micromirs
AAGACACG
>HV596837.1 JP 2010539959-A/2218: Micromirs
CCTTTGGG
>HV596836.1 JP 2010539959-A/2217: Micromirs
AATTCTTT
>HV596835.1 JP 2010539959-A/2216: Micromirs
CCAGCCCC
>HV596834.1 JP 2010539959-A/2215: Micromirs
TTCTCTCC
>HV596833.1 JP 2010539959-A/2214: Micromirs
CTCCGTCC
>HV596832.1 JP 2010539959-A/2213: Micromirs
GTAATTCA
>HV596831.1 JP 2010539959-A/2212: Micromirs
AGTGCCAT
>HV596830.1 JP 2010539959-A/2211: Micromirs
ACTGCCTC
>HV596829.1 JP 2010539959-A/2210: Micromirs
ATGATCAA
>HV596828.1 JP 2010539959-A/2209: Micromirs
GGCACTGG
>HV596827.1 JP 2010539959-A/2208: Micromirs
CTAGAACC
>HV596826.1 JP 2010539959-A/2207: Micromirs
ATTGCCAA
>HV596825.1 JP 2010539959-A/2206: Micromirs
ATGAATGT
>HV596824.1 JP 2010539959-A/2205: Micromirs
TCGATGGT
>HV596823.1 JP 2010539959-A/2204: Micromirs
TTGAATGT
>HV596822.1 JP 2010539959-A/2203: Micromirs
ATGAATGT
>HV596821.1 JP 2010539959-A/2202: Micromirs
GTCAGTGG
>HV596820.1 JP 2010539959-A/2201: Micromirs
GTCGATGG
>HV596819.1 JP 2010539959-A/2200: Micromirs
TTGAATGT
>HV596818.1 JP 2010539959-A/2199: Micromirs
CACTGCAG
>HV596817.1 JP 2010539959-A/2198: Micromirs
AGCACTTT
>HV596816.1 JP 2010539959-A/2197: Micromirs
TAATATTG
>HV596815.1 JP 2010539959-A/2196: Micromirs
TAATACTG
>HV596814.1 JP 2010539959-A/2195: Micromirs
GTGCTGCT
>HV596813.1 JP 2010539959-A/2194: Micromirs
AATGATTC
>HV596812.1 JP 2010539959-A/2193: Micromirs
GTGCTGCT
>HV596811.1 JP 2010539959-A/2192: Micromirs
TATGGCCT
>HV596810.1 JP 2010539959-A/2191: Micromirs
GTGCTGCT
>HV596809.1 JP 2010539959-A/2190: Micromirs
ATGTAGGA
>HV596808.1 JP 2010539959-A/2189: Micromirs
TAGCATTA
>HV596807.1 JP 2010539959-A/2188: Micromirs
TGTATGAT
>HV596806.1 JP 2010539959-A/2187: Micromirs
GATAACCT
>HV596805.1 JP 2010539959-A/2186: Micromirs
CGCGCAGG
>HV596804.1 JP 2010539959-A/2185: Micromirs
CCCGGGCC
>HV596803.1 JP 2010539959-A/2184: Micromirs
GACGGTTT
>HV596802.1 JP 2010539959-A/2183: Micromirs
ACTATGCA
>HV596801.1 JP 2010539959-A/2182: Micromirs
ATGCACTG
>HV596800.1 JP 2010539959-A/2181: Micromirs
GCTCCTCG
>HV596799.1 JP 2010539959-A/2180: Micromirs
TCAGTCTA
>HV596798.1 JP 2010539959-A/2179: Micromirs
CTGTACCA
>HV596797.1 JP 2010539959-A/2178: Micromirs
GTTGGGAG
>HV596796.1 JP 2010539959-A/2177: Micromirs
TCCCTCCC
>HV596795.1 JP 2010539959-A/2176: Micromirs
GGAGCCAG
>HV596794.1 JP 2010539959-A/2175: Micromirs
ACAGAACT
>HV596793.1 JP 2010539959-A/2174: Micromirs
ATGCACTG
>HV596792.1 JP 2010539959-A/2173: Micromirs
CAGAACTT
>HV596791.1 JP 2010539959-A/2172: Micromirs
GTGCACTG
>HV596790.1 JP 2010539959-A/2171: Micromirs
TCCGCACA
>HV596789.1 JP 2010539959-A/2170: Micromirs
CACGCGGG
>HV596788.1 JP 2010539959-A/2169: Micromirs
GCGGAGGG
>HV596787.1 JP 2010539959-A/2168: Micromirs
TCCACACA
>HV596786.1 JP 2010539959-A/2167: Micromirs
CAGTTCTC
>HV596785.1 JP 2010539959-A/2166: Micromirs
CACAGGGC
>HV596784.1 JP 2010539959-A/2165: Micromirs
TTTCAGAG
>HV596783.1 JP 2010539959-A/2164: Micromirs
CAGTTCTC
>HV596782.1 JP 2010539959-A/2163: Micromirs
CGCGCCGA
>HV596781.1 JP 2010539959-A/2162: Micromirs
CAAACGGA
>HV596780.1 JP 2010539959-A/2161: Micromirs
CAGGAATC
>HV596779.1 JP 2010539959-A/2160: Micromirs
AAACTGGA
>HV596778.1 JP 2010539959-A/2159: Micromirs
ATGATATC
>HV596777.1 JP 2010539959-A/2158: Micromirs
TATACTGT
>HV596776.1 JP 2010539959-A/2157: Micromirs
CACTGCAC
>HV596775.1 JP 2010539959-A/2156: Micromirs
TTCATCTC
>HV596774.1 JP 2010539959-A/2155: Micromirs
TACTTTAT
>HV596773.1 JP 2010539959-A/2154: Micromirs
AACACTAC
>HV596772.1 JP 2010539959-A/2153: Micromirs
TGGAAGAT
>HV596771.1 JP 2010539959-A/2152: Micromirs
ACAGTGTT
>HV596770.1 JP 2010539959-A/2151: Micromirs
AAACCACT
>HV596769.1 JP 2010539959-A/2150: Micromirs
CCTGTGGT
>HV596768.1 JP 2010539959-A/2149: Micromirs
CACTGTAG
>HV596767.1 JP 2010539959-A/2148: Micromirs
CGCGTCTC
>HV596766.1 JP 2010539959-A/2147: Micromirs
TGAAATAG
>HV596765.1 JP 2010539959-A/2146: Micromirs
TGAAGTAG
>HV596764.1 JP 2010539959-A/2145: Micromirs
ACACCAGC
>HV596763.1 JP 2010539959-A/2144: Micromirs
AAGCAATA
>HV596762.1 JP 2010539959-A/2143: Micromirs
ACGATGAT
>HV596761.1 JP 2010539959-A/2142: Micromirs
AAATGGAG
>HV596760.1 JP 2010539959-A/2141: Micromirs
GCCCTACA
>HV596759.1 JP 2010539959-A/2140: Micromirs
AAAGCCAT
>HV596758.1 JP 2010539959-A/2139: Micromirs
ATCCCTAT
>HV596757.1 JP 2010539959-A/2138: Micromirs
AAAGCCAT
>HV596756.1 JP 2010539959-A/2137: Micromirs
CCAGTCAC
>HV596755.1 JP 2010539959-A/2136: Micromirs
GGGACCAA
>HV596754.1 JP 2010539959-A/2135: Micromirs
GGGACCAA
>HV596753.1 JP 2010539959-A/2134: Micromirs
TCTGTCTG
>HV596752.1 JP 2010539959-A/2133: Micromirs
CAGTTTTG
>HV596751.1 JP 2010539959-A/2132: Micromirs
AGCATCAT
>HV596750.1 JP 2010539959-A/2131: Micromirs
ACCTCCCT
>HV596749.1 JP 2010539959-A/2130: Micromirs
AGCCACGG
>HV596748.1 JP 2010539959-A/2129: Micromirs
AGACTGTT
>HV596747.1 JP 2010539959-A/2128: Micromirs
GGAAAGAG
>HV596746.1 JP 2010539959-A/2127: Micromirs
ATTGCACT
>HV596745.1 JP 2010539959-A/2126: Micromirs
CAATGTGA
>HV596744.1 JP 2010539959-A/2125: Micromirs
ATTGCACT
>HV596743.1 JP 2010539959-A/2124: Micromirs
CACCCATG
>HV596742.1 JP 2010539959-A/2123: Micromirs
ACGCCGAG
>HV596741.1 JP 2010539959-A/2122: Micromirs
AGCCAACG
>HV596740.1 JP 2010539959-A/2121: Micromirs
AGTTGAAA
>HV596739.1 JP 2010539959-A/2120: Micromirs
AGCCTCAA
>HV596738.1 JP 2010539959-A/2119: Micromirs
GTCTCTAA
>HV596737.1 JP 2010539959-A/2118: Micromirs
ATGTCCCA
>HV596736.1 JP 2010539959-A/2117: Micromirs
CAGCTGCA
>HV596735.1 JP 2010539959-A/2116: Micromirs
CCTTCTCA
>HV596734.1 JP 2010539959-A/2115: Micromirs
ATTCCAGA
>HV596733.1 JP 2010539959-A/2114: Micromirs
CCGAATGA
>HV596732.1 JP 2010539959-A/2113: Micromirs
TTACTTGA
>HV596731.1 JP 2010539959-A/2112: Micromirs
GGGCCCTA
>HV596730.1 JP 2010539959-A/2111: Micromirs
GCGGCCTA
>HV596729.1 JP 2010539959-A/2110: Micromirs
AACCTCAC
>HV596728.1 JP 2010539959-A/2109: Micromirs
GACCACCC
>HV596727.1 JP 2010539959-A/2108: Micromirs
CCGTTCCC
>HV596726.1 JP 2010539959-A/2107: Micromirs
TCAGGGCC
>HV596725.1 JP 2010539959-A/2106: Micromirs
AAAAATCC
>HV596724.1 JP 2010539959-A/2105: Micromirs
CGCAAAAA
>HV596723.1 JP 2010539959-A/2104: Micromirs
TAAGGGCT
>HV596722.1 JP 2010539959-A/2103: Micromirs
TAAGGGCT
>HV596721.1 JP 2010539959-A/2102: Micromirs
TGGACTCC
>HV596720.1 JP 2010539959-A/2101: Micromirs
GGCAGTCC
>HV596719.1 JP 2010539959-A/2100: Micromirs
GATCCAGC
>HV596718.1 JP 2010539959-A/2099: Micromirs
GGTCCTGC
>HV596717.1 JP 2010539959-A/2098: Micromirs
TTGCCCAG
>HV596716.1 JP 2010539959-A/2097: Micromirs
CTGTATAG
>HV596715.1 JP 2010539959-A/2096: Micromirs
CTTTGTAG
>HV596714.1 JP 2010539959-A/2095: Micromirs
GGCAAACG
>HV596713.1 JP 2010539959-A/2094: Micromirs
AGGAGGCG
>HV596712.1 JP 2010539959-A/2093: Micromirs
GCGGTGGG
>HV596711.1 JP 2010539959-A/2092: Micromirs
TCACTGTG
>HV596710.1 JP 2010539959-A/2091: Micromirs
GCAATATG
>HV596709.1 JP 2010539959-A/2090: Micromirs
ACAGTACT
>HV596708.1 JP 2010539959-A/2089: Micromirs
ATCTACGT
>HV596707.1 JP 2010539959-A/2088: Micromirs
GGCTCTTT
>HV596706.1 JP 2010539959-A/2087: Micromirs
CTCCCCCA
>HV596705.1 JP 2010539959-A/2086: Micromirs
GAACAGGG
>HV596704.1 JP 2010539959-A/2085: Micromirs
AACAGGGA
>HV596703.1 JP 2010539959-A/2084: Micromirs
TTGTCGCC
>HV596702.1 JP 2010539959-A/2083: Micromirs
ATCATCAT
>HV596701.1 JP 2010539959-A/2082: Micromirs
GGTGCCAA
>HV596700.1 JP 2010539959-A/2081: Micromirs
TATCTCCA
>HV596699.1 JP 2010539959-A/2080: Micromirs
GAGCTTCA
>HV596698.1 JP 2010539959-A/2079: Micromirs
CGGATCCG
>HV596697.1 JP 2010539959-A/2078: Micromirs
TCAGTCCA
>HV596696.1 JP 2010539959-A/2077: Micromirs
CCACGCCC
>HV596695.1 JP 2010539959-A/2076: Micromirs
TTCAACAG
>HV596694.1 JP 2010539959-A/2075: Micromirs
GCCCTGAG
>HV596693.1 JP 2010539959-A/2074: Micromirs
CACATCCT
>HV596692.1 JP 2010539959-A/2073: Micromirs
TAAGACTT
>HV596691.1 JP 2010539959-A/2072: Micromirs
GGGTACCA
>HV596690.1 JP 2010539959-A/2071: Micromirs
TTCACCCA
>HV596689.1 JP 2010539959-A/2070: Micromirs
CTTATCCA
>HV596688.1 JP 2010539959-A/2069: Micromirs
AGGTGGGA
>HV596687.1 JP 2010539959-A/2068: Micromirs
GTAATAAT
>HV596686.1 JP 2010539959-A/2067: Micromirs
ACGGTACG
>HV596685.1 JP 2010539959-A/2066: Micromirs
GACTTGTG
>HV596684.1 JP 2010539959-A/2065: Micromirs
CTAACCCG
>HV596683.1 JP 2010539959-A/2064: Micromirs
TCTCAGGG
>HV596682.1 JP 2010539959-A/2063: Micromirs
TCTCAGGG
>HV596681.1 JP 2010539959-A/2062: Micromirs
CTCACCTG
>HV596680.1 JP 2010539959-A/2061: Micromirs
ATCATATA
>HV596679.1 JP 2010539959-A/2060: Micromirs
ATCCTAAC
>HV596678.1 JP 2010539959-A/2059: Micromirs
TCATTCAC
>HV596677.1 JP 2010539959-A/2058: Micromirs
TCAATGCC
>HV596676.1 JP 2010539959-A/2057: Micromirs
GCTCATCC
>HV596675.1 JP 2010539959-A/2056: Micromirs
GCTCATCC
>HV596674.1 JP 2010539959-A/2055: Micromirs
TTCCAGGC
>HV596673.1 JP 2010539959-A/2054: Micromirs
TTCTTCTC
>HV596672.1 JP 2010539959-A/2053: Micromirs
TTTCCTTC
>HV596671.1 JP 2010539959-A/2052: Micromirs
AGCTAGAG
>HV596670.1 JP 2010539959-A/2051: Micromirs
CAGCACCG
>HV596669.1 JP 2010539959-A/2050: Micromirs
GAAGGGCG
>HV596668.1 JP 2010539959-A/2049: Micromirs
CAAGAAGG
>HV596667.1 JP 2010539959-A/2048: Micromirs
GGGACGGG
>HV596666.1 JP 2010539959-A/2047: Micromirs
AAATCCAT
>HV596665.1 JP 2010539959-A/2046: Micromirs
AGATCACT
>HV596664.1 JP 2010539959-A/2045: Micromirs
CAACTACT
>HV596663.1 JP 2010539959-A/2044: Micromirs
GATCCAGT
>HV596662.1 JP 2010539959-A/2043: Micromirs
GTGAACAC
>HV596661.1 JP 2010539959-A/2042: Micromirs
CGTGCCTT
>HV596660.1 JP 2010539959-A/2041: Micromirs
ACGAGGAA
>HV596659.1 JP 2010539959-A/2040: Micromirs
GCAGAAGG
>HV596658.1 JP 2010539959-A/2039: Micromirs
GGGAAGAG
>HV596657.1 JP 2010539959-A/2038: Micromirs
TCAGGCCG
>HV596656.1 JP 2010539959-A/2037: Micromirs
CAGGGCTC
>HV596655.1 JP 2010539959-A/2036: Micromirs
CCCAGACA
>HV596654.1 JP 2010539959-A/2035: Micromirs
TGGTGAGA
>HV596653.1 JP 2010539959-A/2034: Micromirs
CCCGCCCA
>HV596652.1 JP 2010539959-A/2033: Micromirs
CAGGTGTG
>HV596651.1 JP 2010539959-A/2032: Micromirs
GGTGGCAC
>HV596650.1 JP 2010539959-A/2031: Micromirs
TGCCCTCA
>HV596649.1 JP 2010539959-A/2030: Micromirs
GGCTGGTG
>HV596648.1 JP 2010539959-A/2029: Micromirs
CGTACCCA
>HV596647.1 JP 2010539959-A/2028: Micromirs
AGGGGCTC
>HV596646.1 JP 2010539959-A/2027: Micromirs
AGTCCTCA
>HV596645.1 JP 2010539959-A/2026: Micromirs
GAGGTGGG
>HV596644.1 JP 2010539959-A/2025: Micromirs
AATGGCGT
>HV596643.1 JP 2010539959-A/2024: Micromirs
CACACTCC
>HV596642.1 JP 2010539959-A/2023: Micromirs
GAACAGTG
>HV596641.1 JP 2010539959-A/2022: Micromirs
TCCCTGCC
>HV596640.1 JP 2010539959-A/2021: Micromirs
GCCAGCTG
>HV596639.1 JP 2010539959-A/2020: Micromirs
ACATGAAC
>HV596638.1 JP 2010539959-A/2019: Micromirs
CCCTGCAG
>HV596637.1 JP 2010539959-A/2018: Micromirs
AGGCCACG
>HV596636.1 JP 2010539959-A/2017: Micromirs
GGCTCCGG
>HV596635.1 JP 2010539959-A/2016: Micromirs
AGCTGGCA
>HV596634.1 JP 2010539959-A/2015: Micromirs
AATCAGGC
>HV596633.1 JP 2010539959-A/2014: Micromirs
GCTCAGGA
>HV596632.1 JP 2010539959-A/2013: Micromirs
TGTGTCCT
>HV596631.1 JP 2010539959-A/2012: Micromirs
GTATCCTC
>HV596630.1 JP 2010539959-A/2011: Micromirs
CGCTGCAG
>HV596629.1 JP 2010539959-A/2010: Micromirs
CCTACAGT
>HV596628.1 JP 2010539959-A/2009: Micromirs
AAGACCCT
>HV596627.1 JP 2010539959-A/2008: Micromirs
CGGCGACG
>HV596626.1 JP 2010539959-A/2007: Micromirs
AGCCGGAA
>HV596625.1 JP 2010539959-A/2006: Micromirs
AGAATGCT
>HV596624.1 JP 2010539959-A/2005: Micromirs
AGTGAGCA
>HV596623.1 JP 2010539959-A/2004: Micromirs
CGAATCTG
>HV596622.1 JP 2010539959-A/2003: Micromirs
TACAGGGT
>HV596621.1 JP 2010539959-A/2002: Micromirs
ACGAATTT
>HV596620.1 JP 2010539959-A/2001: Micromirs
TACAGGGT
>HV596619.1 JP 2010539959-A/2000: Micromirs
AATGCTGC
>HV596618.1 JP 2010539959-A/1999: Micromirs
ACAGTGCG
>HV596617.1 JP 2010539959-A/1998: Micromirs
AGCACTTT
>HV596616.1 JP 2010539959-A/1997: Micromirs
ACATTGCA
>HV596615.1 JP 2010539959-A/1996: Micromirs
AGCACTTT
>HV596614.1 JP 2010539959-A/1995: Micromirs
AACATCCG
>HV596613.1 JP 2010539959-A/1994: Micromirs
AGCATTTG
>HV596612.1 JP 2010539959-A/1993: Micromirs
GGGCTATG
>HV596611.1 JP 2010539959-A/1992: Micromirs
AATGCTGC
>HV596610.1 JP 2010539959-A/1991: Micromirs
TGATAACT
>HV596609.1 JP 2010539959-A/1990: Micromirs
AGTACTGT
>HV596608.1 JP 2010539959-A/1989: Micromirs
ACAAGCTT
>HV596607.1 JP 2010539959-A/1988: Micromirs
CTACGGGT
>HV596606.1 JP 2010539959-A/1987: Micromirs
TACATTCC
>HV596605.1 JP 2010539959-A/1986: Micromirs
CTTGCGCA
>HV596604.1 JP 2010539959-A/1985: Micromirs
ACTACCTC
>HV596603.1 JP 2010539959-A/1984: Micromirs
CCTGTACA
>HV596602.1 JP 2010539959-A/1983: Micromirs
ACTACCTC
>HV596601.1 JP 2010539959-A/1982: Micromirs
ACTGTATA
>HV596600.1 JP 2010539959-A/1981: Micromirs
ATTGTATA
>HV596599.1 JP 2010539959-A/1980: Micromirs
ACTACCTC
>HV596598.1 JP 2010539959-A/1979: Micromirs
GCCGTATA
>HV596597.1 JP 2010539959-A/1978: Micromirs
CCTACCTC
>HV596596.1 JP 2010539959-A/1977: Micromirs
GTCGTATA
>HV596595.1 JP 2010539959-A/1976: Micromirs
ACTACCTC
>HV596594.1 JP 2010539959-A/1975: Micromirs
GTAACTCT
>HV596593.1 JP 2010539959-A/1974: Micromirs
ACTACCTC
>HV596592.1 JP 2010539959-A/1973: Micromirs
GTTGTATA
>HV596591.1 JP 2010539959-A/1972: Micromirs
ACTACCTC
>HV596590.1 JP 2010539959-A/1971: Micromirs
ATTGTATA
>HV596589.1 JP 2010539959-A/1970: Micromirs
ACTACCTC
>HV596588.1 JP 2010539959-A/1969: Micromirs
CTATCATA
>HV596587.1 JP 2010539959-A/1968: Micromirs
GGCTTGTC
>HV596586.1 JP 2010539959-A/1967: Micromirs
TCCATGTC
>HV596585.1 JP 2010539959-A/1966: Micromirs
GGCACAAT
>HV596584.1 JP 2010539959-A/1965: Micromirs
GGACCGTG
>HV596583.1 JP 2010539959-A/1964: Micromirs
CAGACCGC
>HV596582.1 JP 2010539959-A/1963: Micromirs
CAAGTGGA
>HV596581.1 JP 2010539959-A/1962: Micromirs
GCGTTCGG
>HV596580.1 JP 2010539959-A/1961: Micromirs
TGAGCGGT
>HV596579.1 JP 2010539959-A/1960: Micromirs
CGAGACGC
>HV596578.1 JP 2010539959-A/1959: Micromirs
CCCATCCC
>HV596577.1 JP 2010539959-A/1958: Micromirs
ACCTGGAA
>HV596576.1 JP 2010539959-A/1957: Micromirs
CTTCAACG
>HV596575.1 JP 2010539959-A/1956: Micromirs
TTCTGGTG
>HV596574.1 JP 2010539959-A/1955: Micromirs
GGCTAGTT
>HV596573.1 JP 2010539959-A/1954: Micromirs
GGAGGACG
>HV596572.1 JP 2010539959-A/1953: Micromirs
CCGTCACT
>HV596571.1 JP 2010539959-A/1952: Micromirs
TTCCCGTT
>HV596570.1 JP 2010539959-A/1951: Micromirs
ACAGAATT
>HV596569.1 JP 2010539959-A/1950: Micromirs
CAAAAGAT
>HV596568.1 JP 2010539959-A/1949: Micromirs
ATCAGGTT
>HV596567.1 JP 2010539959-A/1948: Micromirs
GGTCCAGT
>HV596566.1 JP 2010539959-A/1947: Micromirs
GAAGTGTT
>HV596565.1 JP 2010539959-A/1946: Micromirs
GATTGTGA
>HV596564.1 JP 2010539959-A/1945: Micromirs
GAAACCGT
>HV596563.1 JP 2010539959-A/1944: Micromirs
AGGTCCAG
>HV596562.1 JP 2010539959-A/1943: Micromirs
ACTATGAT
>HV596561.1 JP 2010539959-A/1942: Micromirs
CCAACCTT
>HV596560.1 JP 2010539959-A/1941: Micromirs
CGATCCCC
>HV596559.1 JP 2010539959-A/1940: Micromirs
TTCACCTT
>HV596558.1 JP 2010539959-A/1939: Micromirs
CATCAGGT
>HV596557.1 JP 2010539959-A/1938: Micromirs
ACACTAGG
>HV596556.1 JP 2010539959-A/1937: Micromirs
AGTGGTGC
>HV596555.1 JP 2010539959-A/1936: Micromirs
TGCCTGCT
>HV596554.1 JP 2010539959-A/1935: Micromirs
GCCTTCAT
>HV596553.1 JP 2010539959-A/1934: Micromirs
CAGAAAAT
>HV596552.1 JP 2010539959-A/1933: Micromirs
TCGCTCCT
>HV596551.1 JP 2010539959-A/1932: Micromirs
GGGGAATG
>HV596550.1 JP 2010539959-A/1931: Micromirs
CAAACAAA
>HV596549.1 JP 2010539959-A/1930: Micromirs
CGAACTTG
>HV596548.1 JP 2010539959-A/1929: Micromirs
CTTCCGAT
>HV596547.1 JP 2010539959-A/1928: Micromirs
GTCCTCTT
>HV596546.1 JP 2010539959-A/1927: Micromirs
AGGCATAC
>HV596545.1 JP 2010539959-A/1926: Micromirs
TCTATCTA
>HV596544.1 JP 2010539959-A/1925: Micromirs
ACCACTGA
>HV596543.1 JP 2010539959-A/1924: Micromirs
CGTAGGGT
>HV596542.1 JP 2010539959-A/1923: Micromirs
CAGCATTT
>HV596541.1 JP 2010539959-A/1922: Micromirs
GAGCCGGT
>HV596540.1 JP 2010539959-A/1921: Micromirs
CAAGTTAC
>HV596539.1 JP 2010539959-A/1920: Micromirs
ACCACAGG
>HV596538.1 JP 2010539959-A/1919: Micromirs
ACTGTCTG
>HV596537.1 JP 2010539959-A/1918: Micromirs
GGTGTGCG
>HV596536.1 JP 2010539959-A/1917: Micromirs
AGAGGTGG
>HV596535.1 JP 2010539959-A/1916: Micromirs
GGTTATGT
>HV596534.1 JP 2010539959-A/1915: Micromirs
CCACTAAG
>HV596533.1 JP 2010539959-A/1914: Micromirs
GCGGTGCT
>HV588790.1 JP 2010273681-A/113: Methods for Selecting Medications
GGCTGCGC
>HV588771.1 JP 2010273681-A/94: Methods for Selecting Medications
GGCGCGGC
>HV588770.1 JP 2010273681-A/93: Methods for Selecting Medications
GGCGCGGG
>HV591545.1 JP 2010273690-A/7: AAV VIRIONS WITH DECREASED IMMUNOREACTIVITY AND USES THEREFOR
CCTGCAGG
>HV598442.1 JP 2010539985-A/34: PEROXISOME BIOGENESIS FACTOR PROTEIN (PEX) DISRUPTIONS FOR ALTERING POLYUNSATURATED FATTY ACIDS AND TOTAL LIPID CONTENT IN OLEAGINOUS EUKARYOTIC ORGANISMS
ACCAGCCC
>HV581966.1 JP 2010263900-A/20: CpG Receptor (CpG-R) And Methods Relating Thereto
TCTTCGAA
>HV581965.1 JP 2010263900-A/19: CpG Receptor (CpG-R) And Methods Relating Thereto
TCATCGAT
>HV581964.1 JP 2010263900-A/18: CpG Receptor (CpG-R) And Methods Relating Thereto
TCAACGCT
>HV581963.1 JP 2010263900-A/17: CpG Receptor (CpG-R) And Methods Relating Thereto
TCAGCGCT
>HV581962.1 JP 2010263900-A/16: CpG Receptor (CpG-R) And Methods Relating Thereto
TCGACGTC
>HV581961.1 JP 2010263900-A/15: CpG Receptor (CpG-R) And Methods Relating Thereto
GCAACGTT
>HV581960.1 JP 2010263900-A/14: CpG Receptor (CpG-R) And Methods Relating Thereto
TCAACGTT
>HV575414.1 JP 2010150280-A/100: IMMUNOSTIMULATORY NUCLEIC ACID MOLECULES
TCAACGTC
>HV575413.1 JP 2010150280-A/99: IMMUNOSTIMULATORY NUCLEIC ACID MOLECULES
CCAACGTT
>HV575412.1 JP 2010150280-A/98: IMMUNOSTIMULATORY NUCLEIC ACID MOLECULES
TCTTCGAA
>HV575411.1 JP 2010150280-A/97: IMMUNOSTIMULATORY NUCLEIC ACID MOLECULES
TCATCGAT
>HV575410.1 JP 2010150280-A/96: IMMUNOSTIMULATORY NUCLEIC ACID MOLECULES
TCAGCGCT
>HV575409.1 JP 2010150280-A/95: IMMUNOSTIMULATORY NUCLEIC ACID MOLECULES
TCAAGCTT
>HV575408.1 JP 2010150280-A/94: IMMUNOSTIMULATORY NUCLEIC ACID MOLECULES
TCAACGTT
>HV594644.1 JP 2010539959-A/25: Micromirs
ACTACCTC
>HV594639.1 JP 2010539959-A/20: Micromirs
ATTTGCAC
>HV594638.1 JP 2010539959-A/19: Micromirs
AGCACTTT
>HV594636.1 JP 2010539959-A/17: Micromirs
CGTAATGA
>HV594635.1 JP 2010539959-A/16: Micromirs
GGTAAACT
>HV594634.1 JP 2010539959-A/15: Micromirs
TCAACATC
>HV594633.1 JP 2010539959-A/14: Micromirs
ATCAGTCT
>HV594632.1 JP 2010539959-A/13: Micromirs
TCTGATAA
>HV594625.1 JP 2010539959-A/6: Micromirs
CACACTCC
>HV594623.1 JP 2010539959-A/4: Micromirs
TAGCATTA
>HV594621.1 JP 2010539959-A/2: Micromirs
GATAAGCT
>HV586407.1 JP 2010535242-A/50: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGTCGTT
>HV586365.1 JP 2010535242-A/8: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGTCGTT
>HV594368.1 JP 2010539893-A/180: C5a binding nucleic acid
NNNVSSNN
>HV594367.1 JP 2010539893-A/179: C5a binding nucleic acid
NNSSBNNN
>HV594363.1 JP 2010539893-A/175: C5a binding nucleic acid
DNYBHNNN
>HV594362.1 JP 2010539893-A/174: C5a binding nucleic acid
NNNKVGNM
>HV594361.1 JP 2010539893-A/173: C5a binding nucleic acid
NNGCCNNN
>HV594360.1 JP 2010539893-A/172: C5a binding nucleic acid
NNNAGCNN
>HV594359.1 JP 2010539893-A/171: C5a binding nucleic acid
NNGCYNNN
>HV594358.1 JP 2010539893-A/170: C5a binding nucleic acid
NNNVVSNN
>HV594357.1 JP 2010539893-A/169: C5a binding nucleic acid
NNSBBNNN
>HV570517.1 JP 2012500009-A/9: DEVICE FOR RAPID IDENTIFICATION OF NUCLEIC ACIDS FOR BINDING TO SPECIFIC CHEMICAL TARGETS
CCAGGAGC
>HV567289.1 JP 2012021995-A/55: METHODS AND MEANS FOR TREATMENT OF OSTEOARTHRITIS
TTGCTATA
>HV565651.1 JP 2012023998-A/35: METHOD FOR REGULATING EXPRESSION OF OBJECTIVE GENE IN EUKARYOTIC CELL, RNA MOLECULE AND DNA MOLECULE
AGCGAGAC
>HV565649.1 JP 2012023998-A/33: METHOD FOR REGULATING EXPRESSION OF OBJECTIVE GENE IN EUKARYOTIC CELL, RNA MOLECULE AND DNA MOLECULE
TCCTAGAC
>HV565644.1 JP 2012023998-A/28: METHOD FOR REGULATING EXPRESSION OF OBJECTIVE GENE IN EUKARYOTIC CELL, RNA MOLECULE AND DNA MOLECULE
GTATAGAC
>HV565641.1 JP 2012023998-A/25: METHOD FOR REGULATING EXPRESSION OF OBJECTIVE GENE IN EUKARYOTIC CELL, RNA MOLECULE AND DNA MOLECULE
AGAGGTCT
>HV565635.1 JP 2012023998-A/19: METHOD FOR REGULATING EXPRESSION OF OBJECTIVE GENE IN EUKARYOTIC CELL, RNA MOLECULE AND DNA MOLECULE
AGACGAAA
>HV565634.1 JP 2012023998-A/18: METHOD FOR REGULATING EXPRESSION OF OBJECTIVE GENE IN EUKARYOTIC CELL, RNA MOLECULE AND DNA MOLECULE
AGACCAAA
>HV565633.1 JP 2012023998-A/17: METHOD FOR REGULATING EXPRESSION OF OBJECTIVE GENE IN EUKARYOTIC CELL, RNA MOLECULE AND DNA MOLECULE
AGACCTAA
>HV565632.1 JP 2012023998-A/16: METHOD FOR REGULATING EXPRESSION OF OBJECTIVE GENE IN EUKARYOTIC CELL, RNA MOLECULE AND DNA MOLECULE
AGACCTCA
>HV565627.1 JP 2012023998-A/11: METHOD FOR REGULATING EXPRESSION OF OBJECTIVE GENE IN EUKARYOTIC CELL, RNA MOLECULE AND DNA MOLECULE
TTGAAGTG
>HV565626.1 JP 2012023998-A/10: METHOD FOR REGULATING EXPRESSION OF OBJECTIVE GENE IN EUKARYOTIC CELL, RNA MOLECULE AND DNA MOLECULE
ACCACTTA
>HV565625.1 JP 2012023998-A/9: METHOD FOR REGULATING EXPRESSION OF OBJECTIVE GENE IN EUKARYOTIC CELL, RNA MOLECULE AND DNA MOLECULE
AGGGCTGC
>HV565624.1 JP 2012023998-A/8: METHOD FOR REGULATING EXPRESSION OF OBJECTIVE GENE IN EUKARYOTIC CELL, RNA MOLECULE AND DNA MOLECULE
ATAAATAT
>HV565623.1 JP 2012023998-A/7: METHOD FOR REGULATING EXPRESSION OF OBJECTIVE GENE IN EUKARYOTIC CELL, RNA MOLECULE AND DNA MOLECULE
ACGAGGGT
>HV565622.1 JP 2012023998-A/6: METHOD FOR REGULATING EXPRESSION OF OBJECTIVE GENE IN EUKARYOTIC CELL, RNA MOLECULE AND DNA MOLECULE
AACCTCGA
>HV565621.1 JP 2012023998-A/5: METHOD FOR REGULATING EXPRESSION OF OBJECTIVE GENE IN EUKARYOTIC CELL, RNA MOLECULE AND DNA MOLECULE
TCCGGTCC
>HV565620.1 JP 2012023998-A/4: METHOD FOR REGULATING EXPRESSION OF OBJECTIVE GENE IN EUKARYOTIC CELL, RNA MOLECULE AND DNA MOLECULE
AGACCTCT
>HV565619.1 JP 2012023998-A/3: METHOD FOR REGULATING EXPRESSION OF OBJECTIVE GENE IN EUKARYOTIC CELL, RNA MOLECULE AND DNA MOLECULE
ATAGCAAT
>HV565618.1 JP 2012023998-A/2: METHOD FOR REGULATING EXPRESSION OF OBJECTIVE GENE IN EUKARYOTIC CELL, RNA MOLECULE AND DNA MOLECULE
AAGATCAC
>HV573681.1 JP 2012502074-A/102: Composition comprising a complexed (m)RNA and a naked mRNA for providing or enhancing an immunostimulatory response in a mammal and uses thereof
TGGATCCA
>HV573680.1 JP 2012502074-A/101: Composition comprising a complexed (m)RNA and a naked mRNA for providing or enhancing an immunostimulatory response in a mammal and uses thereof
ACCTAGGT
>HV573634.1 JP 2012502074-A/55: Composition comprising a complexed (m)RNA and a naked mRNA for providing or enhancing an immunostimulatory response in a mammal and uses thereof
GGTTTTGG
>HV565117.1 JP 2011530289-A/1080: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GAACAGGG
>HV564096.1 JP 2011530289-A/59: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
TCGGAGTT
>HV564089.1 JP 2011530289-A/52: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
TCGGAGTT
>HV564077.1 JP 2011530289-A/40: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GGATCTTA
>HV564067.1 JP 2011530289-A/30: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CGATTTTT
>HV564061.1 JP 2011530289-A/24: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CTACACAA
>HV564049.1 JP 2011530289-A/12: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GGATCTTA
>HV563214.1 JP 2011530288-A/1080: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GAACAGGG
>HV562193.1 JP 2011530288-A/59: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
TCGGAGTT
>HV562186.1 JP 2011530288-A/52: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
TCGGAGTT
>HV562174.1 JP 2011530288-A/40: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GGATCTTA
>HV562164.1 JP 2011530288-A/30: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CGATTTTT
>HV562158.1 JP 2011530288-A/24: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CTACACAA
>HV562146.1 JP 2011530288-A/12: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GGATCTTA
>HV552054.1 JP 2011252922-A/55: METHODS AND MEANS FOR TREATMENT OF OSTEOARTHRITIS
TTGCTATA
>JA760683.1 Sequence 30 from Patent WO2012012716
GCCTGCTG
>JA760678.1 Sequence 25 from Patent WO2012012716
CAGCAGGC
>JA760677.1 Sequence 24 from Patent WO2012012716
ACAGCAGG
>JA760670.1 Sequence 17 from Patent WO2012012716
CCTGCTGT
>JA758910.1 Sequence 139 from Patent EP2412830
GAAGAAAG
>JA758036.1 Sequence 2 from Patent WO2012010711
GATAAGCT
>HV540125.1 JP 2011200248-A/66: STABILIZED IMMUNOMODULATORY OLIGONUCLEOTIDES
TCNTCNTT
>HV540123.1 JP 2011200248-A/64: STABILIZED IMMUNOMODULATORY OLIGONUCLEOTIDES
TCNTCNTT
>HV540103.1 JP 2011200248-A/44: STABILIZED IMMUNOMODULATORY OLIGONUCLEOTIDES
TCGTCGTT
>HV540100.1 JP 2011200248-A/41: STABILIZED IMMUNOMODULATORY OLIGONUCLEOTIDES
TTGTGCTT
>HV540099.1 JP 2011200248-A/40: STABILIZED IMMUNOMODULATORY OLIGONUCLEOTIDES
TCGTCGTT
>HV540098.1 JP 2011200248-A/39: STABILIZED IMMUNOMODULATORY OLIGONUCLEOTIDES
TCGTCGTT
>JA734748.1 Sequence 2 from Patent EP2407558
GCGCCATC
>JA698689.1 Sequence 146 from Patent WO2011156535
YDRATCYG
>JA698642.1 Sequence 99 from Patent WO2011156535
CAGATCTG
>JA718844.1 Sequence 139 from Patent EP2402465
GAAGAAAG
>JA714120.1 Sequence 6 from Patent EP2401404
TTTTGGGG
>JA699559.1 Sequence 78 from Patent EP2402449
GGTGGTGG
>JA713876.1 Sequence 12413 from Patent EP2402463
CGATCTTT
>JA694067.1 Sequence 24 from Patent WO2011154427
CAGGAACT
>JA694055.1 Sequence 12 from Patent WO2011154427
CAGGAACT
>JA692862.1 Sequence 5 from Patent WO2011154385
ACCTCCCC
>HV534514.1 WO 2011111824-A/2: Proliferation of cardiomyocytes using miRNA
GAAGTGCT
>HV534513.1 WO 2011111824-A/1: Proliferation of cardiomyocytes using miRNA
TCAGTGCA
>HV532076.1 JP 2011182795-A/139: Compositions and methods for detection of hepatitis A virus nucleic acid
GAAGAAAG
>JA682691.1 Sequence 7 from Patent WO2011144761
ATCTTGCC
>JA682686.1 Sequence 2 from Patent WO2011144761
GGCAAGAT
>JA682454.1 Sequence 38 from Patent WO2011150408
GCTGGCAG
>JA677376.1 Sequence 113 from Patent EP2393028
GGCTGCGC
>JA677357.1 Sequence 94 from Patent EP2393028
GGCGCGGC
>JA677356.1 Sequence 93 from Patent EP2393028
GGCGCGGG
>HV511436.1 JP 2011521624-A/283: RNAse H-Based Assays Utilizing Modified RNA Monomers
GNNNNNNN
>HV511435.1 JP 2011521624-A/282: RNAse H-Based Assays Utilizing Modified RNA Monomers
TNNNNNNN
>HV511434.1 JP 2011521624-A/281: RNAse H-Based Assays Utilizing Modified RNA Monomers
ANNNNNNN
>HV511433.1 JP 2011521624-A/280: RNAse H-Based Assays Utilizing Modified RNA Monomers
AAGCNNNN
>HV511432.1 JP 2011521624-A/279: RNAse H-Based Assays Utilizing Modified RNA Monomers
AAGCTNNN
>JA639026.1 Sequence 83 from Patent EP2386856
TTGCTATA
>JA642948.1 Sequence 6 from Patent EP2370091
TCGGCGCA
>JA642947.1 Sequence 5 from Patent EP2370091
TCTTGCCA
>JA630894.1 Sequence 4 from Patent WO2011128886
TTCTCCAA
>JA630893.1 Sequence 3 from Patent WO2011128886
TTGGAGAA
>JA618087.1 Sequence 78 from Patent EP2377940
GGTGGTGG
>JA618246.1 Sequence 78 from Patent EP2377941
GGTGGTGG
>JA611050.1 Sequence 1 from Patent EP2374476
CCGCCATG
>JA611039.1 Sequence 1 from Patent EP2374475
CCGCCATG
>HV452328.1 WO 2000035956-A/1: Antihuman VEGF monoclonal antibody
CTCTAGAG
>HV450071.1 WO 1999060025-A/45: Gene recombination antibody
CTCTAGAG
>HV449977.1 WO 1999059636-A/9: VEGF activity inhibitor
CTCTAGAG
>HV446089.1 WO 1998008869-A/8: Hematopoietic stem cell growth factor (SCGF)
CTCTAAAG
>HV452951.1 WO 2000050608-A/14: Novel polypeptide
CTCTAAAG
>HV449255.1 WO 1999040118-A/1: Antibody against human VEGF receptor KDR
CTCTAGAG
>HV450675.1 WO 2000006708-A/5: Novel polypeptide
CTCTAAAG
>HV450481.1 WO 2000010383-A/80: Method for modifying chromosomes or fragments thereof
GCCCGGGC
>JA537478.1 Sequence 1 from Patent EP2371386
CCGCCATG
>JA537467.1 Sequence 1 from Patent EP2371385
CCGCCATG
>JA537456.1 Sequence 1 from Patent EP2371384
CCGCCATG
>JA537445.1 Sequence 1 from Patent EP2371383
CCGCCATG
>JA537434.1 Sequence 1 from Patent EP2371382
CCGCCATG
>JA531605.1 Sequence 66 from Patent EP2371834
TCNTCNTT
>JA531603.1 Sequence 64 from Patent EP2371834
TCNTCNTT
>JA531583.1 Sequence 44 from Patent EP2371834
TCGTCGTT
>JA531580.1 Sequence 41 from Patent EP2371834
TTGTGCTT
>JA531579.1 Sequence 40 from Patent EP2371834
TCGTCGTT
>JA531578.1 Sequence 39 from Patent EP2371834
TCGTCGTT
>JA528998.1 Sequence 10 from Patent EP2367838
GTGCACCC
>JA528992.1 Sequence 4 from Patent EP2367838
GGGTTGGG
>JA528991.1 Sequence 3 from Patent EP2367838
GGGTAGGG
>HV349983.1 JP 2011103886-A/106: Methods and Agents for Screening for Compounds Capable of Modulating Gene Expression
TATTTATT
>HV349217.1 JP 2011126791-A/6: Suppressor for gene expression of allergic disease sensitive gene
ACACTGGA
>JA476305.1 Sequence 9 from Patent EP2329045
CCAGGAGC
>JA487327.1 Sequence 477 from Patent WO2011085062
CACGTGGC
>JA487326.1 Sequence 476 from Patent WO2011085062
GCCACGTG
>JA487325.1 Sequence 475 from Patent WO2011085062
AGATATTT
>JA487324.1 Sequence 474 from Patent WO2011085062
AAATATCT
>JA487323.1 Sequence 473 from Patent WO2011085062
AGATTTTT
>JA487322.1 Sequence 472 from Patent WO2011085062
AAAAATCT
>JA412895.1 Sequence 2 from Patent EP2336309
GAAAGGTC
>JA437287.1 Sequence 83 from Patent EP2360474
TTGCTATA
>JA424033.1 Sequence 124 from Patent WO2011082318
TGAGCTAG
>HV345215.1 JP 2011510640-A/102: Nucleic acids of formula (I) (NuGlXmGnNv)a and derivatives thereof as an immune-stimulating agent/adjuvant
TGGATCCA
>HV345214.1 JP 2011510640-A/101: Nucleic acids of formula (I) (NuGlXmGnNv)a and derivatives thereof as an immune-stimulating agent/adjuvant
ACCTAGGT
>HV345168.1 JP 2011510640-A/55: Nucleic acids of formula (I) (NuGlXmGnNv)a and derivatives thereof as an immune-stimulating agent/adjuvant
GGTTTTGG
>HV340468.1 JP 2011101647-A/72: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
GACNTTCT
>HV340467.1 JP 2011101647-A/71: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
GANGTTCT
>HV340460.1 JP 2011101647-A/64: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
GTCNTTCT
>HV340459.1 JP 2011101647-A/63: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
GTNGTTCT
>HV340456.1 JP 2011101647-A/60: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TTCNTTCT
>HV340455.1 JP 2011101647-A/59: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TTNGTTCT
>HV340451.1 JP 2011101647-A/55: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TTCGTTCT
>HV340443.1 JP 2011101647-A/47: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
GTCGTTCT
>HV340438.1 JP 2011101647-A/42: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
GACGTTCT
>HV347544.1 JP 2011513238-A/71: MICRO-RNAS THAT MODULATE SMOOTH MUSCLE PROLIFERATION AND DIFFERENTIATION AND USES THEREOF
CATGTCCT
>HV341869.1 JP 2011511754-A/1: PREVENTION AND TREATMENT OF SUB-CLINICAL PCVD
CCGCCATG
>HV332610.1 JP 2011509075-A/11: Systems and Methods for Nucleic Acid Sequencing
CTANNTTA
>HV332609.1 JP 2011509075-A/10: Systems and Methods for Nucleic Acid Sequencing
CTNAGNTA
>HV332608.1 JP 2011509075-A/9: Systems and Methods for Nucleic Acid Sequencing
CTAAGTTA
>HV332220.1 JP 2011509072-A/22: Polysaccharide Synthases (H)
ACCTGCCC
>HV325530.1 JP 2011507514-A/11: METHODS FOR PACKAGING PROPAGATION-DEFECTIVE VESICULAR STOMATITIS VIRUS VECTORS USING A STABLE CELL LINE THAT EXPRESSES G PROTEIN
GAATATTC
>HV325529.1 JP 2011507514-A/10: METHODS FOR PACKAGING PROPAGATION-DEFECTIVE VESICULAR STOMATITIS VIRUS VECTORS USING A STABLE CELL LINE THAT EXPRESSES G PROTEIN
GAAATTTC
>HV325528.1 JP 2011507514-A/9: METHODS FOR PACKAGING PROPAGATION-DEFECTIVE VESICULAR STOMATITIS VIRUS VECTORS USING A STABLE CELL LINE THAT EXPRESSES G PROTEIN
GAAGCTTC
>HV325527.1 JP 2011507514-A/8: METHODS FOR PACKAGING PROPAGATION-DEFECTIVE VESICULAR STOMATITIS VIRUS VECTORS USING A STABLE CELL LINE THAT EXPRESSES G PROTEIN
GAACGTTC
>HV325526.1 JP 2011507514-A/7: METHODS FOR PACKAGING PROPAGATION-DEFECTIVE VESICULAR STOMATITIS VIRUS VECTORS USING A STABLE CELL LINE THAT EXPRESSES G PROTEIN
GAANNTTC
>HV042426.1 JP 2009517048-A/4: IMMUNOSTIMULATORY OLIGORIBONUCLEOTIDES
ATAGGCAC
>HV042425.1 JP 2009517048-A/3: IMMUNOSTIMULATORY OLIGORIBONUCLEOTIDES
CTAGGCAC
>HV042424.1 JP 2009517048-A/2: IMMUNOSTIMULATORY OLIGORIBONUCLEOTIDES
TTAGGCAC
>HV042423.1 JP 2009517048-A/1: IMMUNOSTIMULATORY OLIGORIBONUCLEOTIDES
GTAGGCAC
>HV120217.1 JP 2009148264-A/13: NOVEL TUMOR ANTIGEN USEFUL IN DIAGNOSIS AND THERAPY OF BLADDER, OVARY, LUNG, AND KIDNEY CANCERS
ACCTCGGC
>HV199283.1 JP 2001523947-A/21: Telomerase reverse transcriptase
GGGGTTTT
>HV199282.1 JP 2001523947-A/20: Telomerase reverse transcriptase
TTTTGGGG
>HV222615.1 JP 2003510282-A/823: Immunostimulatory Nucleic Acids
CTGACGTG
>HV222605.1 JP 2003510282-A/813: Immunostimulatory Nucleic Acids
CCCCCCCC
>HV222602.1 JP 2003510282-A/810: Immunostimulatory Nucleic Acids
TGCGCTCT
>HV222583.1 JP 2003510282-A/791: Immunostimulatory Nucleic Acids
TCAACGTC
>HV222582.1 JP 2003510282-A/790: Immunostimulatory Nucleic Acids
TCTTCGAA
>HV222481.1 JP 2003510282-A/709: Immunostimulatory Nucleic Acids
TNAACGTT
>HV222479.1 JP 2003510282-A/707: Immunostimulatory Nucleic Acids
TCAGNGCT
>HV222471.1 JP 2003510282-A/699: Immunostimulatory Nucleic Acids
CCTTCGAT
>HV222470.1 JP 2003510282-A/698: Immunostimulatory Nucleic Acids
TCAANGTT
>HV222453.1 JP 2003510282-A/681: Immunostimulatory Nucleic Acids
TCCGTACG
>HV222452.1 JP 2003510282-A/680: Immunostimulatory Nucleic Acids
TCCGATCG
>HV222451.1 JP 2003510282-A/679: Immunostimulatory Nucleic Acids
AACGTTCT
>HV222450.1 JP 2003510282-A/678: Immunostimulatory Nucleic Acids
ATAACGTT
>HV222449.1 JP 2003510282-A/677: Immunostimulatory Nucleic Acids
AAAACGTT
>HV222448.1 JP 2003510282-A/676: Immunostimulatory Nucleic Acids
TTAACGTT
>HV222447.1 JP 2003510282-A/675: Immunostimulatory Nucleic Acids
ACAACGTT
>HV222446.1 JP 2003510282-A/674: Immunostimulatory Nucleic Acids
TGAACGTT
>HV222445.1 JP 2003510282-A/673: Immunostimulatory Nucleic Acids
GGAACGTT
>HV222444.1 JP 2003510282-A/672: Immunostimulatory Nucleic Acids
CTAACGTT
>HV222443.1 JP 2003510282-A/671: Immunostimulatory Nucleic Acids
CAAACGTT
>HV222442.1 JP 2003510282-A/670: Immunostimulatory Nucleic Acids
GAAACGTT
>HV222441.1 JP 2003510282-A/669: Immunostimulatory Nucleic Acids
CGAACGTT
>HV222440.1 JP 2003510282-A/668: Immunostimulatory Nucleic Acids
GTAACGTT
>HV222439.1 JP 2003510282-A/667: Immunostimulatory Nucleic Acids
GCAACGTT
>HV222428.1 JP 2003510282-A/656: Immunostimulatory Nucleic Acids
TAAGCGCT
>HV222427.1 JP 2003510282-A/655: Immunostimulatory Nucleic Acids
CTAGCGCT
>HV222426.1 JP 2003510282-A/654: Immunostimulatory Nucleic Acids
TCGACGTC
>HV222425.1 JP 2003510282-A/653: Immunostimulatory Nucleic Acids
CCATCGAT
>HV222422.1 JP 2003510282-A/650: Immunostimulatory Nucleic Acids
TCACCGGT
>HV222413.1 JP 2003510282-A/641: Immunostimulatory Nucleic Acids
CCAACGTT
>HV222412.1 JP 2003510282-A/640: Immunostimulatory Nucleic Acids
TAAACGTT
>HV222411.1 JP 2003510282-A/639: Immunostimulatory Nucleic Acids
TCATCGAT
>HV222410.1 JP 2003510282-A/638: Immunostimulatory Nucleic Acids
AGAACGTT
>HV222408.1 JP 2003510282-A/636: Immunostimulatory Nucleic Acids
TCAACGTT
>HV222404.1 JP 2003510282-A/632: Immunostimulatory Nucleic Acids
AACGTTGA
>HV222403.1 JP 2003510282-A/631: Immunostimulatory Nucleic Acids
TCAACGTT
>HV222402.1 JP 2003510282-A/630: Immunostimulatory Nucleic Acids
TCAACGTT
>HV222399.1 JP 2003510282-A/627: Immunostimulatory Nucleic Acids
CCTTCGAT
>HV222398.1 JP 2003510282-A/626: Immunostimulatory Nucleic Acids
TCAGCGCT
>HV222397.1 JP 2003510282-A/625: Immunostimulatory Nucleic Acids
AGCGCTGA
>HV222396.1 JP 2003510282-A/624: Immunostimulatory Nucleic Acids
CCATGCAT
>HV222395.1 JP 2003510282-A/623: Immunostimulatory Nucleic Acids
ATGCATGT
>HV222394.1 JP 2003510282-A/622: Immunostimulatory Nucleic Acids
ATCGATGT
>HV222393.1 JP 2003510282-A/621: Immunostimulatory Nucleic Acids
CCATCGAT
>HV222392.1 JP 2003510282-A/620: Immunostimulatory Nucleic Acids
GACGTCAT
>HV222391.1 JP 2003510282-A/619: Immunostimulatory Nucleic Acids
TAGACGTC
>HV222390.1 JP 2003510282-A/618: Immunostimulatory Nucleic Acids
AGGATATC
>HV222388.1 JP 2003510282-A/616: Immunostimulatory Nucleic Acids
TCAAGCTT
>HV222375.1 JP 2003510282-A/603: Immunostimulatory Nucleic Acids
AACGTTGA
>HV222373.1 JP 2003510282-A/601: Immunostimulatory Nucleic Acids
TCAACGTT
>HV198389.1 JP 2000516808-A/14: MHC binding peptide oligomers and methods of use
NNNGGGTC
>HV198388.1 JP 2000516808-A/13: MHC binding peptide oligomers and methods of use
GACCCNNN
>HV198383.1 JP 2000516808-A/8: MHC binding peptide oligomers and methods of use
NNCATTGC
>HV198382.1 JP 2000516808-A/7: MHC binding peptide oligomers and methods of use
GCAATGNN
>HV198379.1 JP 2000516808-A/4: MHC binding peptide oligomers and methods of use
GGTGANNN
>HV198378.1 JP 2000516808-A/3: MHC binding peptide oligomers and methods of use
NNNTCACC
>HV198377.1 JP 2000516808-A/2: MHC binding peptide oligomers and methods of use
NNNTCTTC
>HV198376.1 JP 2000516808-A/1: MHC binding peptide oligomers and methods of use
GAAGANNN
>HV222137.1 JP 2003510282-A/365: Immunostimulatory Nucleic Acids
TCAACGTT
>HV222079.1 JP 2003510282-A/307: Immunostimulatory Nucleic Acids
TCAACGTT
>HV221974.1 JP 2003510282-A/202: Immunostimulatory Nucleic Acids
TCAAGCTT
>HV221973.1 JP 2003510282-A/201: Immunostimulatory Nucleic Acids
TCAACGTT
>HV301659.1 JP 2009232850-A/8: Primer Extention Methods For Detecting Nucleic Acids
TGGTAGTT
>HV301658.1 JP 2009232850-A/7: Primer Extention Methods For Detecting Nucleic Acids
ATAAACTT
>HV301657.1 JP 2009232850-A/6: Primer Extention Methods For Detecting Nucleic Acids
GGAGCTGG
>HV301655.1 JP 2009232850-A/4: Primer Extention Methods For Detecting Nucleic Acids
TGGAGCTG
>HV301654.1 JP 2009232850-A/3: Primer Extention Methods For Detecting Nucleic Acids
TTGGAGCT
>HV301622.1 JP 2009142293-A/107: COMPOSITIONS AND METHODS RELATING TO ANTI IGF-1 RECEPTOR ANTIBODIES
DYKDDDDK
>HV307706.1 JP 2010011859-A/1034: A method for simultaneous production of multiple proteins; vectors and cells for use therein
CAGNNCGC
>HV307689.1 JP 2010011859-A/1017: A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGGNNCCA
>HV307682.1 JP 2010011859-A/1010: A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCGNNGAC
>HV304353.1 JP 2009540867-A/23: Methods for Detection of a Target Nucleic Acid by Forming a Cleavage Structure with a Reverse Transcriptase
TACGTTTA
>HV304352.1 JP 2009540867-A/22: Methods for Detection of a Target Nucleic Acid by Forming a Cleavage Structure with a Reverse Transcriptase
ATGCAAAT
>HV307645.1 JP 2010011859-A/973: A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCGNNGAC
>HV307643.1 JP 2010011859-A/971: A method for simultaneous production of multiple proteins; vectors and cells for use therein
GGCNNCGA
>HV307603.1 JP 2010011859-A/931: A method for simultaneous production of multiple proteins; vectors and cells for use therein
GAGNNCGC
>HV307578.1 JP 2010011859-A/906: A method for simultaneous production of multiple proteins; vectors and cells for use therein
AGGNNCCG
>HV307577.1 JP 2010011859-A/905: A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGGNNCAG
>HV307548.1 JP 2010011859-A/876: A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGANNACG
>HV307542.1 JP 2010011859-A/870: A method for simultaneous production of multiple proteins; vectors and cells for use therein
CAGNNGGC
>HV307535.1 JP 2010011859-A/863: A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCGNNGTC
>HV307534.1 JP 2010011859-A/862: A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCGNNGCA
>HV307531.1 JP 2010011859-A/859: A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCANNGCC
>HV307528.1 JP 2010011859-A/856: A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGGNNGCA
>HV307527.1 JP 2010011859-A/855: A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNNGCC
>HV307516.1 JP 2010011859-A/844: A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGTNNGCA
>HV307506.1 JP 2010011859-A/834: A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGCNNACA
>HV307494.1 JP 2010011859-A/822: A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCANNGGG
>HV307491.1 JP 2010011859-A/819: A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGCNNGGA
>HV307476.1 JP 2010011859-A/804: A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNNGAA
>HV307471.1 JP 2010011859-A/799: A method for simultaneous production of multiple proteins; vectors and cells for use therein
AGCNNCGC
>HV307421.1 JP 2010011859-A/749: A method for simultaneous production of multiple proteins; vectors and cells for use therein
CAGNNGGG
>HV307417.1 JP 2010011859-A/745: A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNNCCC
>HV307410.1 JP 2010011859-A/738: A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCCNNCGA
>HV307402.1 JP 2010011859-A/730: A method for simultaneous production of multiple proteins; vectors and cells for use therein
GACNNCCC
>HV307356.1 JP 2010011859-A/684: A method for simultaneous production of multiple proteins; vectors and cells for use therein
ACGNNCCC
>HV307344.1 JP 2010011859-A/672: A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNNTCC
>HV307341.1 JP 2010011859-A/669: A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGCNNCCG
>HV307334.1 JP 2010011859-A/662: A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCGNNGGC
>HV307325.1 JP 2010011859-A/653: A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGGNNCCC
>HV308499.1 JP 2009530374-A/30: Improved protofibril selective antibodies and the use thereof
ACGTRAGT
>HV307243.1 JP 2010011859-A/571: A method for simultaneous production of multiple proteins; vectors and cells for use therein
GACNNCGC
>HV307238.1 JP 2010011859-A/566: A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCGNNGCC
>HV307174.1 JP 2010011859-A/502: A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNNGCG
>HV307156.1 JP 2010011859-A/484: A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNNCGC
>HV307092.1 JP 2010011859-A/420: A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCGNNCCC
>HV307085.1 JP 2010011859-A/413: A method for simultaneous production of multiple proteins; vectors and cells for use therein
AGGNNGGG
>HV304289.1 JP 2009539412-A/86: Pan-Cell Surface Receptor-Specific Therapeutics
GCGGCCGC
>HV311308.1 JP 2010042015-A/3: OLIGONUCLEOTIDE ANALOG AND METHOD FOR TREATING FLAVIVIRUS INFECTIONS
CATATTGA
>HV311306.1 JP 2010042015-A/1: OLIGONUCLEOTIDE ANALOG AND METHOD FOR TREATING FLAVIVIRUS INFECTIONS
TCAATATG
>HV317386.1 JP 2010503619-A/32: GlmS Riboswitches, structure-based compound design with glmS riboswitches, and methods and compositions for use of and with glmS riboswitches
TGGGGTTT
>HV317376.1 JP 2010503619-A/22: GlmS Riboswitches, structure-based compound design with glmS riboswitches, and methods and compositions for use of and with glmS riboswitches
RGRGRNNT
>HV317366.1 JP 2010503619-A/12: GlmS Riboswitches, structure-based compound design with glmS riboswitches, and methods and compositions for use of and with glmS riboswitches
GACGAGGA
>HV217842.1 JP 2003502383-A/14: A METHOD FOR THE PROPHYLAXIS AND/OR TREATMENT OF MEDICAL DISORDERS
CCCGCCCC
>HV249389.1 JP 2009536039-A/1558: COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF GCCR
GCCACCAA
>HV307079.1 JP 2010011859-A/407: A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCGNNGCC
>HV307056.1 JP 2010011859-A/384: A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNNCGG
>HV235578.1 JP 2009232869-A/2: Evolving New Molecular Function
ACCCGTCA
>HV235577.1 JP 2009232869-A/1: Evolving New Molecular Function
TGACGGGT
>HV214520.1 JP 2002539767-A/111: Complementary DNA's Encoding Proteins with Signal Peptides
CATGGGGA
>HV214519.1 JP 2002539767-A/110: Complementary DNA's Encoding Proteins with Signal Peptides
GCACGTGA
>HV214518.1 JP 2002539767-A/109: Complementary DNA's Encoding Proteins with Signal Peptides
TCACGTGC
>HV214510.1 JP 2002539767-A/101: Complementary DNA's Encoding Proteins with Signal Peptides
AGAGGGGA
>HV214506.1 JP 2002539767-A/97: Complementary DNA's Encoding Proteins with Signal Peptides
GAAGGGGA
>HV214503.1 JP 2002539767-A/94: Complementary DNA's Encoding Proteins with Signal Peptides
TTGGGGGA
>HV214498.1 JP 2002539767-A/89: Complementary DNA's Encoding Proteins with Signal Peptides
CCTGGGGA
>HV214496.1 JP 2002539767-A/87: Complementary DNA's Encoding Proteins with Signal Peptides
TGAGGGGA
>HV214495.1 JP 2002539767-A/86: Complementary DNA's Encoding Proteins with Signal Peptides
TTTAGCGC
>HV040517.1 JP 2008289488-A/336: RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Synthetic Short Interfering Nucleic Acid (siNA)
TCGAAGTA
>HV040511.1 JP 2008289488-A/330: RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Synthetic Short Interfering Nucleic Acid (siNA)
TCGAAGTA
>HV040476.1 JP 2008289488-A/295: RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Synthetic Short Interfering Nucleic Acid (siNA)
TCGAAGTA
>HV040474.1 JP 2008289488-A/293: RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Synthetic Short Interfering Nucleic Acid (siNA)
TCGAAGTA
>HV040264.1 JP 2008289488-A/83: RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Synthetic Short Interfering Nucleic Acid (siNA)
TCGAAGTA
>HV121762.1 JP 2009131287-A/44: ENDOGENOUS RETROVIRUS UP-REGULATED IN PROSTATE CANCER
GCCAAGAA
>HV121757.1 JP 2009131287-A/39: ENDOGENOUS RETROVIRUS UP-REGULATED IN PROSTATE CANCER
AAAATTAA
>HV121731.1 JP 2009131287-A/13: ENDOGENOUS RETROVIRUS UP-REGULATED IN PROSTATE CANCER
TGGCTGTT
>HV121730.1 JP 2009131287-A/12: ENDOGENOUS RETROVIRUS UP-REGULATED IN PROSTATE CANCER
TAGGGGTG
>HV121729.1 JP 2009131287-A/11: ENDOGENOUS RETROVIRUS UP-REGULATED IN PROSTATE CANCER
TAGGTCTC
>HV118253.1 JP 2009201512-A/40: Genetic sequences having methyltransferase activity and uses therefor
GGTCGACC
>HV118252.1 JP 2009201512-A/39: Genetic sequences having methyltransferase activity and uses therefor
GGCGCGCC
>HV118251.1 JP 2009201512-A/38: Genetic sequences having methyltransferase activity and uses therefor
GGGATCCC
>HV197663.1 JP 2000515013-A/16: Novel catalytic RNA molecules
GGCCCTCT
>HV197661.1 JP 2000515013-A/14: Novel catalytic RNA molecules
GGCCCTCT
>HV197660.1 JP 2000515013-A/13: Novel catalytic RNA molecules
GGCCCTCT
>HV197658.1 JP 2000515013-A/11: Novel catalytic RNA molecules
GGCCCTCT
>HV188401.1 JP 2006194897-A/2: COMBINATORIAL STRATEGIES FOR POLYMER SYNTHESIS
GCGTCGGC
>HV188400.1 JP 2006194897-A/1: COMBINATORIAL STRATEGIES FOR POLYMER SYNTHESIS
GCCGACGC
>HV200382.1 JP 1999243999-A/64: Analysing polynucleotide sequences
GAGGACAC
>HV200364.1 JP 1999243999-A/46: Analysing polynucleotide sequences
GAGGACTC
>HV200346.1 JP 1999243999-A/28: Analysing polynucleotide sequences
GAGGATTC
>HV200271.1 JP 2000513948-A/18: Hamster EF-1alpha transcriptional regulatory DNA
TGACGYMR
>HV197592.1 JP 2000503671-A/8: Peptide nucleic acid having elevated binding affinity, sequence specificity and solubility
GCGTTTGC
>HV197586.1 JP 2000503671-A/2: Peptide nucleic acid having elevated binding affinity, sequence specificity and solubility
GCNNNCGC
>HV197563.1 JP 1999513897-A/49: Chemically inducible Arabidopsis PR-1 promoter
CTACGTCA
>HV203155.1 JP 2001516724-A/26: Peptide nucleic acids having antibacterial activity
GCTGTTTC
>HV203145.1 JP 2001516724-A/16: Peptide nucleic acids having antibacterial activity
CTCGAGGT
>HV203086.1 JP 2001516058-A/2: dsRNA/dsRNA-binding protein methods and compositions
ACGTACGT
>HV203074.1 JP 2001515209-A/5: Mass spectrometric detection of polypeptides
TAAGGAGG
>HV220449.1 JP 2003507024-A/3: POLYMERASE EXTENSION AT 3' TERMINUS OF PNA-DNA CHIMERA
TAGTTCTA
>HV216691.1 JP 2002543792-A/6: VECTOR-MEDIATED DELIVERY OF INTEGRATING TRANSPOSON SEQUENCES
ACATACAC
>HV235247.1 JP 2009240320-A/32: Method for differentiating breed of cattle
ACCAGCCC
>HV117557.1 JP 2009515823-A/25: IMMUNE REGULATORY OLIGONUCLEOTIDE (IRO) COMPOUNDS TO MODULATE TOLL-LIKE RECEPTOR BASED IMMUNE RESPONSE
CTATCTGT
>HV117555.1 JP 2009515823-A/23: IMMUNE REGULATORY OLIGONUCLEOTIDE (IRO) COMPOUNDS TO MODULATE TOLL-LIKE RECEPTOR BASED IMMUNE RESPONSE
CTATCTGA
>HV038788.1 JP 2005051082-A/3: A nano-electronic-device using B-Z transration of DNA
CGCGNNCG
>HV038787.1 JP 2005051082-A/2: A nano-electronic-device using B-Z transration of DNA
CGCNNGCG
>HV038786.1 JP 2005051082-A/1: A nano-electronic-device using B-Z transration of DNA
CGCGNGCG
>HV116682.1 JP 2009526543-A/25: DNA CONFORMATION (LOOP STRUCTURES) IN NORMAL AND ABNORMAL GENE EXPRESSION
TAACATAA
>HV199703.1 JP 2001502547-A/27: Methods for generating and screening novel metabolic pathways
GATCCGGA
>HV199685.1 JP 2001502547-A/9: Methods for generating and screening novel metabolic pathways
GATCTCTC
>HV231739.1 JP 2008289495-A/100: IMMUNOSTIMULATORY NUCLEIC ACID MOLECULES
TCAACGTC
>HV231738.1 JP 2008289495-A/99: IMMUNOSTIMULATORY NUCLEIC ACID MOLECULES
CCAACGTT
>HV231737.1 JP 2008289495-A/98: IMMUNOSTIMULATORY NUCLEIC ACID MOLECULES
TCTTCGAA
>HV231736.1 JP 2008289495-A/97: IMMUNOSTIMULATORY NUCLEIC ACID MOLECULES
TCATCGAT
>HV231735.1 JP 2008289495-A/96: IMMUNOSTIMULATORY NUCLEIC ACID MOLECULES
TCAGCGCT
>HV231734.1 JP 2008289495-A/95: IMMUNOSTIMULATORY NUCLEIC ACID MOLECULES
TCAAGCTT
>HV231733.1 JP 2008289495-A/94: IMMUNOSTIMULATORY NUCLEIC ACID MOLECULES
TCAACGTT
>HV222937.1 JP 2003510282-A/1145: Immunostimulatory Nucleic Acids
TCGTCGTT
>HV222930.1 JP 2003510282-A/1138: Immunostimulatory Nucleic Acids
TCGTATGA
>HV222927.1 JP 2003510282-A/1135: Immunostimulatory Nucleic Acids
ATGATCGT
>HV222784.1 JP 2003510282-A/992: Immunostimulatory Nucleic Acids
TCAACGTT
>HV312936.1 JP 2009240332-A/2: MOBILITY-MODIFIED NUCLEOBASE POLYMERS AND METHODS OF USING SAME
ATGCATGC
>HV312935.1 JP 2009240332-A/1: MOBILITY-MODIFIED NUCLEOBASE POLYMERS AND METHODS OF USING SAME
ATGCATGC
>HV120340.1 JP 2009515521-A/43: Methods for Production of Receptor and Ligand Isoforms
GCGGCCGC
>XM_003374739.1 Trichinella spiralis GMP synthase (Tsp_03976) mRNA, partial cds
ATGGTAAA
>XM_003379169.1 Trichinella spiralis conserved hypothetical protein (Tsp_02886a) mRNA, partial cds
CGGTGTAG
>HV036105.1 WO 2011027893-A/36: A method for predicting the efficacy of chronic hepatitis C treatment
TGGAGTGT
>HV036104.1 WO 2011027893-A/35: A method for predicting the efficacy of chronic hepatitis C treatment
CTGGACTT
>HV036098.1 WO 2011027893-A/29: A method for predicting the efficacy of chronic hepatitis C treatment
TACAGTAG
>HV036080.1 WO 2011027893-A/11: A method for predicting the efficacy of chronic hepatitis C treatment
AATGACAC
>FZ422079.1 JP 2011026203-A/8: Aurora Kinese A and Aurora Kinese B Gene Selective Expression Inhibitor
AGATTTGA
>FZ434926.1 JP 2011501661-A/69: OPTIMIZED STRAINS OF YARROWIA LIPOLYTICA FOR HIGH EICOSAPENTAENOIC ACID PRODUCTION
ACCAGCCC
>FZ437097.1 JP 2011501971-A/22: RATIONALLY-DESIGNED SINGLE-CHAIN MEGANUCLEASES WITH NON-PALINDROMIC RECOGNITION SEQUENCES
TCTGTAAA
>FZ437096.1 JP 2011501971-A/21: RATIONALLY-DESIGNED SINGLE-CHAIN MEGANUCLEASES WITH NON-PALINDROMIC RECOGNITION SEQUENCES
TTTACAGA
>FZ437093.1 JP 2011501971-A/18: RATIONALLY-DESIGNED SINGLE-CHAIN MEGANUCLEASES WITH NON-PALINDROMIC RECOGNITION SEQUENCES
GTTCCGGC
>FZ437092.1 JP 2011501971-A/17: RATIONALLY-DESIGNED SINGLE-CHAIN MEGANUCLEASES WITH NON-PALINDROMIC RECOGNITION SEQUENCES
GCCGGAAC
>JA381182.1 Sequence 23 from Patent WO2011051808
CCTCCCCC
>JA381181.1 Sequence 22 from Patent WO2011051808
CCCCCTCC
>JA381169.1 Sequence 10 from Patent WO2011051808
CCCCCCCT
>JA367720.1 Sequence 29 from Patent EP2319935
CCATGGTG
>JA367686.1 Sequence 29 from Patent EP2319934
CCATGGTG
>JA328979.1 Sequence 11 from Patent EP2316975
TGTTGCCA
>JA328678.1 Sequence 4 from Patent EP2316955
TGACGTGA
>JA328677.1 Sequence 3 from Patent EP2316955
TGACGTGG
>JA325725.1 Sequence 10 from Patent EP2316842
CCCCCCCT
>JA333514.1 Sequence 2776 from Patent EP2316953
TTTCCCGC
>JA333513.1 Sequence 2775 from Patent EP2316953
WTTSSCSS
>FZ421555.1 JP 2010539934-A/4: Generation of Human Embryonic Stem-Like Cells Using Intronic RNA
GTAAGAGK
>FZ421018.1 JP 2010539953-A/39: Generation of Tumor-Free Embryonic Stem-Like Pluripotent Cells Using Inducible Recombinant RNA Agents
GTAAGAGT
>FZ420983.1 JP 2010539953-A/4: Generation of Tumor-Free Embryonic Stem-Like Pluripotent Cells Using Inducible Recombinant RNA Agents
GTAAGAGK
>FZ416986.1 JP 2010538039-A/1: REDUCTION OF CONCOMITANT INFECTIONS IN PIGS BY THE USE OF PCV2 ANTIGEN
CCGCCATG
>JA288749.1 Sequence 18 from Patent EP2286792
TCTTCGAA
>JA288748.1 Sequence 17 from Patent EP2286792
TCATCGAT
>JA288747.1 Sequence 16 from Patent EP2286792
TCAACGCT
>JA288746.1 Sequence 15 from Patent EP2286792
TCAGCGCT
>JA288745.1 Sequence 14 from Patent EP2286792
TCGACGTC
>JA288744.1 Sequence 13 from Patent EP2286792
GCAACGTT
>JA288743.1 Sequence 12 from Patent EP2286792
TCAACGTT
>JA214906.1 Sequence 24 from Patent EP2311432
TTCGCGAA
>JA140090.1 Sequence 26 from Patent EP2270160
TTGCTATA
>JA140013.1 Sequence 288 from Patent EP2270513
TTGCTATA
>JA176501.1 Sequence 102 from Patent EP2295466
GTCTAGAC
>JA169763.1 Sequence 4 from Patent WO2011025566
GTAAGAGK
>JA113238.1 Sequence 2776 from Patent EP2302062
TTTCCCGC
>JA113237.1 Sequence 2775 from Patent EP2302062
WTTSSCSS
>JA039630.1 Sequence 1 from Patent EP2275130
CCGCCATG
>JA039006.1 Sequence 1 from Patent EP2275132
CCGCCATG
>JA047372.1 Sequence 1 from Patent WO2011028888
CCGCCATG
>JA071724.1 Sequence 24 from Patent EP2298278
TTCGCGAA
>JA071694.1 Sequence 18 from Patent EP2298935
TAGTGATC
>JA070572.1 Sequence 90 from Patent EP2298929
TAGGCATT
>JA070570.1 Sequence 88 from Patent EP2298929
TTACGGAT
>JA070567.1 Sequence 85 from Patent EP2298929
CTAGGATT
>JA070530.1 Sequence 48 from Patent EP2298929
CTAGGATT
>JA070529.1 Sequence 47 from Patent EP2298929
AATCCTAG
>JA070528.1 Sequence 46 from Patent EP2298929
TACGCATT
>JA070527.1 Sequence 45 from Patent EP2298929
AATGCGTA
>JA070526.1 Sequence 44 from Patent EP2298929
TAGACTGG
>JA070525.1 Sequence 43 from Patent EP2298929
CCAGTCTA
>JA070524.1 Sequence 42 from Patent EP2298929
TATGCCAG
>JA070523.1 Sequence 41 from Patent EP2298929
CTGGCATA
>JA070522.1 Sequence 40 from Patent EP2298929
TAGCAGTT
>JA070521.1 Sequence 39 from Patent EP2298929
AACTGCTA
>JA070520.1 Sequence 38 from Patent EP2298929
TAGTGACT
>JA070519.1 Sequence 37 from Patent EP2298929
AGTCACTA
>JA070518.1 Sequence 36 from Patent EP2298929
TAACGGTT
>JA070517.1 Sequence 35 from Patent EP2298929
AACCGTTA
>JA070516.1 Sequence 34 from Patent EP2298929
TGGCAATT
>JA070515.1 Sequence 33 from Patent EP2298929
AATTGCCA
>JA070514.1 Sequence 32 from Patent EP2298929
TAGTCAGT
>JA070513.1 Sequence 31 from Patent EP2298929
ACTGACTA
>JA070512.1 Sequence 30 from Patent EP2298929
TAAGCGTT
>JA070511.1 Sequence 29 from Patent EP2298929
AACGCTTA
>JA070510.1 Sequence 28 from Patent EP2298929
TAGGTCAT
>JA070509.1 Sequence 27 from Patent EP2298929
ATGACCTA
>JA070508.1 Sequence 26 from Patent EP2298929
TAAGGCTT
>JA070507.1 Sequence 25 from Patent EP2298929
AAGCCTTA
>JA070506.1 Sequence 24 from Patent EP2298929
TGGAACTT
>JA070505.1 Sequence 23 from Patent EP2298929
AAGTTCCA
>JA070504.1 Sequence 22 from Patent EP2298929
TAGCTAGT
>JA070503.1 Sequence 21 from Patent EP2298929
ACTAGCTA
>JA070502.1 Sequence 20 from Patent EP2298929
TAGAGCTT
>JA070501.1 Sequence 19 from Patent EP2298929
AAGCTCTA
>JA070500.1 Sequence 18 from Patent EP2298929
TCGAGATT
>JA070499.1 Sequence 17 from Patent EP2298929
AATCTCGA
>JA070498.1 Sequence 16 from Patent EP2298929
TGAGTACT
>JA070497.1 Sequence 15 from Patent EP2298929
AGTACTCA
>JA070496.1 Sequence 14 from Patent EP2298929
TGAACGTT
>JA070495.1 Sequence 13 from Patent EP2298929
AACGTTCA
>JA070494.1 Sequence 12 from Patent EP2298929
TGCGAATT
>JA070493.1 Sequence 11 from Patent EP2298929
AATTCGCA
>JA070492.1 Sequence 10 from Patent EP2298929
TACGGATT
>JA070491.1 Sequence 9 from Patent EP2298929
AATCCGTA
>JA070490.1 Sequence 8 from Patent EP2298929
TGGACATT
>JA070489.1 Sequence 7 from Patent EP2298929
AATGTCCA
>JA070488.1 Sequence 6 from Patent EP2298929
TAGGACTT
>JA070487.1 Sequence 5 from Patent EP2298929
AAGTCCTA
>JA070486.1 Sequence 4 from Patent EP2298929
TAGCGATT
>JA070485.1 Sequence 3 from Patent EP2298929
AATCGCTA
>JA070484.1 Sequence 2 from Patent EP2298929
TAGGCATT
>JA070483.1 Sequence 1 from Patent EP2298929
AATGCCTA
>JA006815.1 Sequence 16 from Patent EP2278006
CGGGATCC
>JA006813.1 Sequence 14 from Patent EP2278006
CGGGATCC
>HI999593.1 Sequence 1 from Patent EP2281829
CCGCCATG
>JA031475.1 Sequence 27 from Patent WO2010151841
GGCCATTA
>JA031474.1 Sequence 26 from Patent WO2010151841
GAACGTTG
>JA031469.1 Sequence 21 from Patent WO2010151841
GGACGCTG
>JA031468.1 Sequence 20 from Patent WO2010151841
GACCACTA
>JA031467.1 Sequence 19 from Patent WO2010151841
AGCCGCTG
>JA031458.1 Sequence 10 from Patent WO2010151841
GGCCGCTG
>JA031457.1 Sequence 9 from Patent WO2010151841
GGCCGCTA
>JA031456.1 Sequence 8 from Patent WO2010151841
GGCCACTA
>JA031455.1 Sequence 7 from Patent WO2010151841
GGCCACCA
>JA031454.1 Sequence 6 from Patent WO2010151841
GGACGCTA
>JA031453.1 Sequence 5 from Patent WO2010151841
GACGACTA
>JA031452.1 Sequence 4 from Patent WO2010151841
GAACGCTG
>JA031451.1 Sequence 3 from Patent WO2010151841
GAACGCTA
>JA031450.1 Sequence 2 from Patent WO2010151841
AGCCATTA
>JA031449.1 Sequence 1 from Patent WO2010151841
AGCCACTA
>JA030994.1 Sequence 119 from Patent EP2215450
AGAGAGTC
>JA030993.1 Sequence 118 from Patent EP2215450
GACTCTCT
>JA030992.1 Sequence 117 from Patent EP2215450
CTCAGGAA
>JA030991.1 Sequence 116 from Patent EP2215450
TTCCTGAG
>JA030990.1 Sequence 115 from Patent EP2215450
CACTACTG
>JA030989.1 Sequence 114 from Patent EP2215450
CAGTAGTG
>JA030988.1 Sequence 113 from Patent EP2215450
GTCCATCA
>JA030987.1 Sequence 112 from Patent EP2215450
TGATGGAC
>JA030986.1 Sequence 111 from Patent EP2215450
GAAGGCAT
>JA030985.1 Sequence 110 from Patent EP2215450
ATGCCTTC
>JA030984.1 Sequence 109 from Patent EP2215450
CGCAATAC
>JA030983.1 Sequence 108 from Patent EP2215450
GTATTGCG
>JA030982.1 Sequence 107 from Patent EP2215450
CATCCACT
>JA030981.1 Sequence 106 from Patent EP2215450
AGTGGATG
>JA030980.1 Sequence 105 from Patent EP2215450
GAATCGTT
>JA030979.1 Sequence 104 from Patent EP2215450
AACGATTC
>FW590356.1 JP 2010535150-A/30: Method for cloning cognate antibodies
AGTCAGTC
>FW592487.1 JP 2010535248-A/85: POLYPEPTIDE-NUCLEIC ACID CONJUGATE FOR IMMUNOPROPHYLAXIS OR IMMUNOTHERAPY FOR NEOPLASTIC OR INFECTIOUS DISORDERS
GCAGTGGC
>FW592486.1 JP 2010535248-A/84: POLYPEPTIDE-NUCLEIC ACID CONJUGATE FOR IMMUNOPROPHYLAXIS OR IMMUNOTHERAPY FOR NEOPLASTIC OR INFECTIOUS DISORDERS
GCCACTGC
>HI964352.1 Sequence 13 from Patent WO2010138755
NTCGGCAN
>HI964351.1 Sequence 12 from Patent WO2010138755
NTCGGCAA
>HI964350.1 Sequence 11 from Patent WO2010138755
TTCGGCAN
>HI964349.1 Sequence 10 from Patent WO2010138755
TTCGGCAA
>HI964348.1 Sequence 9 from Patent WO2010138755
TTGCCGAA
>HI964347.1 Sequence 8 from Patent WO2010138755
NTCGGCAN
>HI964346.1 Sequence 7 from Patent WO2010138755
NTCGGCAT
>HI964345.1 Sequence 6 from Patent WO2010138755
TTCGGCAN
>HI964344.1 Sequence 5 from Patent WO2010138755
TTCGGCAA
>HI964343.1 Sequence 4 from Patent WO2010138755
TTCGGCAG
>HI964342.1 Sequence 3 from Patent WO2010138755
TTCGGCAC
>HI964341.1 Sequence 2 from Patent WO2010138755
TTCGGCAT
>HI964340.1 Sequence 1 from Patent WO2010138755
ATGCCGAA
>HI981275.1 Sequence 288 from Patent EP2267458
TTGCTATA
>FW560306.1 The topical therapeutic agent for ophtalmic diseases comprising a DNA specific binding compound
AACTTGAG
>FW560296.1 The topical therapeutic agent for ophtalmic diseases comprising a DNA specific binding compound
AGCCTGGA
>FW560292.1 The topical therapeutic agent for ophtalmic diseases comprising a DNA specific binding compound
AGTCAGCA
>FW560289.1 The topical therapeutic agent for ophtalmic diseases comprising a DNA specific binding compound
AGTCAGGT
>FW560287.1 The topical therapeutic agent for ophtalmic diseases comprising a DNA specific binding compound
TGTGTCTC
>FW567290.1 METHODS AND COMPOSITIONS RELATED TO RIBOSWITCHES THAT CONTROL ALTERNATIVE SPLICING AND RNA PROCESSING
CAAGTCCA
>FW567282.1 METHODS AND COMPOSITIONS RELATED TO RIBOSWITCHES THAT CONTROL ALTERNATIVE SPLICING AND RNA PROCESSING
TGTTAGGT
>FW567281.1 METHODS AND COMPOSITIONS RELATED TO RIBOSWITCHES THAT CONTROL ALTERNATIVE SPLICING AND RNA PROCESSING
TGTTAGGT
>FW567279.1 METHODS AND COMPOSITIONS RELATED TO RIBOSWITCHES THAT CONTROL ALTERNATIVE SPLICING AND RNA PROCESSING
CTGTTGGT
>FW561133.1 Novel Acetyl CoA Carboxylase Gene
GCGGCCGC
>FW508095.1 NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND ASSAYS AND METHODS OF USE THEREOF FOR DIAGNOSIS OF BREAST CANCER
TCCCGCCG
>FW507984.1 POTENT MUCOSAL IMMUNE RESPONSE INDUCED BY MODIFIED IMMUNOMODULATORY OLIGONUCLEOTIDES
TCNTCNTT
>FW507983.1 POTENT MUCOSAL IMMUNE RESPONSE INDUCED BY MODIFIED IMMUNOMODULATORY OLIGONUCLEOTIDES
TCNTCNTT
>FW555204.1 process for hybridizing nucleic acid, process for typing single nucleotide polymorphism (SNP), reactor and apparatus for typing SNP
ACTGAAGT
>FW505457.1 STABILIZED IMMUNOMODULATORY OLIGONUCLEOTIDES
TCNTCNTT
>FW505455.1 STABILIZED IMMUNOMODULATORY OLIGONUCLEOTIDES
TCNTCNTT
>FW505435.1 STABILIZED IMMUNOMODULATORY OLIGONUCLEOTIDES
TCGTCGTT
>FW505432.1 STABILIZED IMMUNOMODULATORY OLIGONUCLEOTIDES
TTGTGCTT
>FW505431.1 STABILIZED IMMUNOMODULATORY OLIGONUCLEOTIDES
TCGTCGTT
>FW505430.1 STABILIZED IMMUNOMODULATORY OLIGONUCLEOTIDES
TCGTCGTT
>HI962264.1 Sequence 14 from Patent EP2261240
GNTGAATG
>HI962253.1 Sequence 3 from Patent EP2261240
TGACAGAT
>HI962252.1 Sequence 2 from Patent EP2261240
GGTGAATG
>HI962251.1 Sequence 1 from Patent EP2261240
CATTCACC
>HI962122.1 Sequence 80 from Patent EP2261333
AACGAACA
>HI962119.1 Sequence 77 from Patent EP2261333
TTAGCATT
>HI962116.1 Sequence 74 from Patent EP2261333
TCACACTC
>HI962113.1 Sequence 71 from Patent EP2261333
GATTTGCA
>HI931586.1 Sequence 10 from Patent WO2010133970
ATGCTGCT
>HI936200.1 Sequence 42 from Patent EP2258725
CGCGTCTC
>HI936199.1 Sequence 41 from Patent EP2258725
AATTGAGA
>HI916590.1 Sequence 11 from Patent EP2256213
TGTTGCCA
>HI923341.1 Sequence 26 from Patent EP2256198
TTGCTATA
>HI923046.1 Sequence 26 from Patent EP2256197
TTGCTATA
>FW421119.1 Methods for Selecting Medications
GGCTGCGC
>FW421100.1 Methods for Selecting Medications
GGCGCGGC
>FW421099.1 Methods for Selecting Medications
GGCGCGGG
>FW498043.1 RECOMBINANT EXPRESSION VECTOR ELEMENTS (REVES) FOR ENHANCING EXPRESSION OF RECOMBINANT PROTEINS IN HOST CELLS
AATATATT
>FW495987.1 High-expression promoter and method for producing gene product using the same
TATATTAT
>FW497175.1 PROPHYLAXIS AND TREATMENT OF PRDC
CCGCCATG
>FW497127.1 COMPOSITIONS AND METHODS FOR THE DETECTION OF A NUCLEIC ACID USING A CLEAVAGE REACTION
TACGTTTA
>FW497126.1 COMPOSITIONS AND METHODS FOR THE DETECTION OF A NUCLEIC ACID USING A CLEAVAGE REACTION
ATGCAAAT
>HI651166.1 Sequence 45 from Patent EP2248828
CGCGTCTC
>HI651165.1 Sequence 44 from Patent EP2248828
AATTGAGA
>HI649834.1 Sequence 26 from Patent WO2010122538
GTCACACT
>HI649832.1 Sequence 24 from Patent WO2010122538
TCACACTC
>HI649814.1 Sequence 6 from Patent WO2010122538
CACACTCC
>HI380612.1 Sequence 32 from Patent EP2061480
TGGGGTTT
>HI380602.1 Sequence 22 from Patent EP2061480
RGRGRNNT
>HI380592.1 Sequence 12 from Patent EP2061480
GACGAGGA
>HI380264.1 Sequence 1 from Patent EP2094872
CCGCCATG
>HI377688.1 Sequence 1 from Patent EP2101815
CCGCCATG
>HI376804.1 Sequence 91 from Patent EP2079305
TCNTCNTT
>HI376801.1 Sequence 88 from Patent EP2079305
TCNCNTTT
>HI376313.1 Sequence 8 from Patent EP2114449
TCAACGTT
>HI373914.1 Sequence 1 from Patent EP2099927
CCGCCATG
>HI368415.1 Sequence 1 from Patent EP2081593
AGCTTGCA
>HI424855.1 Sequence 361 from Patent EP2126087
CRCCGGYG
>HI424854.1 Sequence 360 from Patent EP2126087
CCTGCAGG
>HI424851.1 Sequence 357 from Patent EP2126087
GGCCGGCC
>HI424845.1 Sequence 351 from Patent EP2126087
GGCGCGCC
>HI002965.1 Sequence 6448 from Patent EP1716256
CAAAACGG
>HI571500.1 Sequence 18 from Patent EP2219653
AGCAGCAC
>HI584372.1 Sequence 26 from Patent EP2222853
ACCTGCCC
>HI001442.1 Sequence 4925 from Patent EP1716256
GAAGCTAC
>HI001412.1 Sequence 4895 from Patent EP1716256
ACCCCATC
>HI001309.1 Sequence 4792 from Patent EP1716256
ATGGGCAG
>HI003095.1 Sequence 6578 from Patent EP1716256
CAGAAACG
>HI002760.1 Sequence 6243 from Patent EP1716256
GGGCCAGC
>HI002385.1 Sequence 5868 from Patent EP1716256
CTGGCCAG
>HI180600.1 Sequence 208 from Patent EP1996721
CTGGATGA
>HI213223.1 Sequence 133 from Patent EP2087133
TAGCGTGA
>HI553457.1 Sequence 67 from Patent EP2195453
GGCGGCGG
>HI635318.1 Sequence 1 from Patent EP2242511
CCGCCATG
>HI002141.1 Sequence 5624 from Patent EP1716256
CTGTTATC
>HI002140.1 Sequence 5623 from Patent EP1716256
CTTTGTGT
>HI208726.1 Sequence 23 from Patent EP2038428
TACGTTTA
>HI208725.1 Sequence 22 from Patent EP2038428
ATGCAAAT
>HI569450.1 Sequence 28 from Patent EP2215223
TCTGTAAA
>HI569449.1 Sequence 27 from Patent EP2215223
TTTACAGA
>HI569446.1 Sequence 24 from Patent EP2215223
GTTCCGGC
>HI569445.1 Sequence 23 from Patent EP2215223
GCCGGAAC
>HI003729.1 Sequence 304 from Patent EP1735468
ACACGCAC
>HI002002.1 Sequence 5485 from Patent EP1716256
CTGGCCAG
>HI001997.1 Sequence 5480 from Patent EP1716256
GCAAGAAG
>HI001989.1 Sequence 5472 from Patent EP1716256
GTGCCAAG
>HI001981.1 Sequence 5464 from Patent EP1716256
GCGAGGAC
>HI001918.1 Sequence 5401 from Patent EP1716256
GCCAAAAG
>HI000215.1 Sequence 3698 from Patent EP1716256
AAATGACG
>HI000210.1 Sequence 3693 from Patent EP1716256
ATACCAGG
>HI205749.1 Sequence 54 from Patent EP2061482
CAGAAAAC
>HI205748.1 Sequence 53 from Patent EP2061482
TGGAAGAC
>HI205747.1 Sequence 52 from Patent EP2061482
TGGAAGAC
>HI205746.1 Sequence 51 from Patent EP2061482
TACAAGAG
>HI205745.1 Sequence 50 from Patent EP2061482
TGGAAAAG
>HI205744.1 Sequence 49 from Patent EP2061482
TGGAAGAG
>HI205731.1 Sequence 36 from Patent EP2061482
GTTTTCTG
>HI205730.1 Sequence 35 from Patent EP2061482
GTCTTCCA
>HI205729.1 Sequence 34 from Patent EP2061482
GTCTTCCA
>HI205728.1 Sequence 33 from Patent EP2061482
CTCTTGTA
>HI205727.1 Sequence 32 from Patent EP2061482
CTTTTCCA
>HI205726.1 Sequence 31 from Patent EP2061482
CTCTTCCA
>HI136446.1 Sequence 53 from Patent EP1928496
GGCCAGCT
>HI003637.1 Sequence 212 from Patent EP1735468
GTCCCCAC
>HI003552.1 Sequence 127 from Patent EP1735468
GTACTCAC
>HI003551.1 Sequence 126 from Patent EP1735468
AACCGCAC
>HI001856.1 Sequence 5339 from Patent EP1716256
CTGGCCAG
>HI001711.1 Sequence 5194 from Patent EP1716256
CTCAAGAC
>HI001700.1 Sequence 5183 from Patent EP1716256
CTACCAAG
>HI550795.1 Sequence 138 from Patent EP2178896
GCAGTGGC
>HI550794.1 Sequence 137 from Patent EP2178896
GCCACTGC
>HI001687.1 Sequence 5170 from Patent EP1716256
GGAGGCCC
>HI001537.1 Sequence 5020 from Patent EP1716256
TGGGGCAG
>HI463064.1 Sequence 18 from Patent EP2142560
AATATATT
>HH713493.1 Sequence 1 from Patent WO2010084371
GAACGAAG
>HH998032.1 Sequence 1516 from Patent EP1716256
GTGAGAGG
>HH997962.1 Sequence 1446 from Patent EP1716256
CACCCCAG
>HH999597.1 Sequence 3081 from Patent EP1716256
TGGGACAG
>HH999594.1 Sequence 3078 from Patent EP1716256
GGAAGAAG
>HH999573.1 Sequence 3057 from Patent EP1716256
CGCCGTGG
>HH999548.1 Sequence 3032 from Patent EP1716256
CAAGAAGG
>HH997809.1 Sequence 1293 from Patent EP1716256
CCATGCAG
>HH978570.1 Sequence 34 from Patent EP1751180
ATGTATGC
>HH978569.1 Sequence 33 from Patent EP1751180
ATGTCTTC
>HH978568.1 Sequence 32 from Patent EP1751180
ATGGATTC
>HH978567.1 Sequence 31 from Patent EP1751180
ATTTATAC
>HH978566.1 Sequence 30 from Patent EP1751180
AGTTATTC
>HH978565.1 Sequence 29 from Patent EP1751180
ATGTTTCC
>HH978564.1 Sequence 28 from Patent EP1751180
ATGAATCT
>HH978563.1 Sequence 27 from Patent EP1751180
ATCTATCC
>HH978562.1 Sequence 26 from Patent EP1751180
AAGTATCC
>HH978561.1 Sequence 25 from Patent EP1751180
ATGTGTAC
>HH978560.1 Sequence 24 from Patent EP1751180
ATGCATAC
>HH978559.1 Sequence 23 from Patent EP1751180
ATATATAC
>HH978558.1 Sequence 22 from Patent EP1751180
ACGTATAC
>HH978557.1 Sequence 21 from Patent EP1751180
ATGTATTC
>HH978556.1 Sequence 20 from Patent EP1751180
ATGTATCC
>HH978555.1 Sequence 19 from Patent EP1751180
ATGTATAC
>HH978554.1 Sequence 18 from Patent EP1751180
AGGTATGC
>HH978553.1 Sequence 17 from Patent EP1751180
AAGTATGC
>HH978552.1 Sequence 16 from Patent EP1751180
ACGTATGC
>HH978551.1 Sequence 15 from Patent EP1751180
ATGTATAC
>HH978550.1 Sequence 14 from Patent EP1751180
ATGTAGGC
>HH978549.1 Sequence 13 from Patent EP1751180
ATGTACGC
>HH978548.1 Sequence 12 from Patent EP1751180
ATGTCTGC
>HH978547.1 Sequence 11 from Patent EP1751180
ATGTTTGC
>HH978546.1 Sequence 10 from Patent EP1751180
ATGTGTGC
>HH978545.1 Sequence 9 from Patent EP1751180
ATGGATGC
>HH978544.1 Sequence 8 from Patent EP1751180
ATGAATGC
>HH978543.1 Sequence 7 from Patent EP1751180
ATGCATGC
>HH978542.1 Sequence 6 from Patent EP1751180
ATTTATGC
>HH978541.1 Sequence 5 from Patent EP1751180
ATCTATGC
>HH978540.1 Sequence 4 from Patent EP1751180
ATATATGC
>HH978539.1 Sequence 3 from Patent EP1751180
AGGTATGC
>HH978538.1 Sequence 2 from Patent EP1751180
AAGTATGC
>HH978537.1 Sequence 1 from Patent EP1751180
ACGTATGC
>HH999351.1 Sequence 2835 from Patent EP1716256
GAAGATGG
>HH999331.1 Sequence 2815 from Patent EP1716256
CTGGCCTC
>HH997589.1 Sequence 1073 from Patent EP1716256
GTCACACC
>HH997547.1 Sequence 1031 from Patent EP1716256
GGCTGGGG
>HH997546.1 Sequence 1030 from Patent EP1716256
TGGCCGAG
>HH997469.1 Sequence 953 from Patent EP1716256
CTCTCTGG
>HH999282.1 Sequence 2766 from Patent EP1716256
CGTAGCAC
>HH999269.1 Sequence 2753 from Patent EP1716256
CATGGCAG
>HH999255.1 Sequence 2739 from Patent EP1716256
CTTTGGAG
>HH999177.1 Sequence 2661 from Patent EP1716256
TTCTGTAG
>HH998977.1 Sequence 2461 from Patent EP1716256
GTCACAGA
>HH997279.1 Sequence 763 from Patent EP1716256
GCGCGGCC
>HH997277.1 Sequence 761 from Patent EP1716256
CTGTACAT
>HH970250.1 Sequence 14 from Patent EP1680438
CGCTGGGC
>HH970247.1 Sequence 11 from Patent EP1680438
CCGCTCCG
>HH970237.1 Sequence 1 from Patent EP1680438
CCGCTCCG
>HH998743.1 Sequence 2227 from Patent EP1716256
CCATGGCC
>HH996859.1 Sequence 343 from Patent EP1716256
GGGAATCC
>HH996841.1 Sequence 325 from Patent EP1716256
GTCCTCCC
>HH996802.1 Sequence 286 from Patent EP1716256
GTGTCCTC
>HH954154.1 Sequence 1 from Patent EP1654371
GGAATTCC
>HH980577.1 Sequence 1178 from Patent EP1749025
GGATCGCG
>HH987186.1 Sequence 124 from Patent EP1720995
GACCACAT
>HH976605.1 Sequence 66 from Patent EP1732580
NAGGAGGT
>HH979774.1 Sequence 375 from Patent EP1749025
TGAAGCAG
>HH999883.1 Sequence 3367 from Patent EP1716256
CCATGGAG
>HH998199.1 Sequence 1683 from Patent EP1716256
CTAAACAG
>HH979541.1 Sequence 142 from Patent EP1749025
ACACGCAC
>HH931949.1 Sequence 67 from Patent EP2235179
GCAGTGNN
>FW406834.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING VEGF FAMILY GENE EXPRESSION AND USES THEREOF
GAACAGGG
>FW399253.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING AKT GENE EXPRESSION AND USES THEREOF
GAACAGGG
>FW395106.1 Novel Polypeptides
CTCTAAAG
>FW409855.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING BCL2 GENE EXPRESSION AND USES THEREOF
GAACAGGG
>FW402649.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING ERBB FAMILY GENE EXPRESSION AND USES THEREOFF
TCGGAGTT
>FW402642.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING ERBB FAMILY GENE EXPRESSION AND USES THEREOFF
TCGGAGTT
>FW402630.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING ERBB FAMILY GENE EXPRESSION AND USES THEREOFF
GGATCTTA
>FW402620.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING ERBB FAMILY GENE EXPRESSION AND USES THEREOFF
CGATTTTT
>FW402614.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING ERBB FAMILY GENE EXPRESSION AND USES THEREOFF
CTACACAA
>FW402602.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING ERBB FAMILY GENE EXPRESSION AND USES THEREOFF
GGATCTTA
>FW405813.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING VEGF FAMILY GENE EXPRESSION AND USES THEREOF
TCGGAGTT
>FW405806.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING VEGF FAMILY GENE EXPRESSION AND USES THEREOF
TCGGAGTT
>FW405794.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING VEGF FAMILY GENE EXPRESSION AND USES THEREOF
GGATCTTA
>FW405784.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING VEGF FAMILY GENE EXPRESSION AND USES THEREOF
CGATTTTT
>FW405778.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING VEGF FAMILY GENE EXPRESSION AND USES THEREOF
CTACACAA
>FW405766.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING VEGF FAMILY GENE EXPRESSION AND USES THEREOF
GGATCTTA
>FW412993.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING RAS GENE EXPRESSION AND USES THEREOF
GAACAGGG
>FW408858.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING BCL2 GENE EXPRESSION AND USES THEREOF
TCGGAGTT
>FW398256.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING AKT GENE EXPRESSION AND USES THEREOF
TCGGAGTT
>FW398249.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING AKT GENE EXPRESSION AND USES THEREOF
TCGGAGTT
>FW398237.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING AKT GENE EXPRESSION AND USES THEREOF
GGATCTTA
>FW398227.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING AKT GENE EXPRESSION AND USES THEREOF
CGATTTTT
>FW398221.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING AKT GENE EXPRESSION AND USES THEREOF
CTACACAA
>FW398209.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING AKT GENE EXPRESSION AND USES THEREOF
GGATCTTA
>FW398166.1 METHODS AND COMPOSITIONS FOR TREATING TUMOR DISEASES
DYKDDDDK
>FW408851.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING BCL2 GENE EXPRESSION AND USES THEREOF
TCGGAGTT
>FW408839.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING BCL2 GENE EXPRESSION AND USES THEREOF
GGATCTTA
>FW408829.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING BCL2 GENE EXPRESSION AND USES THEREOF
CGATTTTT
>FW408823.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING BCL2 GENE EXPRESSION AND USES THEREOF
CTACACAA
>FW408811.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING BCL2 GENE EXPRESSION AND USES THEREOF
GGATCTTA
>FW415463.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING WNT GENE EXPRESSION AND USES THEREOF
GAACAGGG
>FW411997.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING RAS GENE EXPRESSION AND USES THEREOF
TCGGAGTT
>FW411990.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING RAS GENE EXPRESSION AND USES THEREOF
TCGGAGTT
>FW411978.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING RAS GENE EXPRESSION AND USES THEREOF
GGATCTTA
>FW411968.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING RAS GENE EXPRESSION AND USES THEREOF
CGATTTTT
>FW411962.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING RAS GENE EXPRESSION AND USES THEREOF
CTACACAA
>FW411950.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING RAS GENE EXPRESSION AND USES THEREOF
GGATCTTA
>FW408208.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING HIF1A GENE EXPRESSION AND USES THEREOF
GAACAGGG
>FW397472.1 METHODS OF GENERATING LIBRARIES AND USES THEREOF
CRCCGGYG
>FW397471.1 METHODS OF GENERATING LIBRARIES AND USES THEREOF
CCTGCAGG
>FW397468.1 METHODS OF GENERATING LIBRARIES AND USES THEREOF
GGCCGGCC
>FW397462.1 METHODS OF GENERATING LIBRARIES AND USES THEREOF
GGCGCGCC
>FW411633.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING MYC GENE EXPRESSION AND USES THEREOF
GAACAGGG
>FW403670.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING ERBB FAMILY GENE EXPRESSION AND USES THEREOFF
GAACAGGG
>FW407211.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING HIF1A GENE EXPRESSION AND USES THEREOF
TCGGAGTT
>FW407204.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING HIF1A GENE EXPRESSION AND USES THEREOF
TCGGAGTT
>FW407192.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING HIF1A GENE EXPRESSION AND USES THEREOF
GGATCTTA
>FW407182.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING HIF1A GENE EXPRESSION AND USES THEREOF
CGATTTTT
>FW407176.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING HIF1A GENE EXPRESSION AND USES THEREOF
CTACACAA
>FW407164.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING HIF1A GENE EXPRESSION AND USES THEREOF
GGATCTTA
>FW414442.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING WNT GENE EXPRESSION AND USES THEREOF
TCGGAGTT
>FW414435.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING WNT GENE EXPRESSION AND USES THEREOF
TCGGAGTT
>FW414423.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING WNT GENE EXPRESSION AND USES THEREOF
GGATCTTA
>FW410636.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING MYC GENE EXPRESSION AND USES THEREOF
TCGGAGTT
>FW410629.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING MYC GENE EXPRESSION AND USES THEREOF
TCGGAGTT
>FW410617.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING MYC GENE EXPRESSION AND USES THEREOF
GGATCTTA
>FW410607.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING MYC GENE EXPRESSION AND USES THEREOF
CGATTTTT
>FW410601.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING MYC GENE EXPRESSION AND USES THEREOF
CTACACAA
>FW410589.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING MYC GENE EXPRESSION AND USES THEREOF
GGATCTTA
>FW414413.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING WNT GENE EXPRESSION AND USES THEREOF
CGATTTTT
>FW414407.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING WNT GENE EXPRESSION AND USES THEREOF
CTACACAA
>FW414395.1 NUCLEIC ACID COMPOUNDS FOR INHIBITING WNT GENE EXPRESSION AND USES THEREOF
GGATCTTA
>HH934696.1 Sequence 216 from Patent WO2010108657
GAGAATGG
>HH934694.1 Sequence 214 from Patent WO2010108657
WAGAATSG
>HH934662.1 Sequence 182 from Patent WO2010108657
NNNKVGNM
>HH934661.1 Sequence 181 from Patent WO2010108657
NNGCCNNN
>HH934660.1 Sequence 180 from Patent WO2010108657
NNNAGCNN
>HH934659.1 Sequence 179 from Patent WO2010108657
NNGCYNNN
>HH835076.1 Sequence 153 from Patent WO2010105074
CGCCGCGC
>HH834937.1 Sequence 14 from Patent WO2010105074
CCGCCGGC
>HH834936.1 Sequence 13 from Patent WO2010105074
CAGCCGGC
>FW381700.1 APTAMER THERAPEUTICS USEFUL IN OCULAR PHARMACOTHERAPY
TGAAGCTG
>FW381698.1 APTAMER THERAPEUTICS USEFUL IN OCULAR PHARMACOTHERAPY
TGATCCTG
>FW381696.1 APTAMER THERAPEUTICS USEFUL IN OCULAR PHARMACOTHERAPY
TGATCCTG
>HH925565.1 Sequence 36 from Patent WO2010105819
CCCCNCCC
>HH925564.1 Sequence 35 from Patent WO2010105819
CCCCNCCC
>HH925563.1 Sequence 34 from Patent WO2010105819
CCCCTCCC
>HH925545.1 Sequence 16 from Patent WO2010105819
AAAAGAAA
>HH925540.1 Sequence 11 from Patent WO2010105819
CCCCTCCC
>HH925532.1 Sequence 3 from Patent WO2010105819
GGGGGGGG
>HH925531.1 Sequence 2 from Patent WO2010105819
CCCCCCCC
>HH925530.1 Sequence 1 from Patent WO2010105819
AAAAAAAA
>HH827345.1 Sequence 2 from Patent EP2230303
GGAATTCC
>HH826101.1 Sequence 54 from Patent WO2010100328
ATCGTGCA
>HH826100.1 Sequence 53 from Patent WO2010100328
AACATTCA
>HH826099.1 Sequence 52 from Patent WO2010100328
GAAGTGCT
>HH826098.1 Sequence 51 from Patent WO2010100328
AAAGTGCT
>HH826097.1 Sequence 50 from Patent WO2010100328
CAGTGCAA
>HH826096.1 Sequence 49 from Patent WO2010100328
CAAAGTGC
>HH826095.1 Sequence 48 from Patent WO2010100328
TGATTGTC
>HH826094.1 Sequence 47 from Patent WO2010100328
AAGCTGCC
>HH826093.1 Sequence 46 from Patent WO2010100328
TCTTTGGT
>HH826092.1 Sequence 45 from Patent WO2010100328
TAAGTGCT
>HH826091.1 Sequence 44 from Patent WO2010100328
AACTGGCC
>HH826090.1 Sequence 43 from Patent WO2010100328
TAAGGTGC
>FW373970.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CAGNNCGC
>FW373953.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGGNNCCA
>FW373946.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GCGNNGAC
>FW373909.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCGNNGAC
>FW373907.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GGCNNCGA
>FW373867.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GAGNNCGC
>FW373842.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
AGGNNCCG
>FW373841.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGGNNCAG
>FW373812.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGANNACG
>FW373806.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CAGNNGGC
>FW373799.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCGNNGTC
>FW373798.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GCGNNGCA
>FW373795.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GCANNGCC
>FW373792.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGGNNGCA
>FW373791.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCCNNGCC
>FW373780.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGTNNGCA
>FW373770.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGCNNACA
>FW373758.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCANNGGG
>FW373755.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGCNNGGA
>FW373740.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCCNNGAA
>FW373735.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
AGCNNCGC
>FW373685.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CAGNNGGG
>FW373681.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCCNNCCC
>FW373674.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GCCNNCGA
>FW373666.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GACNNCCC
>FW373620.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
ACGNNCCC
>FW373608.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCCNNTCC
>FW373605.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGCNNCCG
>FW373598.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCGNNGGC
>FW373589.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGGNNCCC
>FW373507.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GACNNCGC
>FW373502.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCGNNGCC
>FW373438.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCCNNGCG
>FW373420.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCCNNCGC
>FW373356.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GCGNNCCC
>FW373349.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
AGGNNGGG
>FW373343.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GCGNNGCC
>FW373320.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCCNNCGG
>FW372891.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CAGNNCGC
>FW372874.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGGNNCCA
>FW372867.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GCGNNGAC
>FW372830.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCGNNGAC
>FW372828.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GGCNNCGA
>FW372788.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GAGNNCGC
>FW372763.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
AGGNNCCG
>FW372762.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGGNNCAG
>FW372733.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGANNACG
>FW372727.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CAGNNGGC
>FW372720.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCGNNGTC
>FW372719.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GCGNNGCA
>FW372716.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GCANNGCC
>FW372713.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGGNNGCA
>FW372712.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCCNNGCC
>FW372701.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGTNNGCA
>FW372691.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGCNNACA
>FW372679.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCANNGGG
>FW372676.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGCNNGGA
>FW372661.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCCNNGAA
>FW372656.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
AGCNNCGC
>FW372606.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CAGNNGGG
>FW372602.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCCNNCCC
>FW372595.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GCCNNCGA
>FW372587.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GACNNCCC
>FW372541.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
ACGNNCCC
>FW372529.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCCNNTCC
>FW372526.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGCNNCCG
>FW372519.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCGNNGGC
>FW372510.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGGNNCCC
>FW372428.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GACNNCGC
>FW372423.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCGNNGCC
>FW372359.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCCNNGCG
>FW372341.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCCNNCGC
>FW372277.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GCGNNCCC
>FW372270.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
AGGNNGGG
>FW372264.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GCGNNGCC
>FW372241.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCCNNCGG
>FW375822.1 HERPES SIMPLEX VIRUS COMBINED SUBUNIT VACCINES AND METHODS OF USE THEREOF
TCAACGTT
>FW375579.1 Methods for detection of a target nucleic acid by forming a cleavage structure with a cleavage resistant probe
TACGTTTA
>FW375578.1 Methods for detection of a target nucleic acid by forming a cleavage structure with a cleavage resistant probe
ATGCAAAT
>FW369584.1 Primer and competitive probe for SNP detection of obesity genes
TCCATTGG
>FW369564.1 Primer and competitive probe for SNP detection of obesity genes
CCTGGACT
>FW374607.1 PROSTATE CANCER-RELATED COMPOSITIONS, METHODS, AND KITS BASED ON DNA MACROARRAY PROTEOMICS PLATFORMS
CACAATGA
>FW374606.1 PROSTATE CANCER-RELATED COMPOSITIONS, METHODS, AND KITS BASED ON DNA MACROARRAY PROTEOMICS PLATFORMS
CACGGATG
>HH736002.1 Sequence 74 from Patent WO2010086602
GCYAGYAG
>HH735999.1 Sequence 71 from Patent WO2010086602
CYACYAGC
>HH735783.1 Sequence 90 from Patent EP2218726
TAGGCATT
>HH735781.1 Sequence 88 from Patent EP2218726
TTACGGAT
>HH735778.1 Sequence 85 from Patent EP2218726
CTAGGATT
>HH735741.1 Sequence 48 from Patent EP2218726
CTAGGATT
>HH735740.1 Sequence 47 from Patent EP2218726
AATCCTAG
>HH735739.1 Sequence 46 from Patent EP2218726
TACGCATT
>HH735738.1 Sequence 45 from Patent EP2218726
AATGCGTA
>HH735737.1 Sequence 44 from Patent EP2218726
TAGACTGG
>HH735736.1 Sequence 43 from Patent EP2218726
CCAGTCTA
>HH735735.1 Sequence 42 from Patent EP2218726
TATGCCAG
>HH735734.1 Sequence 41 from Patent EP2218726
CTGGCATA
>HH735733.1 Sequence 40 from Patent EP2218726
TAGCAGTT
>HH735732.1 Sequence 39 from Patent EP2218726
AACTGCTA
>HH735731.1 Sequence 38 from Patent EP2218726
TAGTGACT
>HH735730.1 Sequence 37 from Patent EP2218726
AGTCACTA
>HH735729.1 Sequence 36 from Patent EP2218726
TAACGGTT
>HH735728.1 Sequence 35 from Patent EP2218726
AACCGTTA
>HH735727.1 Sequence 34 from Patent EP2218726
TGGCAATT
>HH735726.1 Sequence 33 from Patent EP2218726
AATTGCCA
>HH735725.1 Sequence 32 from Patent EP2218726
TAGTCAGT
>HH735724.1 Sequence 31 from Patent EP2218726
ACTGACTA
>HH735723.1 Sequence 30 from Patent EP2218726
TAAGCGTT
>HH735722.1 Sequence 29 from Patent EP2218726
AACGCTTA
>HH735721.1 Sequence 28 from Patent EP2218726
TAGGTCAT
>HH735720.1 Sequence 27 from Patent EP2218726
ATGACCTA
>HH735719.1 Sequence 26 from Patent EP2218726
TAAGGCTT
>HH735718.1 Sequence 25 from Patent EP2218726
AAGCCTTA
>HH735717.1 Sequence 24 from Patent EP2218726
TGGAACTT
>HH735716.1 Sequence 23 from Patent EP2218726
AAGTTCCA
>HH735715.1 Sequence 22 from Patent EP2218726
TAGCTAGT
>HH735714.1 Sequence 21 from Patent EP2218726
ACTAGCTA
>HH735713.1 Sequence 20 from Patent EP2218726
TAGAGCTT
>HH735712.1 Sequence 19 from Patent EP2218726
AAGCTCTA
>HH735711.1 Sequence 18 from Patent EP2218726
TCGAGATT
>HH735710.1 Sequence 17 from Patent EP2218726
AATCTCGA
>HH735709.1 Sequence 16 from Patent EP2218726
TGAGTACT
>HH735708.1 Sequence 15 from Patent EP2218726
AGTACTCA
>HH735707.1 Sequence 14 from Patent EP2218726
TGAACGTT
>HH735706.1 Sequence 13 from Patent EP2218726
AACGTTCA
>HH735705.1 Sequence 12 from Patent EP2218726
TGCGAATT
>HH735704.1 Sequence 11 from Patent EP2218726
AATTCGCA
>HH735703.1 Sequence 10 from Patent EP2218726
TACGGATT
>HH735702.1 Sequence 9 from Patent EP2218726
AATCCGTA
>HH735701.1 Sequence 8 from Patent EP2218726
TGGACATT
>HH735700.1 Sequence 7 from Patent EP2218726
AATGTCCA
>HH735699.1 Sequence 6 from Patent EP2218726
TAGGACTT
>HH735698.1 Sequence 5 from Patent EP2218726
AAGTCCTA
>HH735697.1 Sequence 4 from Patent EP2218726
TAGCGATT
>HH735696.1 Sequence 3 from Patent EP2218726
AATCGCTA
>HH735695.1 Sequence 2 from Patent EP2218726
TAGGCATT
>HH735694.1 Sequence 1 from Patent EP2218726
AATGCCTA
>HH735576.1 Sequence 74 from Patent WO2010086603
GCNAGNAG
>HH735573.1 Sequence 71 from Patent WO2010086603
CNACNAGC
>FW363864.1 LONG TERM DISEASE MODIFICATION USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES
NNCGNNCG
>FW367767.1 SYNTHETIC AGONISTS OF TLR9
TCNTCNTT
>FW367764.1 SYNTHETIC AGONISTS OF TLR9
TCNCNTTT
>FW362205.1 DELTA-17 DESATURASE AND ITS USE IN MAKING POLYUNSATURATED FATTY ACIDS
ACCAGCCC
>FW366084.1 Treatment of PIGS with PCV-2 antigen
CCGCCATG
>FW361383.1 NICKED OR GAPPED NUCLEIC ACID MOLECULES AND USES THEREOF
TCGGAGTT
>FW361376.1 NICKED OR GAPPED NUCLEIC ACID MOLECULES AND USES THEREOF
TCGGAGTT
>FW361364.1 NICKED OR GAPPED NUCLEIC ACID MOLECULES AND USES THEREOF
GGATCTTA
>FW361354.1 NICKED OR GAPPED NUCLEIC ACID MOLECULES AND USES THEREOF
CGATTTTT
>FW361348.1 NICKED OR GAPPED NUCLEIC ACID MOLECULES AND USES THEREOF
CTACACAA
>FW361336.1 NICKED OR GAPPED NUCLEIC ACID MOLECULES AND USES THEREOF
GGATCTTA
>FW360735.1 NUCLEIC ACID OF FORMULA (I): G(l)X(m)G(n), OR (II): C(l)X(m)C(n), IN PARTICULAR AS AN IMMUNE-STIMULATING AGENT/ADJUVANT
GGTTTTGG
>HD082882.1 Sequence 44 from Patent EP2208736
GCCAAGAA
>HD082877.1 Sequence 39 from Patent EP2208736
AAAATTAA
>HD082851.1 Sequence 13 from Patent EP2208736
TGGCTGTT
>HD082850.1 Sequence 12 from Patent EP2208736
TAGGGGTG
>HD082849.1 Sequence 11 from Patent EP2208736
TAGGTCTC
>HD081705.1 Sequence 34 from Patent WO2010075303
TGTACATA
>HD081695.1 Sequence 24 from Patent WO2010075303
TGTGCGTG
>HD081694.1 Sequence 23 from Patent WO2010075303
TTGACATA
>HD081693.1 Sequence 22 from Patent WO2010075303
TGTACGTA
>HD081692.1 Sequence 21 from Patent WO2010075303
TGTACATA
>HD078891.1 Sequence 935 from Patent WO2010075441
GGAAGAGG
>FW343160.1 A method for discriminating blueberry varieties
CTCTCTCT
>FW343158.1 A method for discriminating blueberry varieties
GAGAGAGA
>FW343157.1 A method for discriminating blueberry varieties
GAGAGAGA
>HD063449.1 Sequence 16 from Patent WO2009062604
TAAGGGTG
>HD063441.1 Sequence 8 from Patent WO2009062604
TAAGGGCG
>HD033591.1 Sequence 21 from Patent WO2010064231
TCCGGCCA
>HD033589.1 Sequence 19 from Patent WO2010064231
ACGAACCG
>HD033587.1 Sequence 17 from Patent WO2010064231
ACCACCAA
>HD033580.1 Sequence 10 from Patent WO2010064231
GCAAAAAA
>HD033581.1 Sequence 11 from Patent WO2010064231
GCAAAAAG
>HB386241.1 Sequence 12 from Patent WO2009062789
TGACGTGA
>HB386240.1 Sequence 11 from Patent WO2009062789
TGACGTGG
>FW339650.1 Dbait and uses thereof
GCTGTGCA
>FW339634.1 Dbait and uses thereof
ACGCACGG
>FW339334.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
TTCCGTAA
>FW339307.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
TCGTATTG
>FW339302.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
TCCGCTAA
>FW339294.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
TATTCGCT
>FW339293.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
TATTAGCG
>FW339285.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
TACTCGTT
>FW339282.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
TACCGTTA
>FW339278.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
TAATCGYA
>FW339277.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
TAATAMCG
>FW339261.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
GCGTAATA
>FW339235.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
CTTCGTAA
>FW339232.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
CTATCGTA
>FW339229.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
CGTATAAC
